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ABSTRACT 
 
 
Background 
Evidence indicates that sleep duration predicts increases in BMI over time and 
thus, may lead to obesity.  However, this relationship has not been explored to 
the same extent in the opposite direction and it is unclear whether there is a 
causal association between sleep duration and BMI, or vice versa. Bidirectional 
epidemiological methods can establish the direction of this association and 
genetic epidemiological methods may shed light on whether variation in BMI 
causes changes in sleep duration.  
Methods 
Observational, bidirectional analyses were carried out using the English 
Longitudinal Study of Ageing (ELSA) (Chapter 3) and a Norwegian community 
sample of children (Chapter 4). A genome-wide association study (GWAS) of 
sleep duration was then undertaken, with the aim of replicating previous, as well 
as identifying novel, loci (Chapter 5). A large-scale Mendelian randomization 
(MR) study was subsequently conducted, using genetic variants associated with 
BMI, to investigate the causal association between BMI and sleep duration in 
~142,000 individuals; this was followed by polygenic risk score (PRS) analyses to 
investigate shared genetic aetiology between the two traits (Chapter 6).  
Key findings 
In older adults, higher BMI was associated with very small decreases in sleep 
duration, over 4-year follow-up; there was no association in the opposite 
direction from sleep duration to change in BMI. There was no association in 
either direction, between BMI and objective sleep duration in the sample of 
Norwegian children. The GWAS of sleep duration did not have sufficient power 
to replicate previous, or identify novel genetic variants for sleep duration, yet 
effects were consistent with those of previous GWA studies. The heritability of 
self-reported sleep duration was 7%, which is also in line with previous GWAS. 
  6 
MR findings suggested that it is uncertain whether a causal relationship exists 
between BMI and sleep duration and thus, triangulation of results is necessary. A 
polygenic risk score of BMI was negatively associated with sleep duration, 
showing some evidence of shared genetic aetiology; however, the variance 
explained was only 0.02%.    
Conclusions 
This thesis suggests that BMI and sleep duration are weakly associated and that 
using a combination of approaches is invaluable in helping us understand this 
relationship. In older adults, it appeared that prospectively, BMI predicted small 
changes in sleep duration, whilst in children there was no prospective 
relationship in either direction. Findings from the GWAS suggest that the 
heritability of self-reported sleep duration was low. Using MR it was not possible 
to firmly conclude whether BMI causes changes in sleep duration or not and 
therefore, more research is needed to determine this. Also, BMI and self-reported 
sleep duration do not appear to have much underlying common genetic 
aetiology.  
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IMPACT STATEMENT 
The insight gained from this thesis serves to inform future research for 
investigators interested in how adiposity might affect our sleep and/or vice versa 
across the life course. In general, this is an important area as obesity has now 
reached alarming proportions across the world. Also, there is evidence to suggest 
that at least in Western countries, we are not getting sufficient sleep and the 
quality of our sleep is decreasing, with the pressures and stress of modern life. 
There is still a lot of work to be done, in terms of the relationship between other 
measures of adiposity (besides BMI) and body composition and other sleep 
parameters (besides duration). This future research is likely to be in the areas of 
epidemiology, genetic epidemiology, causal inference, psychology and biology, 
amongst others. In relation to impact outside of academia, findings from this 
thesis suggest that people should be aware of what the benefits are of getting 
sufficient sleep, as well as maintaining a healthy weight, due to the negative 
health outcomes associated with insufficient sleep and with being overweight or 
obese. However, this work does not advocate that improved sleep is necessarily a 
guaranteed benefit of weight loss, or that weight loss is likely to occur as a result 
of getting sufficient sleep.  
 
Throughout my PhD I disseminated findings as they emerged and gave a range of 
presentations, which are listed later (pages 16-17). I presented at a variety of 
events, which included conferences, workshops and seminars. Although most of 
my presentations were national, I also disseminated my work internationally, 
with presentations in Norway and Uruguay. Also, the work carried out in Chapter 
3 is published in a peer-reviewed journal, the work in Chapter 4 will be submitted 
for publication and the work in Chapters 5 and 6 contributed to a scientific paper 
which is currently under review in a scientific journal.  
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1 OBESITY: INTRODUCTION, ASSOCIATION WITH 
SLEEP DURATION AND AIMS OF THE THESIS 
1.1 BRIEF INTRODUCTION AND OVERVIEW OF CHAPTER 
CONTENTS 
Research published within the last ten to fifteen years suggests that adiposity is 
largely associated with shorter sleep duration. However, little is known about 
whether greater adiposity causes changes in sleep duration, or whether 
insufficient/prolonged sleep might cause changes in weight. It may be possible to 
use genetic epidemiological methods to investigate the causal nature of this 
relationship. The work undertaken in this thesis used a combination of 
observational and genetic epidemiology to examine the complex relationship 
between BMI and sleep duration. However, before this literature is reviewed, it is 
necessary to describe the genetics of both BMI and sleep duration, with emphasis 
on recent findings from genome-wide association studies (GWAS).  
Obesity is a medical condition characterised by an excess of adiposity, often 
leading to decreased quality of life, morbidity and/or mortality, due to related 
physical and psychological complications. It is a complex trait, influenced by both 
genetic and environmental factors. Obesity is a major public health concern, as the 
global epidemic of obesity (‘globesity’) has now reached alarming rates across both 
the developed and developing world.   
In this chapter, there is a brief introduction to obesity with current prevalence 
estimates. Next there is an overview of heritability using twin studies, followed by 
GWAS studies. The subsequent two sections describe the main approaches to 
measuring both adiposity and sleep duration, outlining pros and cons of each 
method, with a focus on the measures used in this thesis. This is followed by a brief 
synopsis of the key environmental determinants of obesity, in which the link with 
sleep duration is introduced. The next section summarises the literature on the 
molecular genetic determinants of sleep duration, centred on findings from 
GWAS. The subsequent section provides a detailed review of the extant literature 
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on the association of adiposity with sleep duration, separately for children and 
adults. This chapter ends with the rationale for this research and a description of 
the aims and objectives of the thesis, followed by a chapter summary.  
1.2 BACKGROUND 
Being obese is associated with an elevated risk of developing type II diabetes 
mellitus (T2DM), cardiovascular disease (CVD), hypertension, stroke, certain types 
of cancer, metabolic syndrome1, dyslipidemia and osteoarthritis2 and an elevated 
risk of Vitamin D deficiency3. More recently, evidence suggests an association 
between obesity and psychological outcomes, specifically psychological distress4 
and common mental disorders (CMDs) such as depression5–7 and anxiety5–9, as well 
as poorer cognitive function10.  
The prevalence of obesity has been rising steadily in the developed and non-
developed world and was formally acknowledged as an epidemic by a WHO 
consultation in 199711. The most recent systematic analysis of 128.9 million 
children, adolescents and adults, across 200 countries, estimated that the number 
of obese girls increased from 5 million to 50 million, whilst the number of obese 
boys increased from 6 million to 74 million, between 1975 and 201612. During this 
41-year period, the worldwide number of obese women increased from 69 million 
to 390 million, and the number of men with obesity increased from 31 million to 
281 million. Additionally, 213 million children and adolescents, as well as 1.30 
billion adult men and women, were in the overweight but not obese range.  
Obesity rates in the UK have increased drastically over the last four decades, such 
that in 1975 1.7 million men and 2.1 million women, were obese, compared with 
6.8 million men and 7.7 million women in 201413. Today the UK is ranked as the 
second country in Western Europe with the most excess adiposity, after 
Germany13.  
Obese individuals were once described as gluttonous and lacking in self-control; 
therefore, treatment and prevention of obesity aimed to target individual 
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behaviour11. However, obesity arises, not only due to environmental factors, but 
also to genetic ones.  
1.3 HERITABILITY 
Heritability is the extent to which phenotypic variation in a trait can be accounted 
for by genetic variation in a specific population, at a particular point in time14. It is 
important to differentiate between narrow and broad sense heritability; the former 
refers to the proportion of a trait that is accounted for by additive genetics, whilst 
the latter refers to the proportion of a trait that is due to all genetic variance. 
Heritability is commonly estimated by comparing the resemblance between 
monozygotic (MZ - identical twins, who share 100% of their genes) and dizygotic 
(DZ - non-identical twins, who share 50% of their genes) twins15.   
1.3.1 Twin studies and heritability  
Twin studies have proved invaluable in uncovering the genetic basis of complex 
traits. Their main aim is to unravel and quantify the contributions of genetic, 
shared environmental (factors shared completely by twin pairs, that contribute to 
their similarity, such as maternal gestational weight gain or family socioeconomic 
status) and non-shared environmental factors (factors unique to each twin in a 
pair that contribute to differences between twins) to such traits. The twin 
method compares the similarity of MZ and DZ twins, who usually grow up in very 
similar environments16. Similarity is measured statistically using a correlation 
coefficient and as such, if the correlation for MZ twin pairs is larger than the 
correlation for DZ twin pairs, it is taken as evidence that individual differences in 
the trait of interest (for example BMI) have some genetic basis16. A systematic 
review and meta-analysis of 88 published twin studies suggests that heritability 
estimates of BMI are high, ranging between 47% to 90%, and that heritability of 
BMI is higher at younger ages17.  
1.3.2 Molecular genetic approaches and heritability 
With the advent of GWAS (summarised below in section 1.4) in the last ten to 
fifteen years, researchers discovered that it was possible to also estimate genomic 
heritability, from the aggregated effects of all measured genetic variation 
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primarily in the form of single nucleotide polymorphisms (SNPs). SNPs represent 
single base pair changes in a DNA sequence18; thus two individuals may differ in 
one nucleotide, which could lead to phenotypic variation. For example, these 
differences could mean that person A has different susceptibility to a particular 
disease from person B. However, variance explained by single SNPs identified 
from GWAS appear to explain only a small proportion of the heritability for the 
majority of traits, even when added together to create genetic risk scores 
including all identified risk variants.  
To address this and enable the estimation of variance explained by all SNPs (SNP 
heritability) on a chromosome, or genome-wide SNPs, a set of tools called 
genome-wide complex trait analysis (GCTA) was created by a group of 
researchers19 (explained in more detail in the Methods section of Chapter 5). 
GCTA can also be used to estimate the SNP linkage disequilibrium (LD) structure 
(the non-random association of alleles at a particular locus, i.e. the correlation 
between SNPs), genetic relationships (using all of the autosomal SNPs, on 
chromosomes 1 to 22, GCTA can estimate genetic relationships between all of the 
individuals in a given sample), perform GWAS simulation, and estimate genetic 
correlations between traits (the extent to which the same SNPs are associated 
with variation in two traits, i.e. shared genetic aetiology). However, as GCTA 
requires individual-level genotype data to perform analyses, LD Score regression 
(LDSC) was developed recently to overcome this issue, allowing SNP heritability 
estimation using GWAS summary statistics20.  
1.4 GENOME-WIDE ASSOCIATION STUDIES (GWAS) 
A GWAS is a hypothesis-free approach which aims to find common genetic 
variants that are associated with variation in a particular trait. In GWAS, SNPs 
are used as regional genomic markers. A tag SNP is a variant whose alleles 
(different forms of a gene) ‘tag’ other SNPs that are in the surrounding LD region. 
SNPs included in GWAS usually have a minor allele frequency (MAF – the extent 
to which the less common allele occurs in the population) of at least 1%, as the 
aim is to analyse common genetic variants and those with a MAF of <1% are 
considered to be rare variants.  
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GWAS flourished with the completion of the Human Genome Project in 2003 and 
the International HapMap Project in 2005, as researchers developed new 
technologies that made it possible to carry out this type of research. The GWAS 
method advocates a ‘common disease, common variant’ hypothesis, that 
common genes are likely to influence common disorders21, and has become 
increasingly popular since it first emerged more than a decade ago. There are 
now dozens of GWAS published in major journals every month, as methods have 
become more accessible, costs of genotyping have reduced, and the field of 
Genetic Epidemiology has grown into a largely collaborative one.  
The first published GWAS by Klein and colleagues22 aimed to identify 
polymorphisms associated with age-related macular degeneration (AMD), one of 
the major causes of blindness in older adults and only one SNP was found to be 
associated with AMD. This was, at least, partly related to the narrow coverage of 
SNPs genotyped, which only contained 116,204 genome-wide tagging SNPs. 
However, researchers are now able to include many more millions of SNPs in 
GWAS, due to better genotyping arrays. Genotype imputation is the statistical 
inference of unobserved genotypes, which is done using known haplotypes in the 
population of interest23 (more details are included in Chapter 2).  
Researchers predicted that the GWAS approach would elucidate causal genetic 
variants associated with complex traits. However, this quickly proved not to be 
the case for most of these traits24 and the term ‘missing heritability’ was thus 
adopted to refer to this mismatch between the high variance explained from 
genetic variation in twin studies, and the low variance explained from the SNPs 
identified through GWAS24. One of the main issues is that as GWAS began to 
emerge it was apparent that individual SNPs had, for the most part, very small 
effects. This is directly related to statistical power in GWAS; the conventional p-
value threshold used in GWAS is p<5x10-8, which is particularly stringent because 
millions of associations are tested to examine whether each SNP has an effect on 
the trait of interest and thus, this multiple test correction is required (p<5x10-8 
applies a Bonferroni correction for millions of tests at an alpha level of 0.05). 
Therefore, it is sometimes difficult to detect SNPs of larger effects, even with 
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sizeable samples. For a GWAS to successfully uncover common variants of small 
effect, even larger sample sizes are required. Further important challenges 
proposed were: insufficient power to detect gene-gene and gene-environment 
interactions, and poorly detected rarer variants with potentially larger effects25.  
These issues in GWAS are applicable to both BMI and sleep duration, as 
illustrated below in the sections entitled: GWAS of obesity-related traits and 
GWAS of sleep duration.  
1.5 GENETIC DETERMINANTS OF OBESITY   
1.5.1 Heritability of obesity-related traits using twin studies 
Nearly 30 years ago a study showed that the BMI within-pair correlations for MZ 
twins were 0.70 for males and 0.66 for females26, while correlations within DZ 
were considerably lower (0.30 for males and 0.50 for females), indicating that 
genetic variation contributes importantly to individual difference in BMI. Further 
evidence comes from studies of adopted children, whose weight correlate more 
highly with that of their biological, as opposed to adoptive, parents27. This 
suggests that human body weight has an important genetic basis. 
1.5.2 Genome-wide Association Studies (GWAS) of obesity-related traits 
GWAS use contemporary molecular genetic methods to estimate the heritability 
of complex traits, for example, GCTA19 and more recently, LDSC regression28. 
GCTA and LDSC regression estimate heritability by considering the contribution 
of each single nucleotide polymorphism (SNP) measured in the study.  Therefore, 
GWAS find substantially lower heritability estimates than twin studies for obesity-
related traits. For example, the largest and most recent GWAS estimate of the 
heritability of BMI was 21%29.  
Moreover, GWAS have proved very successful in identifying specific genetic 
variants associated with obesity-related traits1,29–36. Exactly a decade ago a 
genome-wide scan for type-2 diabetes-associated genes found that a variant in 
the intron of the fat mass and obesity associated (FTO) gene, on chromosome 16 
(rs9939609), predisposes to diabetes through its effect on BMI1. This finding was 
ground-breaking at the time and was subsequently replicated in 38,759 
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individuals across thirteen cohorts. Notably, rs9939609 is associated with altered 
BMI and obesity in children by the age of seven, indicating an upward trajectory 
for fat mass. In humans, the FTO gene is predominantly expressed in several 
nuclei of the hypothalamus, the primary centre for energy homeostasis30. FTO 
spans over 400kb and rs9939609 is located in its first and largest intron30. It was 
recently discovered that variants in the FTO gene exert their action on adipocyte 
function by targeting the Iroquois-class homeobox protein 3 (IRX-3) and the 
Iroquois-class homeobox protein 5 (IRX-5)37. Evidence from mice, humans and in 
vitro studies indicate that the IRX3 promoter region interacts with the FTO 
obesity-associated noncoding region. Obesity SNPs are associated with IRX3, but 
not with expression of FTO, as knockout of IRX3 in mice results in a significant 
decrease in body weight, greater activation of brown adipose tissue and higher 
levels of energy expenditure38. A study in humans showed that the SNP rs1421085 
(an intron in the FTO gene) caused activation of IRX3 and IRX5 expression and a 
shift to energy-storing white adipocytes from energy-dissipating beige 
adipocytes37. This suggests that rs1421085 may play a role in genetic 
predisposition for obesity, but this study was only carried out in lean healthy 
adults.  
Following this large-scale GWAS in 2007, various other independent studies in 
both adults and children from different ethnic populations, including Europeans 
39–44, Asians45–48 and Africans49–53 found associations between FTO SNPs and 
obesity-related traits, such as larger hip circumference, body weight and waist to 
hip ratio30. A GWAS carried out in >4,000 Sardinians found that for example, the 
rs9930506 SNP, within the FTO gene, showed strong associations with BMI, hip 
circumference and weight54. The association between rs9930506 and BMI was 
replicated both in a European American population (n=1,496) and in a Hispanic 
American population (n=839), with very modest sample sizes. At the time, these 
authors estimated that approximately another 250 unknown loci of similar effect 
size to those they described, alongside a larger number of loci with smaller effects 
on BMI, had yet to be identified.  
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Common variants in the region near the melanocortin-4 receptor (MC4R) gene 
were also found to be associated with fat mass, weight and increased risk of 
obesity when analysing GWAS from 16,876 individuals of European ancestry31. 
Specifically, the strongest reported signal for BMI was located near MC4R, which 
was confirmed in 60,352 adults. This finding is important as it implicates the 
MC4R gene, mutations of which result in monogenic severe childhood obesity31. 
Associations between BMI and variants within or near the MC4R and FTO genes 
were further confirmed, alongside 6 novel loci near the following genes: TMEM18, 
KCTD15, GNPDA2, SH2B1, MTCH2 and NEGR155. Another genome-wide scan of 
>30,000 individuals (predominantly Icelandic, N=25,000) also replicated 
previously associated BMI variants, and found an additional 7 SNPs on 
undiscovered pathways32. These novel BMI variants are located within or near the 
brain derived neurotrophic factor (BDNF) gene, of which rs6265 had been 
previously implicated in eating behaviour33 and BMI34. 
The Genetic Investigation of ANthropometric Traits (GIANT) Consortium 
subsequently performed a much larger two-stage meta-analysis of 249,796 
European individuals and identified 18 novel loci associated with BMI35, bringing 
the total number to 32. Particularly motivating was the novel association between 
BMI and 7a copy number variant (CNV) near the G protein-coupled receptor, 
class C, group 5, member B (GPRC5B) gene, which is thought to modulate insulin 
secretion, and greater protein expression is associated with type-2 diabetes36. Of 
the remaining 17 novel loci, interestingly, some mapped near important 
hypothalamic energy balance regulatory genes, including: MC4R, 
proopiomelanocortin (POMC), SH2B adapter protein 1 (SH2B1) and BDNF genes. 
Another of these novel loci is located nearby the gastric inhibitory polypeptide 
receptor (GIPR) gene, suggesting a potential link between incretins (metabolic 
hormones), insulin secretion and human body weight regulation.  
A more recent GWAS and Metabochip meta-analysis of BMI in 339,224 
individuals revealed a total of 97 genetic loci, of which 56 were novel29. Taken 
together, these loci account for 2.7% of the variation in BMI. These findings 
provide further support for the roles of key obesity-related molecules including 
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BDNF and MC4R. Moreover, there appears to be overlap between loci associated 
with BMI and genes and pathways involved in neurodevelopment.  
1.6 INTRODUCTION TO SLEEP AND CONSEQUENCES OF SHORT 
SLEEP 
Human adults spend on average one third of their lives asleep. Sleep is defined as 
the shift in consciousness which leads to involuntary processes and is required by 
humans on a daily basis. Sleep is crucial for preserving psychological and physical 
well-being and is not simply a lifestyle choice; like eating and breathing, it is a 
necessity. Important sleep dimensions include: duration, defined as the number 
of hours slept per night, timing or chronotype, which refers to individuals’ sleep 
schedule, and sleep quality, which refers to an individual’s satisfaction with their 
sleep. 
Similarly to obesity, sleep is a particularly complex phenotype, not solely because 
of how it manifests itself but also because of how it is regulated56. Hence it is 
crucial to understand the mechanisms by which sleep is regulated, which are 
twofold: homeostatic and circadian57. This is also known as Borbely’s two-process 
model58, and it is  the dominant model of sleep regulation. 
The homeostatic process increases as a function of hours of wakefulness and 
decreases as we sleep. Therefore, the longer we are awake, sleep pressure or the 
‘homeostatic drive’ increases and the desire to sleep becomes greater.  Once we 
fall asleep, this pressure is relieved and because it is a cyclic process it repeats 
itself, with sleep pressure increasing again during wakefulness and then 
decreasing once we fall asleep again, and so on. Although the specific 
biochemical process that controls homeostasis is less well understood than the 
circadian process, research suggests that sleep pressure intensifies due to a build 
of the molecule adenosine. Adenosine is a nucleoside (an organic compound, 
which is released during the breakdown of nucleic acids) and it is currently the 
only known substance that contributes to sleep regulation during homeostasis. 
Adenosine accumulates in the brain for as long as we stay awake and makes us 
feel sleepy, as it binds to cells in the forebrain and inhibits their activity. During 
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sleep adenosine decreases and glycogen energy stores take its place. However, 
stimulants such as caffeine block the effects of adenosine and thus keep us 
awake.   
The circadian process influences the duration, quality and timing of sleep onset 
and offset, and is governed by the ‘biological clock’, whose cycle lasts 
approximately 24 hours. The biological clock acts as an internal pacemaker and 
regulates the timing of sleep as well as other physiological rhythms that play a 
role in sleep, such as body temperature and secretion of melatonin and cortisol. 
It is located in the suprachiasmatic nucleus (SCN), which is a very small region of 
the hypothalamus and comprises approximately 20,000 nerve cells that respond 
to light through the retina and optic nerve. The 24-hour light-dark cycle is the 
most important external cue that synchronises the biological clock to the timing 
of the natural rotation of the Earth, and therefore this cycle helps regulate the 
homeostatic and circadian processes, whereby decreased sleep pressure 
corresponds to the circadian process that promotes wakefulness. External factors 
such as temperature, physical activity and dietary intake can also affect the 
timing of the biological clock.  
Human infants and children spend a large amount of their time asleep, which 
then tends to plateau in adulthood. Young adults and adults require between 
seven and nine hours of sleep for optimal health, whilst older adults should sleep 
between seven to eight hours per night. However, sleep curtailment has 
increased in the UK59 and has coincided with the obesity epidemic. Evidence 
suggests that the proportion of people sleeping for less than the recommended 
amount is increasing and that due to insufficient sleep the UK economy loses 
200,000 working days per year at a cost of £40 billion59. Germany, another large 
European economy, also loses 200,000 working days per year, at a cost of $60 
billion, due to insufficient sleep59.  
Important predictors of reduced sleep are smoking and alcohol consumption, 
whilst physical inactivity predicts short sleep duration60. Furthermore, meta-
analyses of published studies find that short sleep duration (usually defined as 
less than or equal to five hours, or in some studies less than six hours per night) 
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is predictive of diagnosis or death from CHD and stroke61, as well as greater risk 
of T2D62,63, hypertension64 and all-cause mortality65,66. On the other hand, 
although less prevalent than short sleep, long sleep (usually defined as more than 
eight or nine hours per night) is also associated with greater risk of CHD, stroke, 
total CVD61, T2D62,63.   
1.6.1 The Sleep Cycle 
Mammalian sleep is divided into two broad categories: Non-Rapid Eye Movement 
(NREM) sleep and Rapid Eye Movement (REM) sleep. The sleep cycle is made up 
of four sequential stages (Figure 1.1), which alternate between NREM and REM 
sleep in such a way that throughout a typical night the cycle is repeated 
approximately every ninety minutes. The initial stage NREM stage is 
characterised by light sleep and drifting between wakefulness and sleep. The 
onset of sleep occurs during the second stage, whereby we become disengaged 
from our surroundings, and body temperature decreases. Stage 3, or slow-wave 
sleep (SWS) is regarded as the stage when the most restorative and deep sleep is 
experienced. As blood pressure decreases, breathing becomes slower, muscle 
tone is reduced, there is an increase of blood supply to muscles, growth and 
repair of tissue occurs, energy is restored, and hormones are released (for 
example, Growth hormone). REM sleep is characteristic of the fourth stage and 
happens for the first time approximately ninety minutes after falling asleep, 
recurring every ninety minutes thereafter. This type of sleep supplies energy to 
the brain and body, which allows the brain to be active for dreaming, and the 
body is immobilised and relaxed, as muscle tone is reduced even further. It is 
crucial to experience all four stages of sleep in order to wake up feeling rested.  
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Figure 1.1 The Sleep Cycle67 
 
 
 
1.7 GENETIC DETERMINANTS OF SLEEP DURATION  
1.7.1 Heritability of sleep duration using twin studies 
Currently, a modest body of research exists in the area of human sleep genetics, 
which has shown that specific sleep phenotypes (duration, timing, quality) are 
heritable68. Twin studies have estimated that genetic factors account for between 
30% to 50% of the variance in the duration, quality and patterns of sleep69–71.  
1.7.2 GWAS of sleep duration 
GWAS have described SNPs that are associated with distinct measures of sleep, 
however they remain largely un-replicated68,72–74, and the effect sizes of the 
identified SNPs are very small. However, the variant reported to have the largest 
effect size to date accounted for approximately 5% of the variation in sleep 
duration73, yet this has not been replicated in subsequent studies. A more recent 
and much larger GWAS of sleep duration found that the maximum variance 
explained by a single variant was 0.07%74. 
The first GWAS of sleep duration was published in 2007. Seven hundred and forty 
nine participants were genotyped for 100,000 SNPs, and the analyses examined 
associations between these SNPs and self-reported usual sleep duration72. Only 
one intergenic SNP on chromosome 13 (rs6599077) was associated with sleep 
duration at p=1.4x10-7. This means that no SNPs were associated with sleep 
NREM1 NREM2 SWS REM
75% of the night 25% of the night 
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duration at genome-wide significance, but this SNP was significant at a genome-
wide suggestive level of significance.  
More recently, three GWAS of sleep phenotypes have been published. The first 
GWAS to focus on self-reported sleep duration alone had one SNP (rs11046205) 
reach genome-wide significance 73, which is an intronic variant in the adenosine 
triphosphate-binding cassette, sub-family C, member 9 (ABCC9) gene. This gene 
is involved in encoding a potassium channel (KATP), which contributes to energy 
metabolism; it has also been associated with Cantú syndrome and dilated 
cardiomyopathy75,76. However, neither of these conditions are related to sleep. 
Another GWAS performed on 2,323 Australian individuals found no genome-
wide significant SNPs for self-reported sleep duration, sleep time, latency, quality 
or depth68. Seven SNPs, however, were suggestive of associations and these seven 
variants are located on different chromosomes and nearby or within distinct 
genes. 
The next GWAS was carried out in 47,180 individuals of European ancestry and 
found seven loci associated with self-reported sleep duration, 4 of which are on 
chromosome 2 and 3 on chromosome 6 74. A further 11 loci were suggestive of 
associations with sleep duration but did not reach the genome-wide significant 
threshold. The strongest is an intergenic variant, located on chromosome 2 near 
the paired box thyroid-specific transcription factor (PAX8). PAX8 encodes a 
nuclear protein, which is involved in the expression of thyroid-specific genes, as 
well as thyroid follicular cell development 77, whereas the Cobalamin Synthase W 
Domain-Containing Protein 2 gene (CBWD2) is highly expressed in the brain, but 
remains poorly characterised 74. This association was found to be in the same 
direction in an African-American sample, although it was not genome-wide 
significant (p=9.3*10-4).  
The most recent GWAS of self-reported sleep duration was performed in 127,573 
UK Biobank participants, from which three genome-wide significant variants 
emerged78. The main distinctions between this study, by Jones et al78 and that of 
Gottlieb and colleagues74 were the following: the sample size was almost three 
times greater; SNP heritability was estimated and, rather than combining several 
  36 
studies in a meta-analysis they were able to use a single, very large sample. Only 
three novel loci were found to be associated with self-reported sleep duration: 
rs62158211, rs17190618 and rs1380703 on chromosome 2. The effect alleles for each 
of these two SNPs were associated with a 2-minute decrease in sleep duration, 
whilst the effect allele for rs1380703 was associated with a 1.5-minute increase in 
sleep duration. rs62158211 is an intron in the PAX8 gene and is in high LD with 
two variants previously reported by Gottlieb and colleagues74.  Thus, Jones et al. 
(2016)78 were the first to replicate an association in the same region as previously 
reported.  rs17190618 and rs1380703 are both intronic variants within the Vaccinia 
Related Kinase 2 (VRK2) gene. GWAS have found this gene to be associated with 
schizophrenia79 and epilepsy80 although not these specific sleep duration 
variants.  
The current GWAS literature suggests that there are three SNPs associated with 
self-reported sleep duration. The most recent study in the UK Biobank78 was 
substantially larger than earlier studies, but still only managed to uncover two 
novel loci, with one replicated from previous research. Thus, to date there are 
only three SNPS associated with self-reported sleep duration.  
In terms of how these studies have contributed to our understanding of the 
biology of sleep, the PAX8 gene (for which SNPs associated with sleep duration 
were identified in the GWASs by both the CHARGE and the UKB studies) 
encodes a protein which is involved in the expression of thyroid-related genes. 
PAX8 is associated with hypothyroidism and patients that do not receive 
treatment for this disease are more likely to have obstructive sleep apnoea (OSA) 
episodes81. Mutations in the PAX8 gene, amongst others, may result in the 
thyroid stimulating hormone receptor (TSHR) gene being only partially activated. 
Whilst this is important, as the prevalence of hypothyroidism is approximately 
2% (UK)82, the PAX8 gene is not highly expressed in the hypothalamus, for 
example, which is responsible for the regulation of sleep in the brain.  
Variants in the VRK2 gene have been associated with schizophrenia, a psychiatric 
illness which is known to have consequences for patients’ sleep83. Evidence 
suggests that sleep disturbances may contribute to the onset of psychosis in 
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young people84. However, similarly to the PAX8 gene pathways, this may not be 
so informative when it comes to the average sleep duration of the population, as 
these pathways relate to specific diseases, such as schizophrenia and 
hypothyroidism. Thus, more research is needed to uncover common genes that 
may predispose to increases or decreases in sleep duration.   
1.8 MEASURING ADIPOSITY AND SLEEP DURATION  
1.8.1 Brief overview of adiposity measures 
Numerous methods exist for measuring adiposity, yet they vary in accuracy and 
cost. The most common measurements include: body mass index (BMI), waist 
circumference (WC), waist-to-hip ratio (WHR), bioelectrical impedance and 
skinfold thickness85. However, magnetic resonance imaging (MRI), computerized 
topography (CT) and dual energy X-ray absorptiometry (DEXA) are the most 
widely used “reference measurements” 85. BMI, WC and WHR are all simple to 
collect, as well as inexpensive, which is also the main reason these measures are 
most commonly used in large-scale scientific studies. MRI and CT and DEXA 
scans are more likely to be employed in validation studies of body measurement 
methods. It is well accepted that CT and MRI imaging provide the highest 
accuracy when it comes to measuring organ, tissue, whole-body fat mass, in 
addition to lean mass and bone mass85.  
In this thesis, the main measurement of adiposity analysed was BMI, the reasons 
for which are: accessible datasets all had measured BMI (as opposed to BMI 
calculated from self-reported height and weight); and to date, a total of 97  
genetic variants have been associated with BMI86. This is important when using 
genetic epidemiological methods, such as Mendelian Randomisation, to 
investigate causality between a given exposure and outcome (Chapter 6).  
1.8.1.1 Body Mass Index (BMI) 
BMI is calculated by dividing weight by height squared (kg/m2). A BMI equal to 
or greater than 25 kg/m2 is in the overweight range, whilst individuals with a BMI 
equal to or greater than 30 kg/m2 are classed as obese. BMI is the most commonly 
employed measure of adiposity because it is easy to calculate, cost-effective, has 
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standardized cut-off points, is typically highly correlated with body fat levels, and 
is predictive of chronic diseases and early mortality85. BMI also benefits from 
reliable reference data for children; children’s adiposity varies with age and sex so 
these factors must be taken into account when using paediatric BMI, and this is 
done by comparing the child’s BMI to reference data87.  
However, the reliability of BMI in adults as a measure of adiposity has been 
questioned due to its lack of ability to differentiate between fat and fat-free mass, 
for instance, bone and muscle mass1,88,89. Other disadvantages of BMI are:  it is an 
indirect measurement of adiposity; it has a reduced ability to predict body fat in 
older adults compared to younger and middle-aged adults88,90; its nonlinear 
relationship with percentage of body fat, and that it differs for men and women; 
and its weak sensitivity and specificity90. Regarding sensitivity, some research 
suggests that BMI can lead to false-negative results and in terms of specificity, 
one study observed that BMI incorrectly classified 8% of all men and 7% of all 
women as obese, using standard BMI cut-off points90.  
1.8.2 Brief overview of sleep duration measures 
Sleep duration can be measured in several ways, which broadly fit into subjective 
and objective methods. Self-reported sleep duration usually involves asking how 
many hours individuals sleep per night, whilst objective sleep studies either 
monitor participants in a laboratory setting or ask them to wear a device to track 
their sleep duration. The most widely known objective sleep duration methods 
are: polysomnography (PSG) and actigraphy. PSG is considered to be the gold 
standard for the diagnosis of some sleep disorders91. Actigraphic sleep duration is 
measured using a wearable wrist or waist device and a questionnaire is usually 
administered alongside it. This questionnaire aids interpretation of the 
actigraphic data, as it asks questions about whether individuals are equally as 
active/inactive and whether they have been ill during the time that they wear the 
actigraph.  
The research carried out in this thesis predominantly used self-reported sleep 
duration measures, with the exception of actigraphy-measured sleep duration in 
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the TESS study (Chapter 4). Thus, in this section there is a description of 
actigraphy and self-reported sleep duration. 
1.8.2.1 Self-reported sleep duration 
Self-report sleep duration is widely used in epidemiological research. . Other 
dimensions of sleep such as disturbance and quality are commonly measured by 
means of reliable and valid scales, for example the Pittsburgh Sleep Quality Index 
(PSQI)92, the Epworth Sleepiness Scale (ESS) 93 or the Jenkins Sleep Scale (JSS)94. 
A sleep duration item also forms part of some of these questionnaires.  
The main advantages of self-report sleep duration measures are: they are 
inexpensive and easy to administer, particularly in large studies, as one or two 
questions can usually be asked as part of a larger questionnaire; they are simple 
to code and to analyse, as a typical question asks about the number of hours an 
individual sleeps for, thus researchers can choose to use this or for example, 
convert to minutes if required. The majority of studies measure sleep using self-
report, due to these advantages, thus comparison with other research is always 
possible. Also, as mentioned earlier, these measures have criterion validity as 
evidence shows that both self-reported short and long sleep duration are 
predictive of CHD61 (short sleep RR=1.48, long sleep RR=1.38), stroke61 (short 
sleep RR= 1.15, long sleep RR=1.65), type-2 diabetes mellitus63 (short sleep 
RR=1.09, long sleep RR=1.14) and mortality66 (short sleep RR=1.12, long sleep 
RR=1.22).  
However, there are also limitations of using subjective sleep duration. First, there 
is potential for measurement error, as people might not accurately report how 
many hours they sleep for various reasons. For instance, they may not know and 
may be inclined to guess, they may have irregular sleep patterns making it 
difficult to estimate, or they may not want to provide a true report if they have 
atypical sleep durations (short or long sleep, for example). Second, some 
individuals may report the number of hours they sleep from the time they 
actually go to bed, rather than the time they fall asleep. This time between full 
wakefulness and sleep onset is known as sleep latency and is distinct from sleep 
duration. Notably, though, most normal sleepers, who do not suffer from a sleep 
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disorder (particularly, insomnia) report similar sleep duration estimates to those 
observed in the laboratory, under polysomnography (PSG)95. Third, the 
correlation between objective and subjective sleep duration was reported to be 
around 0.45 by Lauderdale and colleagues96, whilst another study found that in 
34% of participants there was a discrepancy of an hour or more between sleep 
diaries and actigraphic sleep duration97, and more recently, a correlation of only 
0.3  was found between subjective and actigraphic sleep duration98.  
1.8.2.2 Actigraphy 
Actigraphy has been used for more than twenty-five years in the assessment of 
sleep/wake states99. An actigraph is conventionally worn on the wrist of the non-
dominant arm and continuously detects and records body movement 
(predominantly acceleration), and stores the information for long periods of time 
100. However, waist-worn actigraphs are also used for the measurement of sleep 
parameters, as well as for the detection of movement and activity. In addition, it 
is now possible to also collect data using applications on smartphones, as well as 
smart watches.  
Actigraphy is popular for determining patterns of sleep and circadian rhythms 
and, unlike PSG, does not require subjects to spend time in a laboratory, can be 
worn for several weeks, is more affordable for data collection in large-scale 
studies and is less invasive than PSG, particularly for use in infant and elderly 
populations101. Although PSG is regarded as the gold standard for measuring 
sleep/wake behaviours, actigraphy can in fact, provide more reliable 
measurements, as data are collected over several days, rather than for one or two 
nights in the laboratory102. It is also likely to be more ecologically valid, as 
actigraphy measures habitual sleep in an individual’s usual environment, as 
opposed to in a lab, which is an unnatural setting to sleep in and could affect 
sleep.  
Whilst data are being recorded via actigraphs it is possible to continue with daily 
activities and enables individuals to remain in their natural sleep environments. 
Actigraphs are now used in the clinical diagnosis and evaluation of insomnia, 
extreme sleepiness, restless legs syndrome and circadian rhythm disorders102. 
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When using actigraphy, algorithms are employed to calculate sleep and wake 
periods, based on individuals’ activity patterns103.  
However, there are also disadvantages of using actigraphy for the measurement 
of sleep duration. These devices are unable to reliably differentiate sleep stages, 
are more expensive than self-report sleep duration measures, have at times 
shown poor specificity in the measurement of sleep duration, and can sometimes 
over- or underestimate sleep duration. For example, in a study by Paquet and 
colleagues104 actigraphy showed an overall less than 50% specificity in 
determining sleep and also overestimated duration of sleep, in comparison with 
PSG. In another study of sixty-eight adult females, actigraphy underestimated 
sleep durations by an average of 68 minutes in those who slept for less than five 
hours102. This may be due to sleep disturbances causing increases in nocturnal 
movements and thus, leading to the actigraph underestimating duration of sleep. 
1.9 BMI AND SLEEP DURATION  
Obesity arises as a result of an energy imbalance, whereby energy intake 
increases relative to energy expenditure105. Aside from the physical and 
psychological health complications associated with obesity, which are mentioned 
earlier in section 1.2, an intriguing link between adiposity and sleep duration has 
been reported more recently, in both children and adults106,107. As the focus of 
this thesis is on BMI in relation to sleep duration, the literature reviewed pertains 
only to this association, rather than other measures of adiposity.  
Both the PubMed and Web of Science databases were searched for relevant 
literature of the relationship between BMI and sleep duration in adults and 
children. Below is a detailed review of the literature, firstly in adults and then in 
children, followed by summary tables of key findings.   
1.9.1 Literature Review Part I: current evidence in adults for the 
association between BMI and sleep duration 
An extensive literature exists linking BMI and sleep duration in adults, particularly 
published in the last ten to fifteen years. Whilst cross-sectional evidence has 
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uncovered a consistent relationship between the two, longitudinal studies are 
limited and have yielded mixed findings.  
1.9.1.1 Cross-sectional studies using self-reported measures of sleep 
Table 1.1 summarises the key cross-sectional studies in adults that have used 
subjective sleep duration. There has been one systematic review, and one 
systematic review with meta-analysis106,107 of the cross-sectional association 
between sleep duration and BMI in adults. An early review of the literature found 
that short sleep appeared to be independently associated with increased weight 
in adults in 17 of 23 cross-sectional studies106. Of the 23 studies included in the 
review, 11 observed a clear relationship between short sleep duration and higher 
BMI, with two studies reporting mixed findings, due to an effect in one sex and 
not the other. Five studies found no evidence of an association between short 
sleep and greater weight, with one study reporting a relationship between short 
sleep and decreased weight. Furthermore, six studies suggested that the 
association is U-shaped, such that both short and long sleep are implicated in the 
risk of obesity.  
 
The only study to report that shorter sleep is associated with lower BMI was a 
Japanese cohort of over 100,000 participants108. Mean BMIs were 22.9, 22.6, 22.9 
and 22.7 kg/m2 in men who slept 4, 5, 6 and 7 hours, respectively; in women 
these hours of sleep corresponded to mean BMIs of 22.6, 22.9, 22.9 and 22.9 
kg/m2. Importantly, though, these average BMIs are indicative of a lean sample 
and thus, might not be directly comparable to populations such as the USA or 
UK.  
 
As mentioned above, U-shaped associations between sleep duration and BMI 
have been suggested by a few studies. Analysis of the American Sleep Heart 
Health Study (SHHS), indicated that the highest mean BMIs were observed in 
individuals who reported sleeping for less than six hours, six to seven hours or 9 
hours64. Respondents who slept for between seven and eight hours, or eight to 
nine hours had the lowest mean BMIs (28.4 kg/m2), in comparison with those 
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who slept for less than six hours and had the highest average BMIs (29.1 kg/m2). 
The overall sample had a mean age of 63 years and 52% of respondents were 
hypertensive. The highest proportion of individuals who had any CVD was 
observed in the shortest sleep duration group (< 6 hours), at 23%.   
Findings from Canadian individuals, aged between 21 and 64 years (N=740) 
indicated that, compared to normal sleepers (seven to eight hours), those who 
reported sleeping for five to six hours, as well as those who slept for nine to ten 
hours, had increased odds of obesity, ORs=1.69 and 1.38, respectively109. 
Studies included in Patel et al.’s review106 that yielded null findings are described 
in more detail later in this literature review. A systematic review with meta-
analysis of 604,509 adults, published at approximately the same time as the 
review by Patel and colleagues106, concluded that there was a cross-sectional 
association between short sleep and an increased risk of obesity (pooled 
OR=1.55)107 across 18 studies of adults. They also observed a pooled effect size for 
short sleep duration of -0.35 kg/m2 change in BMI per hour of sleep change. 
These findings were obtained through linear analyses of these data, whilst non-
linear associations were not considered. Although these two reviews106,107 largely 
reached the same conclusion, Patel et al.’s106 interpretation was slightly more 
tentative (as discussed earlier, they stated that findings in adults were more 
mixed than those in children). This could be because they considered different 
types of cross-sectional associations in their review, such as linear and non-linear, 
whereas Cappuccio’s107 meta-analysis only examined linear relationships.  
Since the reviews by Patel et al.106 and Cappuccio and colleagues107, several other 
cross-sectional studies on BMI and sleep duration in adults have been published. 
A study of 1,224 twins (mean age of 37), also showed that short sleep was 
associated with higher BMI, after controlling for genetic and shared 
environmental effects71. In this study, analyses were carried out in two ways. First, 
twins were treated as individuals and to account for the correlation structure of 
the data, generalised estimating equations (GEEs) were used. Then, they 
extended the GEE model and modelled within- and between-pair associations of 
sleep duration and BMI. Finally, within and between analyses were repeated after 
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stratifying by twin zygosity. Importantly, this study used both self-reported sleep 
duration and height/weight data, which the authors acknowledged as an 
important limitation.   
Sleep duration and BMI were also inversely associated in 1,248 American middle-
aged respondents110. In a subsample (n=441) of these respondents, actigraphic 
sleep duration was also assessed; the results of this part of the study are discussed 
below in section 1.9.1.3 (‘Studies of BMI and sleep using objectively-measured 
sleep duration’).  
Data from 5,021 British civil servants, aged between 34 and 55, also found an 
inverse association between sleep duration and BMI. Specifically, short sleep (≤5 
hours) was associated with higher BMI, as well as an increased risk of obesity 
(OR=1.65), compared with those who slept for seven hours111. Even after 
controlling for obstructive sleep apnoea (OSA) and physical inactivity, the cross-
sectional association between obesity and sleep duration remained, in a sample 
of 7,641 adults45. Theorell-Haglow and colleagues113 also observed that in the all-
female Sleep and Health Study, short sleepers (<6 hours) had significantly higher 
average BMIs than long sleepers (≥9 hours).  
Dashti and colleagues also observed that in 14,906 adults in the CHARGE 
consortium longer usual sleep duration was associated with lower BMI114. The 
most recently published study in 1,615 UK adults (mean age of 43 years) from the 
National Diet and Nutrion Survey Rolling Programme (NDNS-RP), also supports 
a negative association between sleep duration and BMI, having observed an effect 
of -0.46 kg/m2 per additional hour of sleep115. This finding emerged from linear 
analyses, as their cubic spline modelling yielded no relationship between sleep 
duration and BMI in this sample.  
However, there have also been studies that have found no relationship between 
sleep duration and BMI. A Japanese population-based cohort of 10,000 adults 
found no association between sleep duration and BMI116. However, respondents 
were largely lean, with a mean BMI of 23 kg/m2, their average age was 55 years 
and, at baseline, average sleep duration was 7.6 hours.  
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Two studies of older adults designed to investigate predictors of sleep duration 
found that BMI and sleep duration were unrelated. The first study analysed data 
from 8,091 participants aged 55 and over across seven European countries117. 
Obesity was not associated with being in the lowest fifth percentile of night time 
sleep duration (defined as sleep duration in the lowest fifth percentile respective 
to the age group). However, being underweight (BMI <19kg/m2) was predictive of 
long night time sleep (95th percentile respective to age). Importantly, though, 
these findings could be due to a few factors. For example, perhaps the use of 
weight categories (i.e. underweight, normal weight, overweight, obese), rather 
than modelling BMI as a continuous outcome might mean that information is 
lost and it thus becomes more difficult to find an association. This was also one 
of the first studies to investigate the relationship between BMI and sleep duration 
in older adults and also of importance, is that 21% of the sample were aged 75 
years or over. Also, the paper did not report the prevalence of overweight and 
obesity in this sample, which would have been important to know, in order to 
compare it to other studies (i.e. they may be quite lean or quite 
overweight/obese), as this can have an impact on the findings.  
The second study, in a community sample of 1,026 French adults over the age of 
60, found that, as the obese were more likely to nap during the day, there was no 
evidence of an association between total sleep duration and obesity118. Therefore, 
one potential explanation is that this association between BMI and sleep duration 
only in the obese group may have been because they were more likely to sleep for 
longer during the day (one hour or more, on average). This is in line with 
research which suggests that obese individuals are more likely to sleep for longer 
during the day119 and have shorter night time sleep durations120. Also, similarly to 
the study described above, the authors treated both BMI (exposure) and sleep 
duration (outcome) as categorical variables and although they were able to 
discern that being in the obese category was a risk factor for very short sleep (≤4 
and a half hours), it is possible that categorising continuous measures could 
contribute to loss of information, making it harder to find an association. 
Findings from both of these studies, albeit null, are in line with some research 
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that shows this association to weaken as a function of age121,122 (described below 
in 1.9.1.4).  
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Table 1.1 Summary table of cross-sectional findings in adults using subjective sleep 
duration 
Type of 
article/study 
Authors Year Sample size Outcome Main findings** 
 
 
Systematic review 
(23 studies) 
 
 
Patel & Hu 
 
 
2008 
 
 
1,275,797 
 
 
BMI 
11/23 – negative relationship 
between sleep duration & BMI 
2/23 – mixed: effects in only 
one sex 
4/23 – no relationship 
between sleep duration & BMI 
1/23 – short sleep duration 
decreased weight 
6/23 – U-shaped relationship: 
short/long sleep duration  
risk of obesity 
Systematic review 
w/meta-analysis 
(18 studies) 
 
Cappuccio 
et al. 
 
2008 
 
605,509  
 
BMI/obesity 
Pooled OR for association 
between short sleep & 
increased risk of obesity = 1.55 
Pooled continuous effect size 
for association between short 
sleep & BMI = -0.35 kg/m2* 
Observational 
study (in twins) 
Watson et 
al. 
2010 1,224 BMI Shorter sleep associated with 
higher BMI  
Observational 
study 
  1,248 BMI Shorter sleep associated with 
higher BMI 
Observational 
study 
Stranges et 
al. 
2008 5,021 BMI/obesity Shorter sleep associated with 
higher BMI 
Shorter sleep associated with 
increased risk of obesity  
Observational 
study 
Theorell-
Haglow et 
al. 
2012 7,641 BMI Shorter sleepers had 
significantly higher BMI than 
long sleepers  
Observational 
study 
Dashti et al. 2015 14,906 BMI Longer sleep duration 
associated with lower BMI 
Observational 
study  
Potter et al. 2017 1,615 BMI Shorter sleep duration 
associated with lower BMI  
Null findings 
Observational  Amagai et 
al. 
2004 10,000 BMI Respondents were mostly lean 
(mean BMI=23 kg/m2), mean 
sleep duration was 7.6 hours, 
both potentially indicative of 
a healthy sample  
Observational Ohayon et 
al. 
2004 8,091 BMI BMI was categorised, 21% of 
the sample were 75 years or 
older 
Observational Ohayon et 
al. 
2005 1,026 BMI Obese individuals slept longer 
during the day & less at night, 
both sleep duration & BMI 
were categorised 
Note. *Did not consider non-linear association; **all effects significant/not 
significant at p<0.05.  
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1.9.1.2 Prospective studies using self-reported measures of sleep 
duration 
Cross sectional studies of the association of BMI and sleep duration suggest 
predominantly positive associations with some evidence of non-linear and sex 
specific associations. However, the longitudinal evidence is equivocal, as some 
studies find no relationship between sleep duration and future BMI, whilst others 
fail to observe an association in some age groups. To date, only one meta-analysis 
and one review on the prospective relationship between BMI and sleep duration 
in adults have been published, which indicate that a negative association exists 
between sleep at baseline and weight gain, at follow-up106,123. The prospective 
literature of BMI and subjective sleep duration in adults is summarised in Table 
1.2. 
 Patel et al. (2008)106 reported two studies that indicated that this relationship 
weakened with age121,122. Briefly, Gangwisch and colleagues122 observed that the 
ORs for obesity associated with short sleep (<4 hours) compared to seven hours 
were 3.21, 1.81 and 1.71 for those aged 32-49, 50-67 and 68-86, respectively. Hasler 
et al’s121 findings showed that the obesity ORs for less than six hours sleep at age 
29 was 8.1 cross-sectionally, whilst it was 4.6 at age 34.  
Prospective analysis over 16 years in 68,183 women from the Nurses’ Health Study 
(NHS) found that the lowest BMI was observed in women whose sleep duration 
was between seven and eight hours a night. Further, women who slept ≤5 hours 
gained 1.14 kg more than women who consistently slept for 7 hours, over the 16-
year period124.  
The findings of one study suggest that longer sleep duration increases the risk of 
weight gain in 740 adults125. Over six-year follow-up findings indicated that the 
risk of becoming obese was 27% for short (five to six hours), and 21% for long 
sleepers (nine to 10 hours), in comparison to those who slept for seven to eight 
hours per night; thus, providing evidence of a U-shaped, rather than a linear 
association. The authors stated that these findings show that emphasis should be 
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placed on recommending normal durations of sleep (seven to eight hours), rather 
than merely advocating that people sleep for longer.  
There has been some prospective research in adults that has yielded null 
findings. The longitudinal association between sleep duration and weight gain 
disappeared for 1,648 Japanese males, after adjusting for time-invariant 
unobserved confounders126. The authors referred to genetic factors as potential 
time-invariant unobserved confounders (those which cannot be measured as part 
of a study), whilst other studies have also suggested social, parental and 
environmental factors as time-invariant confounders127,128. To account for this 
type of confounder, Nishiura and colleagues carried out two types of analysis on 
their data. First, they used a generalised estimating equation (GEE), which uses 
the population-averaged model and subsequently, they performed fixed-effects 
(FE) modelling. Whilst both models can account for within-person changes in 
repeated measurements over one wave, the GEE model assumes independence 
between measured exposures with error terms, yet the FE model explicitly allows 
for the covariance between exposures and time-invariant unobserved factors (for 
example, genetics) to be non-zero129. It was then assumed that any difference that 
emerged between the coefficients from the two models would mean that residual 
confounding cannot be discounted, and the FE model should provide a less 
biased result. The most important finding was that the GEE model (population-
averaged) suggested a longitudinal, negative relationship between sleep duration 
and BMI, but the FE model yielded no association. It was therefore suggested that 
the longitudinal association of sleep duration with changes in BMI may 
frequently be overestimated by such unobserved time-invariant factors, as 
opposed to misclassified sleep duration and that therefore, the net effect of sleep 
duration on BMI may not be as large as the effect found by some studies.  
Stranges and colleagues failed to find a prospective association between short 
sleep duration and changes in body mass index, or with obesity incidence in the 
Whitehall II study107. They stated that although they did not find a significant 
prospective relation, their results were in concert with those described earlier, for 
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example, by Hasler et al.121, and Gangwisch et al.122, whose research suggested that 
the association between sleep duration and BMI weakens with age.  
Table 1.2 Summary table of prospective findings in adults using subjective sleep 
duration 
Type of 
article/study 
Authors Year Sample 
size 
Outcome Follow-up 
period 
Main findings * 
Positive findings 
Observational 
study 
Chaput et 
al. 
2007 740 BMI  6 years U-shaped relationship: 
short/long sleep duration  + 
BMI/+ risk of obesity 
Systematic 
review  
(3 studies) 
Patel & 
Hu  
2008  78,267 BMI 9, 13 & 16 
years 
3/3 – short sleep duration 
associated with increased risk of 
obesity 
Meta-analysis 
(11 studies) 
Wu et al. 2014 197,906 Obesity 1 to 12 
years 
Pooled OR for association 
between short sleep duration & 
obesity = 1.25 (8/11 studies, as 3 
affected heterogeneity) 
Null findings 
Type of 
article/study 
Authors Year Sample 
size 
Outcome Follow-up 
period 
Possible reasons for null 
association  
Observational 
study 
Nishiura 
et al. 
2014 1,648 BMI 3 years Authors used an FE* model as a 
second approach, which accounts 
for time-invariant covariates (e.g. 
genetics)  
Observational 
study 
Stranges 
et al. 
2008 5,021 BMI 5 years  In line with some previous 
research, which suggests that the 
association weakens with age 
Note. FE=fixed effects; *all effects significant/not significant at p<0.05. 
 
1.9.1.3 Studies of BMI and sleep using objectively-measured sleep 
duration 
It has been suggested that employing objective measures of sleep duration may 
help to elucidate a more accurate relationship between sleep and obesity 106 and 
prevent potential misclassification of sleep duration, as evidence has shown 
systematic discrepancies between self-reported sleep and sleep measured using 
actigraphy130. There have only been three studies in adults using objective sleep 
measurements, to date. These are summarised in Table 1.3 below. 
1.9.1.3.1 Cross-sectional studies  
A U-shaped association between sleep duration – measured with actigraphy – 
and BMI and obesity, was also found in a study of 983 elderly adults. Compared 
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to normal sleepers (7 to 8 hours), short sleepers (<5 hours) and long sleepers (>8 
hours) were more likely to be obese, ORs=2.76 and 2.93, respectively130. However, 
the authors also measured sleep disturbance and found that after adjusting for it 
the association between short sleep duration and obesity was no longer 
significant, whereas there was no change to the relationship between long sleep 
and obesity. Importantly, there was no association between self-reported sleep 
duration and BMI/obesity in this study, thus the findings differed according to 
measurement method for sleep duration.  
Objective measures were used by a Brazilian study to examine the association 
between BMI and sleep duration, in 1,042 adults131, and found that those with a 
higher BMI had shorter sleep durations. Furthermore, a study by Mezick and 
colleagues110 measured actigraphic sleep duration in 441 respondents of the 
MIDUS study in which they found that shorter sleep was related to a higher BMI. 
This finding supported the association between self-reported sleep duration and 
BMI yielded by an analysis of the entire sample (1,248 respondents).     
As illustrated above, there is very little epidemiological cross-sectional research 
that has exploited objective sleep duration in adults. Whilst both of the studies 
described yielded results in line with the majority of studies which employ self-
reported sleep duration, more research is needed to confirm these findings. Some 
studies, however, have found no cross-sectional relationship between BMI and 
sleep duration. Lauderdale and colleagues132 were amongst the first to examine 
BMI and sleep duration employing objective sleep measurements, in a sample of 
38 to 50 year-olds from the CARDIA Study. However, their inverse, weak 
correlation between sleep duration and BMI was not statistically significant. In 
this study, average sleep duration was only 6.1 hours, which is lower than usual 
for a population-based study. This may be reflective of the differences in 
ethnicity that they observed, for example, mean sleep duration in White women 
was 6.7 hours, whilst in Black men it was 5.1 hours. These disparities appeared 
not to be explained by social position as those with a higher income and 
education spent less time asleep. Also notable was that the sample size was not 
particularly large, with a total n of 669.  
  52 
1.9.1.3.2 Prospective studies 
It appears that to date, the only prospective study of BMI and objectively-
measured sleep duration was carried out in the CARDIA Sleep Study133.  Sleep 
duration did not predict significant prospective changes in BMI in the CARDIA 
Sleep Study133. Lauderdale and colleagues observed that cross-sectionally, shorter 
sleep (4.5 hours) was associated with the highest BMIs, whilst those who slept 
for more than seven and a half hours had the lowest BMIs. Thus, their cross-
sectional results were in concert with several previous studies. However, their 
longitudinal analyses showed that over 5-year follow-up actigraphic sleep 
duration did not predict changes in BMI.  
There are some potential explanations for these null findings. Firstly, 
respondents’ mean age at baseline was 45 years, thus at follow-up their average 
age was around 50 years. As mentioned earlier, there is evidence to suggest that 
the magnitude of the association between sleep duration and BMI weakens with 
age111,121,122. Secondly, it is possible that five years was not sufficient to observe a 
significant change in BMI, as BMI tends to be fairly stable. Thirdly, this study was 
conducted in a sample of only 667 individuals, which may have been 
underpowered to detect small changes in BMI over time.  
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Table 1.3 Summary table of literature in adults using objective sleep duration 
Type of 
article/study 
Authors Year Sample 
size 
Outcome Main findings/ possible reasons for null 
findings 
Positive findings – cross-sectional 
Observational Van den 
Berg et al. 
2008 983 BMI U-shaped relationship: short/long sleep 
duration  risk of obesity (not 
significant after adjustment for sleep 
disturbance)  
Observational Moraes et 
al. 
2013 1,042 BMI  Short sleep duration associated with 
higher BMI   
Observational Mezick et 
al. 
2014 441 BMI  Short sleep duration associated with 
higher BMI   
Null findings – cross-sectional 
Observational Lauderdale 
et al. 
2006 669 BMI Mean sleep duration was low (6.1 hours); 
modest sample size; ethnic differences 
observed between White and Black 
individuals 
Null findings – prospective  
Observational  
(5-year follow-
up) 
Lauderdale 
et al. 
2009 667 BMI Association weakens with age*; follow-
up may not have been long enough; 
modest sample size 
Note. *mean age at baseline was 45 years (50 years at follow-up); *all effects 
significant/not significant at p<0.05. 
1.9.1.4 Sex differences in the association of BMI with 
(objective/subjective) sleep duration in adults 
As mentioned above, there is some evidence to suggest that the association 
between BMI and sleep duration might be moderated by sex. For example, a 
study of 35,247 Japanese adults showed that both short and long sleep duration 
were associated with a weight increase and risk of obesity at one-year follow-up 
in males, but not in females134. Of the non-obese men at baseline, 5.8% became 
obese after a year and the adjusted ORs for those who slept less than five hours 
and five to six hours were 1.91 and 1.50, respectively.  
 
It is possible that this study found no prospective effect in women because new 
overweight and obesity at one-year follow-up were, according to the authors, 
both quite low in women, at 12.5% and 2.4%, respectively. However, 12.5% 
appears, in fact, to be quite a high proportion of incident overweight at one-year 
follow-up. The overall percentage of obesity and overweight in women at follow-
up was not reported. However, a comparison was drawn between a previous 
study of 24,456 Japanese women, which found that 19.4% of them were obese and 
  55 
the National Government’s 2006 Health and Nutrition Survey found that 21.4% of 
women over the age of 20 were obese. Therefore, it might be valuable to perform 
further prospective analyses in this sample to carry out further follow-up of the 
women in this sample.  
Mezick and colleagues found evidence of an inverse association between 
actigraphy-measured sleep duration and BMI, which appeared to be stronger in 
females110. They observed that although there was an association in the overall 
sample, sex moderated the effect of actigraphic sleep duration on BMI. Thus, in 
stratified analyses actigraphy-assessed sleep duration was associated with higher 
BMI in women only. This was in contrast to self-reported sleep duration, for 
which there was no effect modification by gender on BMI.  
1.9.1.5 Summary of evidence in adults 
The cross-sectional systematic reviews and meta-analysis, to date, have largely 
found that shorter sleep is associated with a higher BMI and increased odds of 
being obese. Prospective research has yielded mixed findings in adults, such that 
some support the cross-sectional literature. It is possible that this discrepancy in 
findings is due to differences between studies. For example, studies categorise 
sleep duration differently, some studies use BMI and/or sleep duration as 
categorical instead of continuous and there are disparities in adjustment for 
covariates across studies. Also, importantly, as mentioned earlier the association 
between BMI and sleep duration appears to weaken with age (although few 
studies have been carried out in older adults).  
Some cross-sectional and prospective studies observe a U-shaped relationship, 
such that both short and long duration of sleep are related to higher BMI and 
greater odds of obesity. However, the majority of studies have found a linear 
association, yet this is also potentially a result of most studies having not 
explored non-linear relationships in their data. Thus, more research is needed, in 
which the linear and non-linear, cross-sectional and prospective associations of 
BMI with sleep duration are explored in detail, in large, representative samples.  
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Furthermore, some studies have observed no association between sleep duration 
and BMI/increased risk of obesity, whilst certain studies find a cross-sectional, 
but not a prospective relationship. Moderation by sex has also been suggested by 
some research and a few studies have found an association between sleep 
duration and BMI in one sex, but not the other, for which some explanations 
have been explored earlier (in section 1.9.1.4).  
Importantly, to date, studies have neither investigated the bidirectional 
relationship of BMI with sleep duration, nor have they performed causal 
modelling of this association. Thus, the direction of this association in adults 
remains unclear and whether BMI causes changes in sleep duration, or sleep 
duration might cause changes in BMI is also uncertain.  
1.9.2 Literature Review Part II: current evidence in children for the 
association between BMI and sleep duration 
There is a large body of literature on the relationship between BMI and sleep 
duration in children. The majority of the evidence points toward a clear link 
between the two, particularly in terms of long-term weight gain as a result of 
shorter sleep106,107,135,136. However, these studies have predominantly investigated 
whether sleep duration is associated with future higher BMI and risk of obesity 
and only two studies137,138 to date, have examined the bidirectional relationship 
between sleep duration and BMI (discussed below). At the end of this literature 
review, tables are provided to summarise the evidence in children (Tables 1.4, 1.5 
and 1.6). Cross-sectional and prospective studies that use subjective sleep 
duration are summarised in Tables 1.4 and 1.5, respectively, whilst research that 
uses objective sleep duration is summarised in Table 1.6.  
1.9.2.1 Cross-sectional studies using subjective sleep duration 
A summary table of the cross-sectional paediatric literature of BMI and subjective 
sleep duration is provided below (Table 1.4). Cross-sectional evidence in children 
predominantly supports an association between lower sleep duration and greater 
weight and adiposity106,107,139,140. The first meta-analysis (that of Cappuccio and 
colleagues, the adult findings of which are discussed earlier) of obesity and sleep 
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duration in children107 included 30,002 children from 12 cross-sectional studies 
and concluded that shorter sleep was associated with significantly greater odds of 
obesity (pooled OR=1.89). In addition, two systematic reviews106,135, another meta-
analysis135 and a further review140 also concluded the same.  
Some studies classified short sleep as <10 hours or ≤10 hours, whilst others 
defined it as <8 hours per day, ≤6 hours per night or ≤3 hours. Irrespective of this 
variability in defining sleep duration, results were consistent across paediatric 
studies, which might be because studies used age-specific cut-offs for short sleep 
duration, as a form of standardisation. This association appeared to be stronger 
in children, when compared to studies in adults, which were less uniform, 
suggesting that this relationship may weaken with age, when drawing specific 
comparisons between paediatric studies and geriatric studies. This was further 
supported by evidence which shows that the cross-sectional association of short 
sleep with weight weakened with increased age in two studies121,122. This was in 
contrast to the claim made by Cappuccio and colleagues in the earlier meta-
analysis, whereby they stated that effects were of similar magnitude between 
children and adults107.  
However, as the meta-analyses and systematic reviews described above did not, 
of course, include studies that emerged after their publication, these are reviewed 
separately. Pileggi and colleagues141 investigated BMI in relation to parent-
reported sleep duration in 10-year old children and found that children 
categorised as short sleepers had significantly higher BMI standard deviation 
scores (SDS) (0.77 kg/m2), as compared to normal sleepers. In a sample of obese 
7- to 16-year-olds it was apparent that those who slept fewer hours (n=50) were at 
significantly higher risk of severe obesity142. However, it was unclear how many 
hours of sleep was classified as short sleep in this study.  
A recent Chinese study of 8,760 children aged between 6 and 18 years143 found 
that short sleep duration (defined as ≤7 hours) was associated with obesity 
among girls, but in boys this effect was only apparent in those aged between 13 
and 18 years. They also observed that the odds of obesity in relation to short sleep 
were decreased in boys between 6 and 12 years of age. Although Cao and 
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colleagues’143 overall findings are comparable to those of studies from other 
countries, it is important to consider these differences in the categorisation of 
sleep duration. Recent findings from 6,576 Chinese children144, 303 Mexican 
American children145, 17,769 Japanese children146 and 1,810 Chilean school 
children147 also support a cross-sectional relationship sleep duration and 
BMI/increased risk of obesity.   
Findings from most cross-sectional research are suggestive of a relationship 
between shorter sleep and higher BMI and risk of overweight/obesity. However, 
for different reasons, some studies have reported null associations between sleep 
duration and obesity measures. Klingenberg and colleagues148 observed no 
association between parent-reported sleep duration and BMI in a sample of 211 
Danish 3-year olds, in analyses adjusted for multiple covariates. The lack of effect 
could possibly be because families in this sample tended to have high educational 
attainment, were wealthy and all resided in the Copenhagen region of Denmark, 
as well as the small sample size (n=311). This has implications for 
representativeness of their findings, in particular due to the potential lower risk 
of becoming obese and developing poor sleep habits, for example.  
A recent study of 1,929 8-year old Peruvian children found that 42% percent of 
the sample were short sleepers (<10 hours) and had a 15% greater prevalence of 
obesity, compared to normal sleepers (10-11 hours)149. However, after adjustment 
for several child and family-related factors (maternal and paternal education, 
maternal weight, location and wealth index), they found no significant 
relationship between sleep duration and overweight or obesity. A potential 
explanation put forward for the lack of association included the definition of 
short vs. normal sleep duration was more conservative than other studies that 
yielded a significant effect.  
A study of 3,086 Chinese children aged between seven and fourteen years found 
that, although those who were overweight or obese were less likely to sleep 
longer at the weekends, to compensate for insufficient sleep during the week, 
there was no significant relationship between weekday sleep duration and the 
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odds of being overweight or obese150. One possible explanation for this finding 
could be cultural factors that are not relevant to studies of Western children. 
In summary, very few studies have reported null findings of the association 
between BMI and sleep duration in children. It is therefore important to note the 
potential reasons (discussed above) for these findings, i.e. they had low 
prevalence of obesity, were of particularly high SES and/or defined short and long 
sleep distinctly from other studies that did find an effect.  
Table 1.4 Summary table of cross-sectional findings in children using subjective 
sleep duration 
Type of 
article/study 
Authors Year Sample 
size 
Outcome Main findings/possible reasons for null 
findings 
Systematic 
review w/meta-
analysis  (12 
studies)  
Cappuccio et 
al.  
2008  30,002 BMI 12/12 – shorter sleep duration associated 
with greater odds of obesity (pooled 
OR=1.89) 
Systematic 
review w/meta-
analysis (11 
studies)  
Chen et al. 2008 44,228 BMI  11/11 – shorter sleep duration associated 
with increased risk of obesity (pooled 
OR=1.58) 
Systematic 
review (11 
studies) 
Patel & Hu 2008 26,997 BMI  11/11 – shorter sleep duration associated 
with increased risk of obesity  
Systematic 
review (25 
studies)  
Liu et al. 2012 20,244 BMI 25/25 – shorter sleep duration associated 
with overweight/obesity  
Observational 
study 
Pileggi et al. 2013 542 BMI Shorter sleep duration associated with 
higher BMI 
Observational 
study 
Cao et al. 2015 8,760 BMI Shorter sleep duration associated with 
obesity in girls only 
 
Observational 
study 
Meng et al. 2012 6,576 BMI  Shorter sleep duration associated with 
higher BMI 
Observational 
study 
Sakamoto et 
al. 
2017 17,769 BMI Shorter sleep duration associated with 
increased risk of obesity 
Observational 
study 
Aguero et al. 2016 1,810 BMI Shorter sleep duration associated with 
increased risk of obesity 
Null findings 
Observational 
study 
Klingenberg 
et al. 
2013  211 BMI Families of high SES; all residents in urban 
area 
Observational 
study 
Carrillo-
Larco et al. 
2014 1,929 BMI  Authors suggested low prevalence of 
overweight/obesity (but in fact totalled 
21% so not that low)  
Observational 
study 
Zhang et al. 2015 3,086 BMI In Chinese culture children are under 
strict parental surveillance, irrespective of 
whether they are of normal 
weight/overweight/obese & all children 
appear to have insufficient sleep, not only 
overweight/obese children 
*All effects significant/not significant at p<0.05. 
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1.9.2.2 Prospective studies using subjective sleep duration 
Prospective studies of BMI and subjective sleep duration are summarised in Table 
1.5 below. Systematic reviews and meta-analyses of prospective studies are largely 
in line with findings from the cross-sectional literature, such that shorter sleep is 
associated with changes in BMI and an increased risk of obesity106,107,139,140,151–153. 
However, discrepancies exist between studies regarding sex differences 
(described in 1.9.2.8 below), and there is some evidence for a U-shaped, as 
opposed to a linear association.  
Patel and Hu154 published the first systematic review of paediatric prospective 
studies and observed a strong and consistent relationship between shorter sleep 
and future obesity risk. Although the authors concluded that there is a 
longitudinal association between shorter sleep and increased risk of weight gain 
and obesity, they based this on the only two longitudinal studies that had been 
published at the time. Briefly, one of these studies followed 8,234 children from 
three to seven years of age and observed ORs for obesity of 1.45, 1.35 and 1.04 for 
those who slept either <10.5 hours, between 10.5 to 10.9 hours and 11 to 11.9 hours, 
compared to 12-hour sleepers155. The other study found that in 150 children aged 
between three and five years at baseline, the risk of becoming overweight at age 
nine and a half years, was predicted by short sleep duration. Those who became 
overweight slept for approximately 30 minutes less than the normal weight 
children156. Importantly, though, Patel and Hu acknowledged that neither of 
these studies adjusted for weight at the time when sleep duration data were 
collected, thus did not measure actual changes in weight.  
The conclusion that shorter sleep confers an increased risk of overweight and 
obesity was supported by another systematic review with meta-analysis published 
the same year135. Subsequently, in 2015 two further systematic reviews with meta-
analyses emerged151,152. Fatima and colleagues151 found that sleep duration was 
inversely associated with future BMI in children, such that those who have 
shorter sleep durations are approximately twice as likely (OR=2.15) to become 
overweight/obese compared to their normal-sleeping counterparts. The authors 
stated that their findings concurred with those of previous meta-analyses, yet 
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they observed a stronger effect and speculated that this was because they 
weighted more heavily the three studies that used objective sleep duration, 
measured (rather than self- or parent-reported) BMI and had at least a three-year 
follow-up period. A further systematic review and meta-analysis152 of 25 studies 
with a total of 56,584 children also found that over an average of 3.4 years follow-
up, those who slept for approximately 10 hours, compared to those who slept 12 
hours, were 75% more likely to be overweight/obese (OR=1.76). Additionally, 
these children had relatively greater annual BMI gain (0.13 kg/m2) for every hour 
decrease in sleep duration.  
The most recent meta-analyses of the association of sleep duration and change in 
BMI (and other measures of adiposity) support the notion that short sleep is 
associated with increases in future BMI153,157. However, there is heterogeneity in 
these meta-analyses which may be related to a number of factors including the 
definition of short and long sleep, length of follow-up time, geographic location, 
and ethnic group.   
1.9.2.3 Bidirectional, prospective studies of BMI and sleep duration 
When reviewing this literature, it was apparent that studies have largely 
investigated the prospective association between sleep duration and BMI over 
time, rather than vice versa, with the exception of two studies that have examined 
potential bidirectionality. This research is important, as it attempts to ascertain 
the direction of this association, which in turn, provides information on whether 
children’s sleep duration might change as a consequence of being 
overweight/obese, or whether the reverse might be true158. Only two studies to 
date have investigated the bidirectional, longitudinal relationship between BMI 
and sleep duration in children137,138. Although these studies were included in 
some of the meta-analyses described earlier they will be described here 
separately.  
The first to investigate the bidirectional relationship of BMI with sleep duration 
were Hiscock and colleagues, who observed that, in Australian children, BMI did 
not predict changes in sleep duration, or vice versa137. They performed two sets of 
cross-sectional and prospective analyses in 3,857 infants and 3,844 children. The 
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infants were between zero and one year of age at baseline, and age two to three 
years at follow-up; the children were aged between four and five years at baseline, 
and six to seven at follow-up. Prevalence of overweight was around 15% and 
obesity 5%, at each follow-up, but the authors observed no longitudinal 
association in either direction; from ages zero/one to two/three years, or four/five 
to six/seven years. Cross-sectionally, however, they found that obese six/seven-
year-olds slept for 30 minutes less than their underweight, normal weight and 
overweight peers.  
These negative findings contrasted with numerous epidemiological studies and 
this could be due to at least two reasons. Firstly, the authors used 24-hour time 
diaries to collect data on sleep duration whilst the majority of previous research 
at the time had used parent-reported sleep duration and it is this measure, rather 
than time diary reports, that predict obesity. Therefore, this could mean that 
their results were, in fact, more accurate than studies that use parent-reported 
sleep duration. However, the study used a bespoke measure to ascertain sleep, 
which has not been used in other studies and for which no validity or reliability 
measures were provided and may mean that the findings are uncertain.   
Secondly, it is possible that the relationship between short sleep and paediatric 
obesity develops slightly later, which is in line with their finding from the six-to-
seven-year-old children. One hypothesis could be that the relationship between 
shorter sleep and obesity is via eating behaviour and as such, a child would need 
to consume excessive amounts of food over a certain number of years (as a 
consequence of short sleep), which would then lead to increased weight/risk of 
obesity later. Also, it is possible that children who eat more when they are tired 
are likely to have more autonomy over what, when and how they consume food, 
which is a privilege that usually comes as children get older. This is supported by 
epidemiological research in which shorter sleep in early life (16 months) is 
associated with greater energy intake, but this effect emerges prior to the 
association with weight159. More specifically, this study by Fisher and colleagues159 
showed that there was no relationship between sleep duration and weight in this 
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sample of 1,303 British children, but the association between energy intake and 
sleep duration was strong.  
Collings et al.138 also investigated the bidirectional relationship between BMI and 
sleep duration. They analysed data from 776 South Asian and 562 White children 
from the Born in Bradford-1000 (BiB-1000) cohort, at ages 12, 18, 24 and 36 
months of age. Their results showed that the association between BMI and 
parent-reported sleep duration was significant in both directions in South Asian 
children, but the findings were null in White children138. In the South Asian 
children BMI had a two to threefold larger effect on sleep duration, rather than 
the other way around (i.e. sleep duration as the exposure, which is the direction 
modelled in all, but two prospective epidemiological studies, to date). Finding 
that BMI and sleep duration are associated in both directions in South Asian 
children requires replication in a larger and independent sample. The findings in 
White children are comparable with those of the earlier study137, even though 
Collings used parent-reported sleep duration, as opposed to sleep diaries.  
Both of the studies described above observed no bidirectional relationship 
between BMI and subjective sleep duration in White children from the UK and 
Australia. Although each study used a distinct sleep duration measure (24-hour 
diaries vs. parent-reported duration) these findings have yet to be replicated in a 
paediatric sample using objectively-measured sleep duration.  
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Table 1.5 Summary table of prospective findings in children using subjective sleep 
duration 
Type of 
article/study 
Authors Year Sample 
size 
Outcome Follow-
up 
period 
Main findings*  
Systematic 
review (2 
studies) 
Patel & 
Hu 
2008 8,384 BMI 4 – 4.5 
years 
 Shorter sleep 
associated with increased weight & 
risk of obesity 
Systematic 
review w/meta-
analysis (3 
studies) 
Chen et 
al. 
2008 10,189 BMI 3 – 9 
years  
Shorter sleep associated with 
increased risk of becoming 
overweight/obese 
Systematic 
review (22 
studies) 
Fatima 
et al. 
2015 42,223 BMI 1 – 9.5 
years 
Shorter sleep associated with 
higher BMI/increased risk of 
overweight/obesity 
Meta-analysis (11 
studies) 
Fatima 
et al. 
2015 24,821 BMI 2 – 9.5 
years 
Shorter sleep associated with 
higher BMI/those who sleep for 
less twice as likely (pooled 
OR=2.15) to become 
overweight/obese  
Meta-analysis 
(25 studies) 
Ruan et 
al. 
2015 56,584 BMI  0.5 – 10 
years  
Shorter sleep associated with 
greater odds of obesity (pooled 
OR=1.76) 
Meta-analysis (12 
studies) 
Li et al. 2017 44,200 BMI 2 – 15 
years  
Shorter sleep associated with 
higher prospective BMI & 30% 
increased risk of obesity 
Meta-analysis (13 
studies) 
Wu et al. 2017 35,540 BMI  1 – 5 
years 
Shorter sleep associated with 
greater odds of obesity (pooled 
OR=1.71) 
Bidirectional prospective studies 
Observational 
study  
Collings 
et al.  
2017 776 
(South 
Asian) 
BMI & 
sleep 
duration 
18, 24 
and 36 
months 
Higher BMI associated with 
decreased sleep from baseline (6 
months) to 12, 18 and 24 months, 
but not 36 months 
AND 
Longer sleep (at baseline) 
associated with decreased BMI at 
12, 18, 24 and 36 months  
Null findings 
Observational 
study 
Hiscock 
et al. 
2014 3,844 BMI & 
sleep 
duration 
1 – 7 
years 
Sleep duration did not predict 
changes in BMI, BMI did not 
predict changes in sleep duration  
Observational 
study 
Collings 
et al. 
2017 562 
(White) 
BMI & 
sleep 
duration 
18, 24 
and 36 
months 
Sleep duration did not predict 
changes in BMI, BMI did not 
predict changes in sleep duration 
*All effects significant/not significant at p<0.05. 
1.9.2.4 Studies using objectively-measured sleep duration 
There are very few studies to date, that have used objective sleep duration to 
examine its relationship with BMI in children and their findings are equivocal. 
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Both cross-sectional and prospective studies that have used objective sleep 
duration measures are summarised in Table 1.6 below. 
1.9.2.5 Cross-sectional studies 
Chaput and colleagues160 objectively measured sleep duration over seven days in 
a sample of Canadian children aged 10. After adjustment for a number of lifestyle 
and demographic covariates they observed that short sleepers (<10 hours) had 
increased odds of overweight/obesity (OR=2.08).  
In 308 American children161 between the ages of four and ten average actigraphic 
sleep duration was eight hours, which is markedly below the recommended 
amount for children. Analysis of both weekday and weekend sleep duration 
showed that there were no differences between normal weight, overweight and 
obese groups. However, the authors then examined sleep variability values within 
BMI SDS groups. They found that in obese children, sleep duration was more 
variable on weekends than on weekdays, in comparison with children in the 
normal and overweight BMI SDS groups. Overall, shorter sleep duration was 
associated with other metabolic markers, such as altered insulin, LDL and high-
sensitivity CRP and thus, the authors concluded that these might be more 
important in this context (i.e. that shorter sleep might have a greater impact on 
these other metabolic markers, rather than BMI).  
A Swedish study of 1,231 children162 aged between six and ten years found 
objectively-measured sleep duration to be negatively associated with BMI. One 
important limitation of this study was the lack of sleep diary data; thus, 
evaluation of sleep times was more difficult. Research conducted in 303 mother-
child pairs using both mother-reported and objective sleep duration suggests that 
BMI was associated with both of these measures145. However, the sleep measures 
were weakly correlated and the objective data appeared to provide a more 
reliable estimate of children’s sleep durations145. A 2015 study using data from 
6,025 children across twelve countries from the International Study of Childhood 
Obesity, Lifestyle and the Environment (ISCOLE) also showed an association 
between longer sleep duration and decreased odds of obesity (OR=0.79)163. 
Findings from Wilkie and colleagues164 are in concert with the ISCOLE data, as 
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they observed a relationship between lower odds of obesity and longer sleep 
duration, in 374 UK children.  
In a Canadian sample of 567 10-year old children no cross-sectional association 
was observed between actigraphic sleep duration and BMI165. As the effect of 
sleep duration on BMI was no longer significant following adjustment for several 
covariates (age, sex, ethnicity, family income, parental education, maturity offset, 
moderate to vigorous physical activity (MVPA), sleep efficiency and sleep timing) 
these findings were comparable to some previous research166 in which this effect 
was diminished after adjustment for covariates. However, this sample had higher 
sleep efficiencies than others that previously objectively-measured this in 
children, which could in turn be explained by the fact that this cohort were 
relatively lean and active. However, these high sleep efficiencies might also have 
been influenced by the fact that data were collected using waist-worn actigraphy, 
which may overestimate both sleep duration and sleep efficiency167, as compared 
to wrist-worn actigraphs and this might at least, in part, explain the high sleep 
efficiency values in this sample.  
1.9.2.6 Prospective studies 
Prospective studies that examine objective sleep duration in relation to BMI are 
still scarce, with few published to date. Using data from 304 participants of the 
Tucson Children’s Assessment of Sleep Apnoea study, researchers found that 
those who slept less than seven and a half hours a night at age six were at 
increased odds (OR=3.3) of becoming obese 5 years later, compared to those who 
slept ≥9 hours per night168. Additionally, short sleep was associated with a mean 
BMI increase of 1.7 kg/m2 at 5-year follow-up. Another study published in 2011 
yielded similar results in 244 children followed from ages three to seven years169. 
From baseline to follow-up each additional hour of sleep was associated with a 
0.48 kg/m2 reduction in BMI, as well as decreased risk of being overweight.  
From reviewing the extensive paediatric literature on the relationship between 
BMI and sleep duration, it is apparent that few studies collect objective sleep 
data. As mentioned earlier, one underlying reason for this is that it is still too 
costly to collect these data from hundreds, if not thousands, of participants.  
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Table 1.6 Summary table of cross-sectional & prospective findings in children using 
objective sleep duration 
Type of 
article/study 
Authors Year Sample 
size 
Outcome Main findings/possible reasons for null 
findings 
Cross-sectional – positive findings 
Observational Chaput et al. 2011 550 BMI Shorter sleep duration associated with 
increased risk of obesity  
Observational  Ekstedt et al. 2013 1,231 BMI Shorter sleep duration associated with 
higher BMI 
Observational Martinez et 
al. 
2014 303 BMI Shorter sleep duration associated with 
higher BMI 
Observational Katzmarzyk 
et al. 
2015 6,025 BMI Longer sleep duration associated with 
decreased odds of obesity.  
Observational Wilkie et al. 2016 374 BMI Longer sleep duration associated with 
decreased odds of obesity.  
Cross-sectional – null findings 
Observational Spruyt et al. 2011 308 BMI Sleep duration was more variable in obese 
children on weekends vs. weekdays; sleep 
duration was much lower (8 hours) than 
the recommended amount for children; 
shorter sleep duration was associated 
with other metabolic markers, not BMI 
Observational Mcneil et al. 2015 567 BMI Sample were lean & active compared to 
other studies; sleep efficiency was very 
high on average; waist-worn actigraphy 
was used, which can overestimate sleep 
duration/efficiency 
Prospective – positive findings 
Observational Silva et al. 2011 304 BMI Shorter sleep duration associated with 
increased odds of obesity at 5-year follow-
up & with increased BMI at follow-up 
Observational Carter et al. 2011 244 BMI Longer sleep duration associated with 
decreased BMI at 4-year follow-up  
*All effects significant/not significant at p<0.05. 
1.9.2.7 Sex differences in the association of obesity and 
(subjective/objective) sleep duration in children  
Some studies in children suggest that there is a marked difference in the 
magnitude of association between BMI and sleep duration in boys and girls. For 
example, one of the earlier reviews described three studies that found boys were 
more likely to sleep for less hours than girls106. Specifically, one of these studies 
observed distinct obesity ORs associated with <8 hours vs. >10 hours sleep, such 
that for boys it was 5.5 and girls 2.1170. A UK cross-sectional study of 1,294 children 
aged between 7 and 18 years revealed an association between age-adjusted BMI 
and sleep duration in boys, but not girls171. This was further supported by Chaput 
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and colleagues’ work172, which found an OR for obesity related to sleep duration 
of ≤10 hours, compared to 12 or more hours was 3.2 in girls and 5.7 in boys.  
Research conducted in 6,324 children from the Australian Health and Fitness 
Survey observed a dose-response relationship between short sleep (<8 hours 
sleep vs. >10 hours sleep) and odds of being overweight/obese in boys only173. 
This is in line with research from a Canadian sample, which suggested that at 
ages 6 and 7, sleep duration was inversely associated with overweight/obesity in 
boys, but not girls174. They also found that sleep duration at age 2.5 years 
predicted overweight/obesity in boys at ages 6 and 7. Notably, the researchers 
also discovered that in boys, shorter sleep duration was associated with 
unfavourable eating behaviours and thus, at age six, they were more likely to eat 
at irregular times and consume too much food, too fast. This was suggestive of a 
mediating effect of eating behaviours between sleep duration and 
overweight/obesity in boys.   
In the ISCOLE study described earlier, longer sleep duration was associated with 
decreased odds of obesity in both boys and girls in this multi-country analysis163. 
However, the OR for boys was 0.83 (17% reduction in risk), whilst for girls it was 
0.75 (25% reduction in risk), a result which is important, not only because this 
study was conducted across 12 countries, but also because they used objective 
sleep duration. Therefore, this study’s findings differed from those of the studies 
discussed above, which suggested that the effect of sleep duration on obesity risk 
is greater for boys, rather than girls.  
1.9.2.8 Summary of evidence in children 
Both cross-sectionally and prospectively, evidence in children largely suggests 
that shorter sleep is associated with higher BMI, as well as risk of 
overweight/obesity. In recent years, several large-scale meta-analyses and 
systematic reviews have supported this finding, yet there are some differences 
across study results. These discrepancies in conclusions might be due to factors 
that have been explored above, in this literature review, in more detail. For 
example, similarly to adult research, there have been differences in the way that 
studies define short/long sleep, the analysis of BMI as a categorical (using weight 
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status categories) vs. a continuous measure and the inclusion of covariates is also 
disparate. These important factors can have an impact on study findings, all of 
which have been explored above in this literature review.  
Some research finds that boys are, on average, more susceptible to sleep loss and 
potentially, increases in BMI and greater odds of overweight/obesity, which could 
perhaps be explained by evolutionary or physiological sleep differences. However, 
one of these studies, which analysed data from 6,025 children across 12 countries, 
found that, in fact, there was a larger effect of sleep duration on obesity risk for 
girls, rather than boys. Other studies find a U-shaped relationship between sleep 
duration and weight gain, for example, suggestive of a non-linear, rather than a 
linear effect. However, the majority of studies have reported a linear relationship 
between the two.  
Unlike in adults, there have been two studies to explore the bidirectional 
association of sleep duration and BMI in childhood. These studies’ findings were 
identical for children of White ethnicity, in that they yielded no prospective 
relationship in either direction. However, one of these studies found a 
relationship in both directions (BMI predicting changes in sleep duration, as well 
as sleep duration predicting changes in BMI) in children of South Asian ethnicity. 
Both of these bidirectional, epidemiological studies used only subjective sleep 
duration measurements; no studies have yet investigated the bidirectional 
association between BMI and sleep duration using objective sleep duration. 
Notably as well, no research has attempted to investigate whether the 
relationship between BMI and sleep duration might be causal, in either direction. 
1.9.3 Potential explanations for sex differences in both children and 
adults  
Eisenmann et al.173 suggested that one explanation for sex differences in the 
association between BMI and sleep duration could be that females might need to 
experience greater sleep loss before they are affected, as they tend to be more 
resilient to environmental stress than males, from an evolutionary perspective. 
This is grounded in the theory that sex differences in early vulnerability are due 
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to the natural selection of optimum maternal strategies that maximise 
reproductive success, and that irrespective of medical care advances early life 
environmental stressors will always disproportionately affect males175.  
An alternative account for the difference between males and females comes from 
physiological and behavioural distinctions in sleep architecture between the 
sexes176. For example, there is some evidence that boys score more poorly on 
actigraphic sleep measures; they experience more awakenings and interruptions 
during sleep, whilst girls sleep for longer with fewer interruptions177. Further, 
these sex differences might influence how insufficient sleep affects phenotypes 
such as diet, eating behaviour and physical activity of boys differently from 
girls174. For example, perhaps boys are more sensitive to obesogenic eating 
behaviours when they do not have the required amount of sleep for prolonged 
periods. However, it might also be important to note that younger boys are likely 
to have their diets and eating behaviours quite closely monitored by 
parents/caregivers. 
Explanations have also been offered for why some studies find an association 
between sleep duration and BMI/increased risk of obesity in females, but not 
males. For example, an experimental study showed that when men and women’s 
sleep was restricted to five hours per night (compared to nine hours), both sexes 
were more likely to consume more calories at night, when food was available ad 
libitum178. However, men gained weight irrespective of sleep condition (five vs. 
nine hours), whereas women’s weight only increased in the five-hour restricted 
sleep condition, thus the authors concluded that insufficient sleep may lead to 
less dietary restraint in females.  
Overall, the majority of studies have observed an association between sleep 
duration and BMI, irrespective of sex. However, some research shows an 
association in males, but not females and vice versa and some potential biological 
explanations have been explored. More research is still required to examine this 
moderation by sex in very large samples and across diverse age groups. Also, the 
opposite direction should be investigated to ascertain whether sex might modify 
the effects of BMI on longitudinal changes in sleep duration.   
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1.9.4 Proposed pathways in the literature underlying the relationship of 
BMI with sleep duration 
A few pathways via which sleep duration can influence the onset of obesity have 
been proposed. For example, there is evidence to suggest that short sleep 
duration is linked to changes in levels of the appetite hormones leptin (the 
‘satiety’ hormone) and ghrelin (the ‘hunger’ hormone),109,179–181 and that such 
alterations in appetite could mediate the relationship between sleep duration and 
obesity182. Spiegel et al179 found that after two days of sleep restriction and two 
days of sleep extension, during which caloric intake and physical activity were 
systematically controlled, leptin (involved in the homeostatic regulation and 
reduction of appetite via increased satiety) levels decreased by 18%, while ghrelin 
(which increases hunger) increased by 28%, 24% and 23%, respectively. 
Importantly, though, this study had a very limited sample of 12 men and did not 
measure energy expenditure. This finding was, however, supported by two 
studies in which short sleep duration was associated with reduced leptin109,180 (i.e. 
reduced satiety and higher hunger), and two reported that short sleep was 
associated with increased ghrelin levels180,181 (i.e. higher hunger). In contrast, one 
of these studies saw no changes in the leptin levels of nine men, who had spent 
three nights (7 hours, 4.5 hours and total deprivation) in a sleep laboratory, 
separated by two weeks each time181. The sample analysed was particularly small 
and thus this study may not have been particularly well powered to detect effects.  
Another pathway that could underlie the relationship between sleep duration 
and adiposity is related to certain obesity-related behaviours. In a study of 30,000 
Japanese adults, although 80% reported getting enough sleep per night, 28% of 
the population reported sleeping for less than six hours nightly183. Findings 
further indicated that sleep loss was associated with an unhealthy lifestyle, such 
as insufficient physical activity and regular snacking between meals. Further, in 
the Whitehall II study Stamatakis and colleagues184 found an association between 
short sleep duration and obesity-related behaviours, such as insufficient physical 
activity and reduced fruit and vegetable consumption. They suggested that 
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interventions that promote physical activity and improved nutrition should also 
consider sleep duration as a modifiable risk factor for obesity.  
Another, more simple explanation, is that people who sleep less have more time 
to eat. However, the evidence in support of this explanation is not clear-cut, as 
individuals in the short and long sleep categories frequently have a higher BMI, 
compared to those who have normal sleep durations. This is supported by some 
evidence reviewed earlier that suggests a U-shaped relationship between BMI and 
sleep duration. Some research nonetheless, suggests that at least in young 
children, there may be partial support for this account. One such study examined 
the relationship between sleep and energy intake in early childhood, by analysing 
data from 1,303 children from the UK Gemini twin birth cohort159. Sleep duration 
data were collected from parents using a questionnaire when the children were 16 
months old, whilst the diet diaries were completed when they were between 20-
21 months of age. Findings revealed that shorter night-time sleep duration was 
associated with higher energy intake and that these infants consumed, on 
average, 50 kilocalories (kcal) more per day than children who had optimal 
durations of sleep. Although this difference appeared to be small, it equated to 
approximately 5% of the daily energy intake in this sample. Further analysis of 
the Gemini children showed that those sleeping for <10 hours, in fact, consumed 
an average of 120 kcal (15% of the daily intake) more at night specifically, 
compared to those sleeping 13 hours185 . 
Another conceivable explanation, which remains untested to date, is that BMI 
and sleep duration could have overlapping genetic factors. This is otherwise 
known as pleiotropy, whereby the same genes influence multiple traits186. The 
reason that this potential explanation is focused on BMI, rather than waist 
circumference, is that it is possible to test for pleiotropy between common 
genetic variants associated with BMI and sleep duration, but not WC and sleep 
duration. This is because there are now ninety-seven published and replicated 
genome-wide SNPs associated with BMI29. Testing for shared genetic pathways 
between BMI and sleep duration seems plausible, as some of the genetic variants 
in certain genes, such as FTO for example, are predominantly expressed in the 
  73 
hypothalamus30. The hypothalamus is a key area in the brain involved in inducing 
sleep and promotes wakefulness.  
The ventrolateral preoptic nucleus (VLPO) is a cluster of neurons in the anterior 
hypothalamus, which are directly connected to the brain’s arousal-promoting 
centres and therefore, promote sleep by inhibiting these other arousal centres. 
Thus, it is possible that one or more SNPs in these genes may lie on the causal 
pathway between BMI and sleep duration and that if an individual has an 
elevated genetic risk of BMI, this may then confer an increased risk of shorter 
sleep duration. As mentioned earlier in this chapter, short sleep duration has 
been associated with CVD61, T2D-mellitus63,187, hypertension64,188 and earlier 
mortality65,66.  
In summary, a few important pathways have been proposed in relation to why 
BMI and sleep duration are frequently associated in the epidemiological 
literature. However, it is clear that further research is required to investigate 
other previously understudied pathways and mechanisms, some of which will be 
explored in this thesis.  
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1.10  LIMITATIONS OF THE CURRENT EVIDENCE AND RATIONALE 
FOR THIS RESEARCH  
The evidence reviewed here on the relationship between adiposity and sleep 
duration in children and adults has important limitations, which are discussed in 
this section. These limitations then lead to an outline of the rationale for the 
research carried out in this thesis.  
The majority of research in this area has used observational epidemiological 
methods. These studies are unable to draw conclusions about causality, even 
those that employ a prospective design whereby participants may have been 
followed over a number of years189. The inability of observational studies to infer 
causality is due to two main reasons. Firstly, residual confounding occurs when 
unmeasured factors that may underlie associations cannot be accounted for in 
analyses and, secondly, reverse causation refers to when the ‘outcome’ may 
precede the ‘exposure’. Both confounding and reverse causation can be addressed 
through the exploitation of genomic data, using a design called Mendelian 
randomisation190 (described in more detail in Chapter 6).  
Reverse causation can also be partially addressed using approaches that examine 
bidirectionality, which has been suggested regarding the association of adiposity 
measures and sleep duration158. However, to date, this has only been investigated 
in two paediatric studies137,138, and never in adults. Furthermore, there have now 
been hundreds of studies that have investigated the relationship between 
measures of adiposity and sleep duration, yet no studies have attempted to use 
causal modelling to determine whether this association is causal, in either 
direction.  
There have also been far fewer studies in older adults than in children and 
younger adults and none of these have used a bidirectional approach to this 
question. Whilst it is important to determine what effect BMI has on sleep 
duration, or vice versa, in children and young adults, it is both timely and 
important to determine the nature and size of this relationship in older adults. 
Although studies have suggested that the effect of sleep duration on BMI 
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weakens with age, the prospective effect of BMI on sleep duration has not been 
explored in older adults. The main reasons that this is important are twofold. The 
ageing population is rapidly growing, with the number of people aged over sixty 
expected to represent 22% of the world’s population by 2050191. As a consequence, 
the second reason for more research in older people in this area, is the need to 
better understand the health of the elderly, as this is the time when disease and 
frailty are most common192.  
1.11 AIMS AND OBJECTIVES OF THIS THESIS  
The overarching aim of this thesis was to examine the relationship between BMI 
and sleep duration using both observational and genetic epidemiological 
approaches. The literature on BMI and sleep duration to date, in both children 
and adults is mostly observational. It remains unclear whether BMI might 
precede changes in sleep duration, or whether sleep duration precedes changes in 
BMI. Also, whether this relationship is causal remains to be established, in either, 
or both directions. Thus, the research undertaken in this thesis aimed to: (i) 
investigate the direction of this association in both children and older adults; (ii) 
understand this complex relationship at both ends of the life course; (iii) and use 
causal analyses – Mendelian randomisation (MR) – to test the causal relationship 
between BMI and sleep duration. MR requires robust and replicated SNPs 
through GWAS (for both BMI and sleep duration), so in order to perform 
bidirectional MR it was also necessary to carry out a meta-GWAS of sleep 
duration (this project preceded the UKB 2016 GWAS published by Jones and 
colleagues78).  
1.11.1 Hypotheses 
The following hypotheses were tested in this thesis:  
i) That in older adults, there would be a negative cross-sectional 
association between BMI and self-reported sleep duration (Chapter 3); 
ii) That in older adults, there would be a negative prospective association 
between BMI and changes in self-reported sleep duration over four 
years, but not in the opposite direction (Chapter 3); 
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iii) That in children, there would be a cross-sectional negative relationship 
between BMI and objective sleep duration (Chapter 4); 
iv) That in children, there would be a prospective, negative association 
between objective sleep duration and change in BMI and/or a negative 
association between BMI and change in objective sleep duration 
(Chapter 4); 
v) That BMI may be causally associated with self-reported sleep duration, 
such that a higher BMI might cause short/long sleep duration (Chapter 
6).  
1.11.2 Specific objectives  
 Investigate the bidirectional observational association between adiposity 
and self-reported sleep duration, in cross-sectional and longitudinal 
analyses in older adults, using data from a large English community 
sample (Chapter 3).  
 Investigate the bidirectional, observational relationship between BMI and 
objective sleep duration using a paediatric community sample (Chapter 4), 
with the aim of establishing the direction of effect in early life, given that 
there have only been two bidirectional studies in children, to date.  
 Perform a large-scale GWAS of self-reported sleep duration in three UK 
population studies, as a precursor to performing a Mendelian 
randomisation analysis to examine whether the association between sleep 
duration and BMI is causal (Chapter 5).  
 Perform a large-scale Mendelian randomisation study to investigate the 
potential causal effect of BMI on self-reported sleep duration, using the 
most up-to-date methodologies (Chapter 6).  
 Discuss the key findings, strengths and limitations of this research; 
potential implications for policy and practice and prospects for future 
research (Chapter 7).  
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Figure 1.2 Work flow for the studies carried out in Chapters 3, 4, 5 and 6 in this 
thesis 
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2 DATASETS USED IN THIS THESIS  
2.1 BRIEF INTRODUCTION AND OVERVIEW OF CHAPTER 
CONTENTS 
This research thesis took a multidisciplinary approach to establishing the nature 
of the relationship between sleep and BMI and employed a combination of 
observational and genetic epidemiological methods. To maximise power for the 
genetic analyses, data from four epidemiological studies were used in this work: 
ALSPAC (mothers), ELSA and UKHLS. This chapter provides an overview of the 
datasets used throughout this thesis, with details of relevant phenotypic 
measures [height, weight, waist circumference (only ELSA analyses in Chapter 3 
used WC) and sleep duration], as well as summary statistics and information 
about collection of DNA samples, genotyping quality control (QC) metrics and 
genotype imputation.  
The work conducted in this thesis did not involve any subject recruitment, 
genotyping, QC of genetic data or genotype imputation. For the ALSPAC 
mothers’ data, there was no involvement in preparation of the phenotypic sleep 
duration data either. At the end of this chapter Table 2.5 presents a summary of 
the phenotypic and genetic data used in this thesis.  
2.2 DATASETS 
2.2.1 Avon Longitudinal Study of Parents and Children (ALSPAC): 
mothers 
ALSPAC was established with the aim of understanding how genetic and 
environmental factors influence health and development of parents and their 
children. Through an existing link with the University of Bristol it was possible to 
collaborate on the GWAS of sleep duration with Dr. Gibran Hemani from the 
Integrative Epidemiology Unit, who cleaned the sleep duration data and 
performed the analyses. Dr Hemani then uploaded the results to a secure server, 
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which were then downloaded and included in the genome-wide meta-analysis, 
along with two other studies.  
2.2.1.1 Ethics 
Ethical approval was initially granted by the Bristol and Weston Health Authority 
(E1808) and then the Mothers clinic was approved by the North Somerset & 
South Bristol Research Ethics Committee (08/H0106/96). Written informed 
consent was also obtained at recruitment.  
2.2.1.2 Participants 
Pregnant women from a specific area in the South West of England (Avon), with 
an expected delivery date between 1st April 1991 and 31st December 1992 were 
eligible, of whom 13,761 were recruited into ALSPAC. Participants have been 
followed up for more than 20 years, from the 8th gestational week; data have been 
collected using self-report, health records, biological samples and physical 
measurements193. 
2.2.1.3 Phenotypic data description: sleep duration 
Data from ALSPAC mothers contributed to the GWAS of self-reported sleep 
duration (Chapter 5) in this thesis. Table 2.1 below provides summary statistics 
for the ALSPAC phenotypic data.  
Self-reported sleep duration data was collected from ALSPAC mothers by asking 
them to report the number of hours and minutes they sleep for during weekdays 
and weekends, then a weighted average was taken:  
(weekdays x 5 + weekends x 2) 
      7 
Although this question on sleep duration has been asked at six time points, in 
this thesis sleep duration was analysed from the 2003 data collection. The six data 
collections in which sleep measures were taken are 1991 (during pregnancy), 1994, 
1995, 1997, 1999 and 2003. At each time point sleep duration has been collected 
via questionnaire, but prior to 2003 it was measured categorically using the 
following groups: 0-3 hours, 4-5 hours, 6-7 hours and 8+ hours. However, in 2003, 
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quantitative raw sleep duration was collected via questionnaire and ALSPAC 
researchers state that it is preferable to use this measure, as some information 
can be lost when categorising this kind of variable194. For example, the fact that 
all durations greater than 8 hours are in a single category might mask U-shaped 
associations with other important traits194.  
Prior to performing GWAS analyses (Chapter 5) on the sleep duration phenotype, 
outliers were removed and thus, respondents who reported sleeping for <4 hours 
and >11.5 hours were excluded. Also, n=329 women who reported taking sleep 
medication were not included in the analyses.  
Table 2.1 Summary statistics for self-reported sleep duration in ALSPAC (after 
cleaning, as described above) 
Timepoint N Mean SD 
2003 weekday 7,404 7.38 1.03 
2003 weekend 7,404 8.20 1.16 
2003 average 7,404 7.61 0.97 
Note. N= number of observations, SD= standard deviation.  
2.2.1.4 Genetic data 
Informed consent was obtained to take DNA from blood samples and genome-
wide genotyping in 10,321 women.  
2.2.1.4.1 Genotyping and QC 
DNA has been collected from blood samples continuously since initial 
recruitment193. Genotyping was performed in 10,107 of the 10,321 women who had 
DNA available, using the Illumina 660 W-quad array, which had a total of 557,124 
SNPs prior to QC. QC metrics included removing SNPs with ≥5% missingness, 
<1% minor allele frequency (MAF – the extent to which the less common allele 
occurs in the population) and those that deviated from Hardy Weinberg 
equilibrium (HWE – whereby genetic variation remains constant from generation 
to generation) at 1x10-6. Individuals with missingess of ≥5% and those with cryptic 
relatedness of >5% (Identity by state cut-off of 0.05) were also removed. Cryptic 
relatedness refers to the presence of close relationships within a sample of largely 
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unrelated and outbred individuals195. Identity by state is used to describe two 
identical alleles or DNA segments195. 
For the purposes of the GWAS in Chapter 5, data from 4,914 ALSPAC mothers 
(out of the 10,107 with GWAS data) were analysed, as this was the maximum 
number of individuals who had genetic data, as well as the sleep duration 
phenotype. 
2.2.1.4.2 Imputation 
Genotype imputation enables the inference of unobserved genotypes23, that is, in 
the case of GWA studies, SNPs that have not been directly genotyped. 
Imputation is done using known haplotypes (a group of genes that are inherited 
together from one parent) in a particular population, which is possible, as the 
DNA sequence of any two individuals is 99.5% identical. However, it is the 
remaining variation (0.5%) that may lead to different disease risks. It is because 
of this that common genotype imputation reference panels, such as HapMap, 
1000 Genomes and the Haplotype Reference Consortium (HRC).  
Imputation is performed by using the LD structure within a sample of genotyped 
individuals. When choosing a reference panel it is best to select one that is a 
close ancestral match to the population under study, as this increases imputation 
accuracy196. Also, selecting a larger reference panel (for example, 1000 Genomes 
over HapMap) allows a broader range of variants to be imputed with greater 
accuracy197. Phasing (estimating haplotypes) is done to reconstruct the 
haplotypes, which is then compared to one of the aforementioned reference 
panels; finally, the LD structure is used to impute the missing genotypes.  
In ALSPAC, genotype data were imputed to 1000 Genomes (Phase 1, version 3). 
First, SNPs were flipped to the positive strand and to hg19, GRCh37. Phasing was 
done using SHAPEIT, version 2198,199 and then imputation was performed in 
IMPUTE2197. 
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2.2.2 English Longitudinal Study of Ageing (ELSA) 
Data from ELSA were used throughout this thesis, with the exception of Chapter 
3. ELSA is an on-going, nationally representative panel study of health and ageing 
in English adults aged 50 and over.  
2.2.2.1 Ethics 
ELSA was granted ethical approval by the London Multicentre Research Ethics 
Committee (MREC 01/2/91) and at each wave respondents provide informed 
consent.  
2.2.2.2 Participants 
At inception ELSA had a total of 11,391 respondents (wave 1, 2002-3), who were 
drawn from the Health Survey for England200. Data have subsequently been 
collected from participants at another six waves to date: 2 (2004-5), 3 (2006-7), 4 
(2008-9), 5 (2010-11), 6 (2012-13) and 7 (2014-15), whilst wave 8 data collection is 
on-going. At every other wave (2, 4 and 6) a proportion of respondents undergo a 
nurse visit, in which detailed clinical and biological measurements are taken, to 
complement the self-reported measurements that are collected at every wave. So 
far, four refreshment samples have also been introduced (waves 3, 4, 6, and 7) to 
ensure that representation of the younger age group remains (those closer to 50) 
(see Figure 2.1 below).  
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Figure 2.1 ELSA data collection timetable 
2002/03 Wave 1  
Main interview 
(12,099) 
------------------> 
 
Original sample interviewed in HSE 1998/1999/2001 
Age 50+ on 1 Mar 2002 
    
 
2004/05 
 
Wave 2 ------> 
Main interview 
(9,432) 
 
Nurse visit (7,666) 
 
    
 
2006/07 
 
Wave 3 ------> 
Main interview 
(9,771) 
 
Life history (7,855) 
 
Refreshment sample (HSE 2001/02/03/04) Age 50-52 
on 1 Mar 2006 
    
2008/09 Wave 4 ------> 
Main interview 
(11,050) 
Nurse visit (8,643) Refreshment sample (HSE 2006) Age 50- 74 on 1 Mar 
2008 
    
2010/11 Wave 5 ------> 
Main interview 
(10,275) 
Risk module (1060 
approx) 
 
    
 
2012/13 
 
Wave 6 ------>  
Main interview 
(10,601) 
 
 
Nurse visit (7,731) 
 
Refreshment sample (HSE 2009/10/11) Age 50-55 on 1 
Mar 2012 
 
2014/15 
Wave 7  
Main interview 
(9,666) 
 
 
Refreshment sample (HSE 2011/2012). Age 50-51 on 1st 
March 2014 
  
  84 
2.2.2.3 Phenotypic data description: BMI & sleep duration 
Table 2.2 presents summary statistics of the ELSA phenotypic data used in this 
thesis.  
2.2.2.3.1 BMI 
At waves 2, 4 and 6, 7,666, 8,643 and 7,731 respondents received a nurse visit, 
respectively (there was no nurse visit at wave 1). During these visits, the nurse 
measured respondents’ height (m) and weight (kg). Standing height was 
measured using a portable stadiometer standardised with head in the Frankfort 
plane, whilst weight was recorded to the nearest 0.1 kg, using digital scales 
(Tanita). BMI was subsequently derived at each wave using the formula: weight 
divided by height squared (kg/m2). Mean BMIs for each wave are displayed in 
Table 2.2, after data were cleaned for missing values.  
The work in this thesis uses data from ELSA waves 4 and 6, as these included a 
nurse visit and importantly, wave 4 was the first time that questions on sleep 
were asked. Of the 11,050 ELSA respondents at wave 4, 8,641 were interviewed 
and clinical measurements were obtained by a nurse; whilst at wave 6 there were 
10,601 interviews and 7,731 nurse visits. There were no values that had to be 
removed at either wave 4 or 6 in ELSA.   
2.2.2.3.2 Waist circumference (WC)  
During the nurse visit, two measurements of WC were taken at the midpoint 
between the lower rib and the iliac crest using measuring tape. A mean of the two 
measurements was then used, unless they differed by more than 3 cm, in which 
case a third measurement was taken and then an average of the closest two 
measurements was used. At wave 4, two individuals whose WC values were 
999.99cm were removed from the data, as these values were deemed extreme and 
could even be errors.  WC categories were defined using the WHO definition for 
risk of metabolic syndrome. Categories were as follows: Not-at-risk <80 cm 
(females) and <94 cm (males), At increased risk>=80 cm, but <88 cm (females) 
and >=94 cm, but <102 cm (males), Substantially increased risk >=88 cm 
(females) and >=102 cm (males).  
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2.2.2.3.3 Sleep duration 
Participants were asked to self-report their sleep duration at waves 4 and 6. They 
were asked: “How many hours of sleep do you have on an average weeknight?” 
Mean sleep duration for waves 4 and 6 can be seen in Table 2.2, after the 
variables were cleaned for missing data. Individuals who slept for < 2 hours or >12 
hours were excluded (1 hour=7 individuals, 1.5 hours =1 individual, 13 hours=2 
individuals, 13.5 hours=1 individual, 14 hours=2 individuals). This differed 
somewhat from the phenotype inclusion criteria for ALSPAC. The decision was 
made to remove the n=13 individuals who slept for <2 hours and >12 hours in 
ELSA because in adults >50 years of age these values are more likely to reflect 
errors and/or illness. In ALSPAC it was also more important to keep as many 
participants in the sample as possible, as they contributed only to the GWAS in 
this thesis (Chapter 5) for which ample power is required.  
Table 2.2 Summary statistics of BMI and sleep duration in ELSA across waves for 
all respondents (after data cleaning, as described above) 
Wave N Mean (SD) 
 BMI (kg/m2)  
2 7,225 27.93 (4.89) 
4 8,262 28.27 (5.30) 
6  7,693  28.21 (5.10) 
 WC (cm)  
2 7,416 95.67 (13.18) 
4 8,409  96.97 (13.65) 
6 7,866 96.38 (13.94) 
Sleep duration (hours) 
4 10,566 6.85 (1.34) 
6 9,964 6.84 (1.33) 
Note. N=number of observations, SD=standard deviation.  
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2.2.2.4 Genetic data 
At waves 2 and 4 written consent was obtained to extract DNA from blood 
samples (obtained during the nurse visit); from 5,662 at wave 2 and a further 
1,945 individuals at wave 4. Therefore, genotype data was available for a total of 
7,607 individuals.   
2.2.2.4.1 Genotyping and QC 
Genotyping was carried out at UCL Genomics and the QC procedure was 
performed by Drs. Delilah Zabaneh and Ghazaleh Fatemifar. Genotyping was 
performed in two batches (5,662 individuals from wave 2 and 1,945 from wave 4) 
using the Illumina HumanOmni 2.5M platform. QC was done on each batch 
separately, prior to merging them. Both SNP and individual missingness were set 
to 5% and therefore, individuals who had more than 5% missing genotypes were 
excluded, as well as SNPs that had more than 5% missing genotype rates. MAF 
and HWE were not included in the QC and thus these checks were performed as 
part of the GWAS (Chapter 5). Individuals who reported non-White/European 
ethnicity were removed (n=133). It is important to remove these individuals of 
different genetic ancestry (known as population stratification or substructure), as 
it can lead to spurious associations due to differences in ancestry, rather than 
true associations. PLINK 1.9 was used to estimate relatedness with one individual 
of a related pair kept in the data, thus 40 were excluded during this QC step. A 
sex check was also carried out using PLINK and discrepancies were corrected, 
which means that participants’ sex was either confirmed or refuted (versus self-
reported sex), using DNA. After excluding related individuals and ethnic outliers 
the total sample size with genetic data was 7,412.  
2.2.2.4.1.1 Imputation 
Prior to imputing the genotypes, family groups with genetic relatedness 
discordant with stated relationships were removed, as well as SNPs with a MAF of 
≤1%. Genotypes were imputed to the European component of 1000 Genomes, 
Phase 1. Phasing was carried out using MaCH1 software201 and imputation was 
performed in Minimac202. Imputation was carried out in chunks of 1000 markers, 
with an overlap of 250 markers between chunks. After imputation chunks were 
  87 
merged with the ‘best’ (highest R2) kept in the overlapped segments. All imputed 
genotypes had an R2 of ≥0.3.  
2.2.3 Trondheim Early Secure Study (TESS) 
Data from waves 2, 3 and 4 from the TESS study were used to investigate the 
bidirectional epidemiological relationship between BMI and objective sleep 
duration in children (Chapter 4). TESS comprises a prospective community 
sample of children born in Trondheim, Norway, in 2003 and 2004 and its primary 
aim was the assessment of mental health in children. A letter of invitation was 
sent, which included the Strengths and Difficulties Questionnaire (SDQ), version 
4-16203 for participants’ parents to complete. This was administered because the 
SDQ is a commonly-used screening tool to detect conduct and emotional 
problems, which was one of the primary emphases of TESS.  
2.2.3.1 Ethics 
Ethical approval for TESS was granted by the Regional Committee for Medical 
and Health Research Ethics, Mid-Norway. Written informed consent has been 
obtained at each data collection, from children’s parents/primary caregivers.  
2.2.3.2 Participants 
Data have been collected from children at ages 4 (wave 1), 6 (wave 2), 8 (wave 3) 
and 10 (wave 4), to date. From the 2003 and 2004 birth cohorts (N=3,456) in 
Trondheim, 1,250 children were recruited into TESS at wave 1, by means of a 
letter of invitation, which included the SDQ, as mentioned above. Thus, all 
children in these birth cohorts were invited to participate in TESS and of the 
3,456 children, 3,358 attended the well-child clinic at age four for a routine health 
check, from whom the 1,250 who were recruited into TESS were drawn.  Due to 
the purposeful oversampling of children with behavioural and emotional 
problems, sample weights are always applied in all TESS analyses. At waves 2, 3 
and 4, 795, 699 and 702 children took part in the study, respectively.  
2.2.3.3 Phenotypic data description: BMI & sleep duration 
Summary statistics for BMI and sleep duration are presented in Table 2.3.  
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2.2.3.3.1 BMI 
Height (m) and weight (kg) were measured at each wave by a nurse, using a 
digital stadiometer (Heightronic digiral stadiometer: QuickMedical, Model 235A) 
and electronic weighing scales (Tanita BC420MA). Then BMI was calculated 
using the standard formula: weight (kg) / height (m2). BMI standard deviation 
scores (SDS) were derived at each age, using the British growth curve reference 
for those aged between birth and 23 years87. Mean BMIs are displayed in Table 
2.3. BMI SDS at waves 2 and 3 were created by TESS researchers, yet BMI SDS 
values at wave 4 were calculated as part of the work in this thesis, as this had not 
previously been done. To do this, the LMS Growth87 Microsoft Excel add-in was 
used, in which the raw BMI data (wave 4=age 10) were inputted and BMI SDS 
values were calculated according to the British 1990 growth reference87. A BMI 
SDS value of 0 means that the child’s BMI is in line with the reference data 
average, whilst a value >0 means they have a higher BMI than the reference data 
average and values <0 mean that their BMI is lower than the reference data 
average. BMI SDS data are also used to derive weight status in children. 
International Obesity Task Force (IOTF) weight status categories were also 
derived using LMS Growth in Excel, which use age- and sex-specific BMI centile 
values associated with BMIs of 25 (overweight in adults) and 30 (obese in adults) 
at age 18y204. The BMI data had already been cleaned (by TESS Research 
Assistants) and therefore, a dataset was provided that was ready for analysis.  
2.2.3.3.2 Sleep duration 
Sleep duration was objectively measured using the ActiGraph™ GT3X 
accelerometer (Manufacturing Technology Incorporated, Fort Walton Beach, FL, 
USA). Participants (children) wore the actigraphs on their hip for 7 consecutive 
days, including whilst asleep, and were only required to remove them whilst 
showering or bathing. Only data from participants with ≥ 3 days of recordings 
were included, as Acebo and colleagues recommend that at least 3 nights are 
necessary to ascertain reliable individual differences. Sleep duration was 
converted from raw data by employing Sadeh’s algorithm205, once time in bed 
and out of bed had been manually set by examining each night, using ActiLife 
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software. A technician who was experienced with accelerometers set this 
manually, aided by the sleep detection algorithm provided by ActiLife. Bedtime 
was assumed by a sharp decrease in activity, which is characteristic of bedtime, in 
so far as it is often preceded by a marked increase about 20 minutes prior to this. 
Bedtime was recorded when there were approximately five consecutive epochs 
with less than 100 counts per epoch. Sadeh’s algorithm automatically 
differentiates prolonged sitting from sleep. In addition to actigraphy, a 
questionnaire was supplied for parents to complete, asking whether participants 
had been ill and more/less active than usual during the seven days of data 
collection. However, parents were not asked to log children’s bedtimes and wake 
times, but this will be included in TESS from age 14 onwards. TESS sleep duration 
data had already been cleaned and prepared for analysis (by the actigraphy 
technician) and a clean dataset was provided for the analyses in this thesis. Mean 
sleep durations are displayed below in Table 2.3.  
Table 2.3 Summary statistics for BMI and sleep duration in TESS across waves 
Wave N Mean (SD) 
BMI-SDS  
2  552 -0.11 (0.88) 
3 509 0.09 (0.90) 
4 686 0.12 (1.01) 
Sleep duration (hours) 
2 674 9.62 (0.72) 
3 547 9.09 (0.57) 
4 633 9.19 (0.70) 
Note. BMI-SDS= BMI standard deviation scores, N=number of observations, 
SD=standard deviation, wave 2=age 6, wave 3=age 8, wave 4=age 10.  
2.2.4 The UK Biobank Study  
Summary-level data from the UK Biobank (UKB) study were used for the 
Mendelian randomisation analyses in Chapter 6. UKB comprises 500,000 
individuals between the ages of 40 and 69 years, who have undergone detailed 
phenotyping and genotyping.  
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2.2.4.1 Ethics  
UKB participants provided full informed consent. More details on the complex 
Ethics and Governance Framework in UKB can be found in Sudlow et al. 
(2015)206.  
2.2.4.2 Participants 
The 500,000 participants were assessed between 2006 and 2010 across 22 UK 
assessment centres, with the aim of covering a diversity of socioeconomic and 
ethnic backgrounds. Data have been collected via self-completion touch-screen 
questionnaires, a computer assisted interview, as well as functional and physical 
measures and blood, saliva and urine samples.  
2.2.4.3 Phenotypic data description: sleep duration  
In UKB sleep duration was ascertained by asking participants for the average 
number of hours that they slept in a 24-hour period. For GWAS analyses (from 
which summary statistics were used in Chapter 6 for the purposes of MR), Jones 
and colleagues78 derived their sleep duration measure by excluding those who 
slept for >18 hours, then adjusted for age, sex and study centre, obtained the 
model residuals and then applied an inverse-normal transformation.  
2.2.5 The UK Household Longitudinal Study (UKHLS) 
Data from UKHLS207 were used in the GWAS (Chapter 5), Mendelian 
randomisation and polygenic risk score analyses (Chapter 6). UKHLS is an 
ongoing, nationally representative panel study of over 40,000 UK households, 
which collects social and economic data, as well as behavioural and health data.   
2.2.5.1 Ethics 
UKHLS received ethical approval from the University of Essex Ethics Committee 
and nurse visits (waves 2 and 3) have been approved by the National Research 
Ethics Service. 
2.2.5.2 Participants 
Data are collected annually from UKHLS respondents; it comprises a General 
Population Sample (GPS), a stratified clustered random sample of representative 
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UK households (joined in 2009-10) and participants from the well-established 
British Household Panel Survey (BHPS)207. UKHLS has collected data at six 
waves, to date, with 50,994 (wave 1), 54,597 (wave 2), 49,739 (wave 3), 47,157 
(wave 4), 44,903 (wave 5) and 45,290 (wave 6) observations.  
In addition to the main interview at waves 2 (GPS sample component) and 3 
(BHPS sample component), 26,961 and 8,914 participants, respectively, were 
eligible (had been interviewed in English, were aged over 16 years, were not 
pregnant at the time and lived in England, Wales or Scotland) to take part in the 
nurse health assessment. Thus, these participants had objective measurements of 
anthropometry taken by a nurse and blood samples were also collected for 
extraction of DNA. Of those eligible at wave 2, 10,175 participated and at wave 3, 
5,053 participated, of whom 10,175 and 3,342 individuals provided blood samples.  
2.2.5.3 Phenotypic data description: BMI & sleep duration 
Table 2.4 presents summary statistics for the UKHLS phenotype data used in this 
thesis.  
Table 2.4 Summary statistics for BMI and sleep duration in UKHLS for participants 
with phenotype data  
Wave N Mean (SD) 
BMI (kg/m2) 
2/3 9,660 28.07 (5.60) 
Sleep duration (hours) 
1 5,754 6.85 (1.44) 
4 8,855 6.61 (1.36) 
Note. N=number of observations for individuals who were visited by a nurse, 
SD=standard deviation, wave 2/3= indicates that BMIs were combined into one 
variable, from the waves 2 and 3 nurse visits, as respondents had their 
height/weight measured at either one of these waves.   
 
2.2.5.3.1 BMI 
Height (m) was measured during the nurse visits at waves 2 and 3, using a 
portable stadiometer with the respondent’s head in the Frankfort plane. One 
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measurement, to the nearest millimetre was recorded. Weight (kg) was measured 
using a digital floor Tanita scale (BF 522) during the nurse visits. Participants 
whose weight was greater than 130kg were asked to estimate their weight, as the 
scales are not accurate above this level. However, there was only n=1 respondent 
with a weight value >130 kg and they were excluded, as participants estimating 
their own weight is unlikely to be reliable. Subsequently, BMI was calculated 
using the standard formula (weight in kg/height2 in cm).  
2.2.5.3.2 Sleep duration 
Self-reported sleep duration was measured at waves 1 and 4. At each wave 
participants were asked: “How many hours of actual sleep did you usually get at 
night during the last month? This may be different than the actual number of 
hours you spent in bed”. Individuals who reported sleeping for <2 hours or >12 
hours were excluded (1 hour = 27 individuals, 13 hours = 1 individual, 16 hours = 1 
individual, 17 hours = 2 individuals, 18 hours = 1 individual). The reason for this 
was that these sleep duration values were considered extreme, as it is possible 
that these values were errors or could reflect illness in these respondents. Thus, 
sleep duration was cleaned in the same way as in ELSA.  
2.2.5.3.3 Phenotypic data included in this thesis 
For the purposes of this thesis, data from UKHLS respondents were used only if 
they had phenotypic data and genotypic data. This is because UKHLS was 
included in both of the genetic studies (Chapters 5 and 6). Thus, Table 2.4 
displays summary statistics for BMI and sleep duration for individuals who had 
phenotype and genotype data.  
As BMI was collected from two different nurse visits (waves 2 and 3), to maximise 
the sample size for the genetic analyses, both waves were used. Thus, as different 
respondents received a nurse visit at wave 2 from those in wave 3, the sample size 
was maximized for BMI by combining these participants.  
This collapsed variable that combined all respondents who had a BMI 
measurement was provided, alongside the genetic data. Similarly, to maximise 
the sample size for sleep duration from waves 1 and 4, an overall sleep duration 
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variable was created that took into account respondents who had sleep duration 
at either wave 1 or 4. Thus, if a participant completed the sleep duration question 
at wave 1, but they were no longer in the study at wave 4, their wave 1 
measurement was used, and if a participant entered the study at wave 4 and 
hence, lacked sleep duration at wave 1, then their wave 4 response was analysed. 
Wave 1 was prioritised, as it had a larger sample size than wave 4; specifically, at 
wave 1, 5,486 respondents had both genetic data and sleep duration, whilst at 
wave 4, 5,001 respondents had genetic and sleep duration data. Therefore, if a 
participant had sleep duration data at wave 1, that was used for analysis, whereas 
for those who did not have sleep duration measurements at wave 1, but did have 
them at wave 4, those data were used.  
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 Genetic data 
During the wave 2 and 3 nurse visits participants provided informed consent to 
have a blood sample taken and to have DNA extracted from it for use in scientific 
research. Of the 13,517 individuals who consented to giving a blood sample, 10,484 
White/European individuals were genotyped.  
2.2.5.3.4 Genotyping & QC 
The genotyping and QC of the data were led by Prof. Eleftheria Zeggini’s group at 
the Wellcome Trust Sanger Institute. Genotyping was done using the Illumina 
Infinium HumanCoreExome BeadChip Kit, which includes a panel of more 
>240,000 common and rare exonic variants, as well as >250,000 genome-wide 
SNPs. Individual-level QC included the following filters: call rate of <98%, gender 
discrepancies, duplicate individuals as per an identity by descent (IBD: refers to a 
matching DNA segment shared by at least two people, which is inherited from a 
common ancestor with no recombination, that is when offspring are produced 
with trait combinations that are distinct from those of either parent) cut-off >0.9, 
ethnic outliers. A total of 9,965 individuals survived this QC. During the SNP-
level QC, variants with a HWE p-value <1x10-4, call rate <98%, poor genotype 
clustering values (<0.4), alongside Y-chromosome and mitochondrial variants. 
This left a total of 525,314 SNPs that passed QC.  
As UKHLS is a household study, further relatedness exclusions were applied prior 
to GWAS analyses (Chapter 5). There are different methods for dealing with 
relatedness; the chosen method here was that recommended by Yang et al., 
201019, in which an identity-by-descent cut-off is chosen to remove closely related 
individuals prior to performing the main analyses 208. In this method, the genetic 
relationship matrix (GRM) was estimated between pairs of individuals from a set 
of SNPs. Then an identity by descent (IBD) cut-off of 0.025 was used, which 
excludes individuals who are related up to third or fourth cousins209. Thus, of the 
original sample (n=9,994) who were genotyped and passed QC, IBD excluded 
n=1,001 individuals (one per related pair). 
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2.2.5.3.4.1 Imputation 
Prior to imputation family groups with genetic relatedness discordant with stated 
relationships were removed, as well as SNPs with a MAF of ≤1%. Genotypes were 
imputed to the European component of 1000 Genomes, Phase 1. Phasing was 
carried out using MACH1 software and imputation was carried out in Minimac. 
Imputation was performed in chunks of 1000 markers, with an overlap of 250 
markers between chunks. Post imputation chunks were merged with the ‘best’ 
(highest R2) kept in the overlapped segments. All imputed genotypes had an R2 of 
≥0.3.  
Table 2.5 Summary of datasets  
Study Phenotype – n (mean, SD) n Genotyped  Imputation n for 
analyses* 
(chapter) 
 BMI** Sleep 
duration 
WC Wave    
ALSPAC N/A 7,404  
(7.61, 0.97) 
 
N/A 
2003  
10,321 
 
1k Genomes 
4,914 (5) 
ELSA 8,262  
(28.27, 5.30) 
7,693  
(28.21, 5.10) 
10,566  
(6.85, 1.34) 
9,964  
(6.84, 1.33) 
 
 
7,866  
(96.38 
,13.94) 
4 
 
6 
 
7,607 
 
1k Genomes 
5,015 (3) 
6,028 (5,6) 
5,296 (6)## 
 
TESS 552 (-0.11, 0.88) 
509 (0.09, 0.90) 
686 (0.12, 1.01) 
674 (9.62, 
0.72) 
547 (9.09, 
0.57) 
633 (9.19, 
0.70) 
 
N/A 
2 
3 
4 
 
N/A 
 
N/A 
 
794*** (4) 
UKHLS 9,660  
(28.07, 5.60) 
 
 
5,574 (6.85, 
1.44) 
8,855 (6.61, 
1.36) 
N/A 2/3# 
1 
4 
 
10,484 
 
1k Genomes 
 
8,608 (5,6) 
6,811 (6)## 
 
Note. ALSPAC= Avon Longitudinal Study of Parents and Children, ELSA= English 
Longitudinal Study of Ageing, TESS= Trondheim Early Secure Study, UKHLS= 
UK Household Longitudinal Study, *number of individuals with complete data 
for relevant analysis, **BMI-SDS, ***these analyses were performed using a 
maximum likelihood approach and therefore, all available data were used, #BMI 
measurements were collected at a nurse visit during either wave 2 or 3 (for 
different participants), see section on UKHLS above for more details, ##number 
of individuals included in observational analysis in Mendelian randomisation 
study in Chapter 6.  
2.3 CHAPTER SUMMARY 
 An overview of the datasets used in this thesis was provided. 
 A description of each sample was given including ethics and participant 
information. 
 Information was provided about how the main phenotypic data analysed in 
this thesis were collected: BMI and sleep duration, including summary 
statistics. 
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 Where necessary (all datasets, with the exception of TESS), an overview of the 
genetic data was provided, including genotyping, QC and imputation 
methods.  
 
 
3 INVESTIGATING THE BIDIRECTIONAL 
ASSOCIATION OF ADIPOSITY AND SLEEP 
DURATION IN OLDER ADULTS 
 
Results from the work in this chapter are published in: Garfield, V., Llewellyn, C. 
H., Steptoe, A. & Kumari, M. Investigating the Bidirectional Associations of 
Adiposity with Sleep Duration in Older Adults: The English Longitudinal Study of 
Ageing (ELSA). Sci. Rep. 7, (2017).  
3.1 BRIEF INTRODUCTION AND OVERVIEW OF CHAPTER 
CONTENTS 
As mentioned in Chapter 1 when reviewing the literature on BMI and sleep 
duration, it appeared that the magnitude of this relationship might differ by age 
group such that associations diminish in older age groups. As stated earlier in 
this thesis, it has been hypothesized that greater BMI may precede shorter sleep 
duration or that shorter sleep duration may precede weight gain. Thus, it is 
important to determine the direction of this association in older adults because if 
the direction of this relationship is established it will enable health professionals 
to understand better where to target interventions in older age groups, when 
disease and frailty are most likely to occur. 
Cross-sectional evidence in older adults primarily suggests that short sleep is 
associated with greater adiposity106,107. However, the prospective relationship is 
less clear in this age group. For example, analyses of the Whitehall II study found 
no evidence of an association between shorter sleep duration and changes in BMI 
or obesity incidence over 4 years, in a sample with a mean age of fifty-six years111, 
yet prospective analysis of 3,576 Spanish older adults suggests that a sleep 
duration of less than or equal to 5 hours, as well as a sleep duration of 8 or 9 
hours is associated with obesity and with weight gain over a period of two years, 
but only in females210.   
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This study is also very timely since the UK has an increasing ageing population. 
Over twenty-three million people are currently aged 50 and over, which 
constitutes more than a third of the UK population211. Projections suggest that by 
2040, 24.2% of the population will be aged 65 or over212. Adults between the ages 
of fifty-five and sixty-four are the most likely to be obese, and whilst obesity 
prevalence decreases, the percentage of overweight adults increases with age213, 
whilst sleep duration decreases as a function of age67. Furthermore, a recent 
report suggests that sleep deprivation costs the UK economy £40 billion 
annually59. These authors also reiterate the importance of sufficient sleep in 
relation to decreased risk of hypertension64, T2D63,187, CVD61 and mortality66.  
It appears that no studies have to date, tested the prospective, bidirectional 
relationship between adiposity and sleep duration in a single study, in older 
adults. Also, importantly, BMI may not be the most optimal adiposity indicator in 
older adults, due to its reduced ability to predict body fat in this population88,90. 
This is because muscle mass decreases as a function of age, which is known as 
sarcopenia88,90. Few studies have investigated the association of alternative 
adiposity measures with sleep duration, such as waist circumference (WC), with 
evidence emerging in favour of a cross-sectional110,214, but not a prospective 
relationship215. No studies have previously examined the association between WC 
and potential change in sleep duration over time, nor have they incorporated 
bidirectional analyses. Also, evidence suggests that there is a relationship 
between lower socioeconomic position (SEP) and sleep duration64,216–219, 
depression and sleep duration60,220, SEP and obesity221,222, and BMI and 
depression223 and thus, these factors should be explored as important covariates 
in this relationship.  
This chapter begins with specific aims for the study presented here, followed by 
the methods used to examine this bidirectional relationship of adiposity and 
sleep duration in older adults. There is then a description of results from both 
cross-sectional and longitudinal analyses. This is followed by a discussion of the 
findings, in which potential mechanisms for the association of adiposity and 
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sleep duration are put forward. The discussion ends with directions for future 
research and the final section of this chapter provides a summary of key points.   
3.2 AIMS OF THIS CHAPTER 
The aim of this chapter was to investigate the following two hypotheses: i) in 
cross-sectional analyses baseline adiposity (BMI and WC) is negatively associated 
with baseline sleep duration and ii) prospectively, that the relationship between 
adiposity (BMI and WC) and self-reported sleep duration, would be bidirectional, 
such that greater adiposity at baseline is associated with shorter sleep duration at 
follow-up, and that shorter sleep duration at baseline is associated with great 
adiposity at follow-up. 
3.3 METHODS 
For the work carried out in this chapter, I designed the study, performed all data 
cleaning and all of the statistical analyses.  
3.3.1 Sample: ELSA 
In this study data were analysed from 5,015 respondents from waves 4 and 6 of 
ELSA; inclusion of respondents was based on whether they had complete data for 
measures of adiposity, sleep duration and all covariates at both waves of data 
collection. Thus, after each variable was cleaned (details in Chapter 2), all 
variables were merged into one file, individuals who did not have two BMI and 
WC measures, two sleep duration measures and all covariates were excluded 
from the analyses (n=1,090).  
3.3.2 Measures 
Details of how each measure was cleaned and prepared are in Chapter 2.  
BMI 
BMI was derived from height and weight using the standard formula: weight 
divided by height squared (kg/m2).  
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WC  
An average of two WC measurements taken during the nurse visits at waves 4 
and 6 was used (see Chapter 2). These categories were defined using the WHO 
definition for risk of metabolic syndrome224.   
Sleep duration and change in sleep duration 
Respondents were asked ‘How many hours of sleep do you have on an average 
week night?’ (Further details on cleaning and preparing the measure are in 
Chapter 2). Change in sleep duration from baseline to follow-up was calculated 
by subtracting sleep duration at wave 6 from sleep duration at wave 4. 
Covariates 
Demographic, socio-economic and health behaviour measures collected at wave 
4 were used as covariates in the analyses. The covariates included in these 
analyses were chosen on the basis that they might be associated with the 
outcome of interest (sleep duration or BMI/WC).  
Demographics 
Age was recorded as a continuous number (in years) until 90 years, with ages 
above 90 collapsed to the value of 91. Socio-economic position was determined by 
quintiles of non-pension wealth, which is regarded as the most salient measure of 
standard of living in older age groups225. 
Health behaviours 
Frequency of alcohol consumption within the last 12 months [categorised to less 
than daily; daily (5-7 times per week)] was measured with the question: ‘Thinking 
now about all kinds of drinks, how often have you had an alcoholic drink of any 
kind in the last 12 months?’ The category of ‘less than daily’ also included 
respondents who were non-drinkers. 
Participants were first asked whether they had ever been a smoker and those who 
responded ‘yes’ were asked if they ‘smoke cigarettes at all nowadays’ during the 
wave 4 data collection. Thus, responses were combined from these two questions 
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and a third variable was derived, whereby respondents were categorised into: 
never smoked, ex-smoker and current smoker. 
Physical activity level (Sedentary; Low; Moderate; High) was derived by 
summarising responses to the level of work activity and the ‘type and amount of 
physical activity involved in daily life’ questions (how often respondents 
participated in mild/moderate/vigorous sports or activities). These were 
subsequently categorised into: Sedentary (mild exercise, one to three times per 
week), Low (mild, but no vigorous activity at least once a week), Moderate 
(moderate activity more than once a week, or vigorous activity between one to 
three times per month) and High (heavy manual work or vigorous activity more 
than once per week).  
Health problems 
Long-standing illness was assessed with the following question: ‘do you have any 
long-standing illness, disability or infirmity? By long-standing I mean anything 
that has troubled over a period of time, or that is likely to affect over a period of 
time’, to which they could answer ‘No’ or ‘Yes’). If respondents answered ‘yes’ 
then a further question was asked about whether the illness/illnesses limit 
activities in any way.  
Depressive symptoms (measured with the Centre for Epidemiologic Studies – 
Depression Scale – CESD – 8 item scale) were also assessed by questionnaire. 
CES-D responses were summed (with the exception of the item: “whether 
respondent felt their sleep was restless in the past week”) to obtain a total score, 
which was then dichotomized using a cut-off of >=3, which has recently been 
used in other ELSA publications226. Due to removal of the sleep item, it seemed 
plausible to check whether retaining at cut-off of >=3 was appropriate or whether 
this should be lowered to >=2. However, the cut-off of >=3 was retained, as 
lowering the cut-off to >=2 meant that this was unlikely to be accurately 
capturing those who had depressive symptoms because the percentage of those 
without depressive symptoms changed from 67% to 2%. This was due to the large 
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number of respondents who scored 2 and would thus, be classed as ‘depressed’ 
using this lower cut-off.   
Season 
As sleep duration can differ depending on the season, a dichotomous season 
variable was created using the date that respondents completed their interview, 
which resulted in a categorisation of 0= “BST” (British Summer Time) and 1= 
“GMT” (Greenwich Mean Time). However, in linear regression models adjusted 
for age and sex, no association was observed between season at baseline and 
sleep duration at wave 4 [B (unstandardised coefficient) = 0.022, (95% CI= -0.047; 
0.091), P=0.533] or wave 6 [B= 0.009, (95% CI= -0.079; 0.061), P=0.800], and were 
therefore not included in subsequent analyses.  
3.3.3 Statistical analyses 
Analyses were performed in STATA, version 13. 
3.3.3.1 Power calculations 
Observed (post-hoc) power was calculated using G*Power, by taking the R2 values 
from the simple linear regression models of exposures on outcomes in this study. 
This was done in the exact same way for the cross-sectional and bidirectional 
prospective regression models. The parameters used to calculate power were: 
effect size F2, % error probability, total sample size and number of tested 
predictors. F2 for the effect size was calculated as: R2 / 1 - R2, by taking the R2 from 
simple (unadjusted) cross-sectional and prospective bidirectional models.   
The alpha level was set at 0.05, the total n was 5,015 and the number of tested 
predictors was 1 for cross-sectional and prospective analyses. Power calculations 
indicated that there was sufficient power to detect the observed effect sizes 
(Table 3.2).   
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Table 3.1 Power calculations for cross-sectional and bidirectional prospective 
analyses in ELSA 
Model Effect 
size F2* 
% error 
probability 
N No. tested 
predictors 
Power 
Cross-sectional 0.0025 0.05 5015 1 94.2% 
Prospective  
BMI on sleep 
duration 
0.0041 0.05 5015 1 99.4% 
Prospective Sleep 
duration on BMI   
0.0021 0.05 5015 1 88.6% 
Note. *For cross-sectional models this (F2) was calculated as: R2/ 1 – R2 = 0.0025 / 1 
– 0.0025 = 0.0025; for prospective models of BMI on sleep duration this was 
calculated as:  R2/ 1 – R2 = 0.0041 / 1 – 0.0041 = 0.0041; for prospective models of 
sleep duration on BMI this was calculated as: R2/ 1 – R2 = 0.0021 / 1 – 0.0021 = 
0.0021. All of these R2 values were taken from results of simple linear regression 
models (exposure  outcome only) in ELSA.   
3.3.3.2 Univariate associations 
For examination of baseline sample characteristics sleep categories were created 
to examine potential differences in adiposity and covariates, as well as to examine 
linearity of adiposity, according to how much sleep participants reported. More 
specifically, these categories were defined as 1= ≤5 up to 5.4 hours, 2= 5.5 hours 
up to and including 7 hours, 3= 7.5 hours up to and including 9 hours and 4= >9 
hours.  
Then, one-way ANOVAs were used to compare means for age, BMI and WC, 
whilst Chi-squared tests were used to examine differences in categorical 
demographic variables (smoking status, alcohol consumption, long-standing 
illness, wealth, sex, ethnicity and depressive symptoms) across the 4 sleep 
duration groups. Depressive symptoms are also described by sex in the Results, 
due to known differences in prevalence of depression in men and women227. Also, 
two-sample t-tests were performed to examine whether there were significant 
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differences between baseline and follow-up mean BMI and WC to establish the 
amount of change over time.  
3.3.3.3 Regression models  
Regression analyses were performed to examine the linear cross-sectional and 
bidirectional prospective relationships of BMI with sleep duration. BMI, WC and 
sleep duration were treated as continuous variables and thus, linear models were 
tested, both cross-sectionally and prospectively. In all linear regression models 
the coefficients presented in Tables 3.2, 3.3 and 3.4 represent unstandardised 
coefficients (B). Multicollinearity was tested in all regression models using the 
variance inflation factor (VIF) to examine the extent to which predictors were 
correlated. A VIF of 1 indicates no correlation, whilst values >10 are generally 
cause for concern32. 
3.3.3.3.1 Cross-sectional models 
To examine whether there was an inverse cross-sectional relationship between 
adiposity and sleep duration, four regression models were performed, with BMI 
or WC as the exposure and sleep duration as the outcome.  
Model 1 was minimally-adjusted (age, sex, wealth, ethnicity). Model 2 was 
adjusted for the covariates in model 1 + health behaviours (model 1 + alcohol 
consumption, smoking status, physical activity levels). Model 3 was adjusted for 
the covariates in model 1 + health problems (model 1 + depressive symptoms, 
long-standing illness). Model 4 was the final model and was fully-adjusted for all 
covariates [model 1 (demographics) + model 2 (health behaviours) + model 3 
(health problems)]. These models were adjusted hierarchically to examine 
whether there was confounding in the association of adiposity and sleep 
duration, by important behavioural and health factors. 
3.3.3.3.2 Prospective models 
Prospectively, the association between baseline adiposity (BMI and WC) and 
changes in sleep duration, as well as baseline sleep duration and changes in 
adiposity were investigated. To examine change in sleep duration, linear 
regressions were performed with adiposity measures (BMI or WC) as the 
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exposure, sleep duration as the outcome, and models were adjusted for covariates 
as well as baseline sleep duration. Conversely, in analyses to examine changes in 
adiposity, BMI or WC at follow-up was analysed as the outcome with sleep 
duration at baseline adjusted for BMI or WC at baseline as the exposure. Aside 
from this difference, Models 1 to 4 were identical to the cross-sectional models 
described above.  
3.3.3.3.3 Non-linear models 
Quadratic regression modelling was used to investigate potential non-linear 
associations in cross-sectional and prospective, bidirectional relationships 
between adiposity measures (BMI and WC) and sleep duration. Models were run 
to examine the possible quadratic cross-sectional relationship between BMI and 
WC as exposures with sleep duration (outcome) at wave 4 (baseline) of ELSA. 
These models varied in adjustments, which were as follows: Model 1= age, sex, 
wealth and ethnicity, Model 2= Model 1 + health behaviours (alcohol 
consumption, physical activity and smoking status), Model 3= Model 1 + health 
problems (depressive symptoms, long-standing illness), Model 4= Model 1 + 
Model 2 + Model 3. Covariates were grouped into these categories 
(demographics, health behaviours and health problems), as the aim was to 
examine whether clusters of factors might affect the association between the 
exposure and outcome.   
As the aim of this study was to test the bidirectional association of adiposity with 
sleep duration, two sets of quadratic analyses were performed on the prospective 
data. To investigate whether there was a U-shaped prospective relationship 
between BMI/WC at baseline and follow-up sleep duration, quadratic (BMI2 and 
WC2) terms were created and included in the regression models. Analyses were 
then performed to investigate the potential U-shaped association of sleep 
duration-squared at baseline with BMI and WC at follow-up. In models where 
BMI2 or WC2 predicted changes in sleep duration covariates were identical to the 
cross-sectional models described above, but included additional adjustments for 
baseline sleep duration (Model 1= demographics + baseline sleep duration; Model 
2= model 1 + health behaviours + baseline sleep duration; Model 3= model 1 + 
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health problems + sleep duration; Model 4= model 1 + model 2 + model 3). In 
regression models that predicted changes in adiposity (BMI or WC), a sleep 
duration2 term was created to test for a U-shaped association between sleep 
duration and adiposity. Four models were run for BMI and WC separately, with 
adjustments for covariates as above, but also included adjustments for baseline 
BMI or WC to investigate change.  
3.3.3.3.4 Difference in coefficients before and after adjustments for 
covariates 
To test for confounding of the relationship between adiposity and sleep duration 
by demographics, health behaviours and health problems, the percentage 
reduction in the regression coefficient following adjustment was calculated by 
comparing the coefficient for each exposure from models with and without 
adjustment for covariates. For example, if the unstandardised coefficient changes 
from B=0.60 to B=0.40 from one model to the next, this would mean that there is 
a 33% reduction in the coefficient. This is illustrated as follows:  
B1 =0.60 (B from Model 1) 
B2=0.40 (B from Model 2) 
To calculate the percentage change:  
[(B1 – B2) / B1] = [(0.60 – 0.40) / 0.60] = 0.33  33%  
3.3.3.3.5 Moderation by age and sex 
Cross-sectional interactions with age and sex 
To investigate potential moderation by age and sex, interaction terms between 
baseline adiposity (BMI and WC) and sleep duration with age and sex were 
created. Analyses were not stratified if there was no significant interaction 
between these variables, as this is not common practice in epidemiological 
analyses228, nor is it statistically correct. The pursuit of stratified analysis, in the 
absence of a significant interaction can yield significant subgroup effects, but 
these are likely to be due to chance228.  
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Prospective interactions with age and sex 
An interaction term was also created to examine the potential effect modification 
of sleep duration by age and sex on adiposity measures. Then, linear regression 
modelling was used to examine whether there were any differential effects of BMI 
by age or sex on sleep duration and changes in sleep duration. Linear regressions 
were also performed to examine whether there were any differential effects of 
sleep duration by age and sex on adiposity. 
3.4 RESULTS 
3.4.1 Sample characteristics 
Compared with all participants at wave 4 of ELSA, those included in this study 
were wealthier, slightly older and less likely to report having a long-standing 
illness (all p<0.05).  
Table 3.1 shows baseline (wave 4) characteristics of participants, according to 
their sleep duration category. It can be seen that the majority of respondents 
reported sleeping between 6 to 7 hours (53.06%) or 8 to 9 hours (33.12%), whilst 
only a small proportion slept for ≤5 hours (12.6%) and even fewer reported 
sleeping for >9 hours (1.22%). Although not presented in a table, a chi-squared 
test showed that there were significant differences (p<0.001) between the number 
of females vs. males, who reported depressive symptoms: 1,032 (37.16%) females 
out of 2,777 vs. 578 (25.83%) males out of 2,238. This is in relation to an earlier 
point about differences between males and females in prevalence estimates of 
depression227. 
One-way ANOVAs showed that there were significant differences across sleep 
duration categories for both age and BMI, such that respondents who slept >9 
hours were on average, older than the rest of the sample and that those who slept 
for ≤5 hours had on average, the highest BMIs. There were, however, no 
significant differences in baseline waist circumference across the four sleep 
duration categories. Pearson’s correlations between BMI and WC (at baseline) for 
males and females were r=0.87 (p<0.001) and r=0.86 (p<0.001), respectively.  
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Chi-squared analyses showed that sex, smoking status, alcohol consumption, 
limiting illness, wealth, depressive symptoms and physical activity levels, were all 
significantly associated with sleep duration. Short sleepers (≤5 hours) were 
significantly more likely to be females, ex-smokers, less wealthy, consume less 
alcohol, report a long-standing illness and engage in ‘moderate’ physical activity 
(Table 3.1). There was no evidence of multicollinearity in any of our cross-
sectional or prospective regression models, as all VIF values were around 1 when 
tested.    
Mean BMI values were 28.20 kg/m2 and 28.17 kg/m2, at baseline and follow-up 
respectively, whilst average duration of sleep was 6.86 hours at baseline and 6.87 
hours at follow-up indicating no change over time for either BMI or sleep 
duration, across the sample as a whole. Respondents who slept for five hours or 
less had the highest mean BMI both at baseline (28.72 kg/m2) and follow-up 
(28.71 kg/m2), whilst those who slept between eight and nine hours had the 
lowest mean BMI at baseline (27.99 kg/m2), which remained identical at follow-
up (27.99 kg/m2). Overall, mean WC at baseline was 96.49 cm and 96.09 cm at 
follow-up.    
Figures 3.1 and 3.2 depict baseline and follow-up sleep duration by weight status. 
In Figure 3.1 it can be seen that respondents in the normal weight group had the 
longest mean sleep duration at baseline (6.93 hours), whilst at follow-up the 
longest mean sleep duration was observed in the underweight group (7.14 hours). 
The shortest duration of sleep at baseline was observed in the underweight group 
(6.77 hours) and at follow-up, those with the shortest average sleep duration 
were respondents in the obese category (6.76 hours). In Figure 3.2 it can be seen 
that at baseline, those with the longest average sleep duration were respondents 
in the not-at-risk group (6.95 hours), which was identical at follow-up. Similarly, 
at both baseline and follow-up, respondents with the shortest mean sleep 
durations were those at substantially increased risk (6.82 and 6.80 hours). 
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Table 3.2 Sample characteristics at baseline by sleep duration category (N=5,015) 
 
≤5 hrs 6-7 hrs 8-9 hrs >9 hrs Total P 
 n=632 n=2,661 n=1,661 n=61 N=5,015  
Age (years)** 65.25 (8.56) 64.29 (8.43) 65.15 (8.03) 68.51 (8.86)  <0.001 
Sex** 
Male 
Female 
 
219 (34.65) 
413 (65.35) 
 
1,243 (46.71) 
1,418 (53.29) 
 
755 (45.45) 
906 (54.55) 
 
21 (35.43) 
40 (65.57) 
 
2,238 (44.63) 
2,777 (55.37) 
<0.001 
Ethnicity  
White 
Non-white 
 
616 (97.47) 
16 (2.53) 
 
2,615 (98.27) 
46 (1.73) 
 
1,635 (98.43) 
26 (1.57) 
 
60 (98.36) 
1 (1.64) 
 
4,926 (98.23) 
89 (1.77) 
>0.05 
BMI (kg/m2)* 
  
28.75 (5.54) 
 
28.10 (4.91) 
 
27.99 (4.78) 
 
28.09 (5.76) 
 
5,015  
 
<0.05 
WC (cm) 
Males 
Females 
103.72 (12.91) 
93.47 (13.31) 
102.22 (11.28) 
91.63 (12.69) 
101.36 (11.13) 
91.76 (12.72) 
102.55 (8.65) 
94.32 (16.29) 
102.08 (11.39) 
91.99 (12.86) 
<0.05 
<0.05 
Smoking status* 
Never smoked 
Ex-smoker 
Current smoker 
 
244 (38.61) 
290 (45.89) 
98 (15.51) 
 
1,160 (43.59) 
1,198 (45.02) 
303 (11.39) 
 
739 (44.49) 
751 (45.21) 
171 (10.30) 
 
26 (42.62) 
23 (37.70) 
12 (19.67) 
 
2,169 (43.25) 
2,262 (45.10) 
584 (11.65) 
 
 
<0.05 
Alcohol 
consumption* 
Less than daily 
Daily (5-7 
days/week) 
 
 
517 (81.80) 
115 (18.20) 
 
 
2,042 (76.74) 
619 (23.26) 
 
 
1,257 (75.68) 
404 (24.32) 
 
 
47 (77.05) 
14 (22.95) 
 
 
3,863 (77.03) 
1,152 (22.97) 
 
 
 
<0.05 
Wealth 
quintile** 
Lowest 
Others  
 
 
154 (24.37) 
478 (75.63) 
 
 
313 (11.76) 
2,348 (88.24) 
 
 
166 (9.99) 
1 518 (90.01) 
 
 
13 (21.31) 
48 (78.69) 
 
 
646 (12.88) 
4,369 (87.12) 
 
 
<0.001 
Long-standing 
illness** 
No 
Yes 
 
 
246 (38.92) 
386 (61.08) 
  
 
1,323 (49.72) 
1,338 (50.28) 
 
 
842 (50.69) 
819 (49.31) 
 
 
20 (32.79) 
41 (67.21) 
 
 
2,431 (48.47) 
2,584 (51.53) 
 
 
 
<0.001 
CES-D** 
No 
Yes (score >=3) 
 
293 (46.36) 
339 (53.64) 
 
1,859 (69.86) 
802 (30.14) 
 
1,221 (73.51) 
440 (26.49) 
 
32 (52.46) 
29 (47.54) 
 
3,405 (67.90) 
1,610 (32.10) 
 
<0.001 
PA levels* 
Sedentary 
Low 
Moderate  
High 
 
36 (5.70) 
185 (29.27) 
291 (46.04) 
120 (18.99) 
 
64 (2.41)  
497 (18.68) 
1,440 (54.11) 
660 (24.80) 
 
36 (2.17) 
285 (17.16) 
956 (57.56) 
384 (23.12) 
 
4 (6.56) 
22 (36.07) 
22 (36/07) 
13 (21.31) 
 
140 (2.79) 
989 (19.72) 
2,709 (54.02) 
1,177 (23.47) 
 
 
<0.05 
Note. BMI = Body Mass Index; WC= waist circumference, Means (SDs) or n (%), 
PA = physical activity, CES-D = Centre for Epidemiologic Studies of Depression 
Scale.  
3.4.2 Cross-sectional associations: BMI and sleep duration at baseline 
and WC and sleep duration at baseline 
3.4.2.1 BMI and sleep duration at baseline 
Model 1 (with adjustment for age, sex, wealth, ethnicity) revealed a small, inverse 
linear relationship between BMI and sleep duration, which was attenuated and 
no longer significant in Model 2 (Model 1 with additional adjustment for health 
behaviours; Model 1 to Model 2 = 11% decrease in the coefficient), and further 
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weakened in Model 3 (Model 1 with adjustment for health problems; Model 1 to 
Model 3 = 34% decrease in the coefficient). In the final model adjusted for all 
covariates this effect was again, attenuated (Model 1 to Model 4 = 36% decrease in 
the coefficient) (Table 3.2). There was no interaction between sex (p=0.822) or 
age (p=0.366) and BMI at baseline on sleep duration, in any of the four models. 
Quadratic cross-sectional regression models were also performed to test for a U-
shaped relationship between BMI and sleep duration, but this was not significant 
(p=0.987).  
3.4.2.2 WC and sleep duration at baseline 
The pattern of results for waist circumference and sleep duration was almost 
identical to that of BMI and sleep duration (Table 3.2). In a model adjusted only 
for demographics there was a significant, negative association between WC and 
sleep duration (Model 1), which was attenuated with inclusion of health 
behaviours in Model 2 (Model 1 to Model 2 = 22% decrease in the coefficient). 
With adjustments for health problems, the coefficient was again, reduced (Model 
1 to Model 3 = 39% decrease in the coefficient) and a final model including all 
covariates resulted in further attenuation (Model 1 to Model 4 = 44% decrease in 
the coefficient). We observed no evidence of a U-shaped association between 
baseline WC and sleep duration (p=0.103), nor did we find a significant 
interaction of age (p=0.084), or sex (p=0.300) with baseline WC on sleep 
duration.  
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Table 3.3 Cross-sectional associations between adiposity and sleep duration at 
Wave 4 of ELSA (N=5,015) 
BMI (baseline) 
Sleep duration (baseline)  B (minutes) 95% CI P 
Basic model (1) -0.44 -0.014 – -0.000 0.033 
Adjusted for health behaviours (2) -0.39 -0.013 – -0.000 0.065 
Adjusted for health problems (3)  -0.29 -0.012 – -0.002 0.167 
Fully-adjusted model (4) -0.28 -0.012 – 0.002 0.190 
Waist circumference (baseline) 
Sleep duration (baseline) B (minutes) 95% CI P 
Basic model (1) -0.18 -0.006 – -0.000 0.034 
Adjusted for health behaviours (2) -0.14 -0.005 – 0.000 0.087 
Adjusted for health problems (3) -0.11 -0.005 – -0.000 0.198 
Fully-adjusted model (4) -0.10 -0.004 – 0.001 0.270 
Note. This table presents the cross-sectional association between baseline 
BMI/WC as exposures and baseline sleep duration as the outcome, with different 
levels of adjustment for covariates. (1) Adjusted for age, sex, wealth, ethnicity; (2) 
Basic model + physical activity, smoking status, alcohol consumption; (3) Basic 
model + long-standing illness, depressive symptoms; (4) Basic model + health 
behaviours + health; B (Unstandardized coefficient) = difference in sleep duration 
(minutes) per difference in WC (cm), 95% CI= 95% confidence interval, P= 
regression p-value.  
3.4.3 Prospective associations I: BMI and changes in sleep duration; WC 
and changes in sleep duration  
3.4.3.1 BMI and changes in sleep duration 
The first set of prospective analyses performed had baseline BMI as the exposure 
and follow-up sleep duration as the outcome, the results of which are shown in 
Table 3.3. Model 1 revealed a negative association between baseline BMI and 
follow-up sleep duration, such that a higher BMI was associated with increasingly 
shorter sleep at wave 6. In Model 4, the longitudinal association between BMI 
and sleep duration was only slightly attenuated (Model 1 to Model 4, 12.5% non-
significant decrease in the coefficient, p>0.05).  
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3.4.3.2 WC and changes in sleep duration 
On average, the change in sleep duration from baseline to follow-up was -0.42 
minutes per unit increase in BMI. A very similar pattern of associations was 
observed between WC and changes in sleep duration, such that for every 
centimetre increase in WC at baseline, sleep duration at follow up decreased, on 
average, by 0.18 minutes. Although very small, this effect remained significant 
after adjustment for all covariates in Model 4 and the coefficient was identical 
throughout the models (Table 3.3). The mean change in sleep duration from 
baseline (6.867 hours) to follow-up (6.872 hours) was 0.005 hours (0.3 minutes), 
standard deviation = 1.13 hours (67.5 minutes). This indicated that, on average, 
durations of sleep did not change over the 4-year follow-up period. 
There were no interactions of baseline age or sex with BMI and WC on follow-up 
sleep duration in any of the 4 models (p>0.05).  There was no evidence of a 
quadratic association between baseline BMI or WC and follow-up sleep duration 
(p>0.05).  
3.4.4 Prospective associations II: Sleep duration and changes in BMI; 
sleep duration and WC  
3.4.4.1 Sleep duration and changes in BMI 
The longitudinal analyses presented in Table 3.4 revealed no significant 
associations between sleep duration and future BMI. Across all 4 models, there 
was no evidence of a linear association between sleep duration at baseline and 
BMI at 4-year follow-up. Nor was a U-shaped association observed (p>0.05). 
Although age at baseline was strongly associated with BMI at follow-up [B=-0.020 
kg/m2, (95% CI= -0.027; -0.013) P<0.001] after adjustment for BMI at baseline and 
all other covariates, there were no interactions between baseline age or sex with 
sleep duration on BMI at follow-up in any of the 4 models (all p>0.05).  
3.4.4.2 Sleep duration and changes in WC  
Similarly, there was no significant association between sleep duration at baseline 
and changes in waist circumference (Table 3.4) in any of the 4 regression models 
(all p>0.05). There were also no significant interactions between age and baseline 
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sleep duration, or sex and baseline sleep duration on follow-up WC, nor was 
there evidence of a quadratic association (all p>0.05). Thus, results are presented 
for males and females together, with the exception of WC in the sample 
characteristics table (Table 3.1), which is presented separately for males and 
females, across sleep duration categories. 
Table 3.4 Prospective associations between adiposity at Wave 4 (baseline) and 
change in sleep duration at Wave 6 (follow-up) of ELSA (N=5,015) 
BMI (baseline) 
Sleep duration (follow-up) B (minutes) 95% CI P 
Basic model (1) -0.48 -0.014 – -0.003 0.004 
Adjusted for health behaviours 
(2) 
-0.48 -0.014 – -0.003 0.004 
Adjusted for health problems (3)  -0.48 -0.013 – -0.002 0.012 
Fully-adjusted model (4) -0.42 -0.013 – -0.002 0.013 
Waist circumference (baseline) 
Sleep duration (follow-up) B (minutes) 95% CI P 
Basic model (1) -0.18 -0.006 – -0.000 0.005 
Adjusted for health behaviours 
(2) 
-0.18 -0.006 – -0.000 0.007 
Adjusted for health problems (3)  -0.18 -0.005 – -0.000 0.015 
Fully-adjusted model (4) -0.18 -0.005 – -0.000 0.016 
Note. This table presents the prospective association between baseline BMI/WC 
as exposures and follow-up sleep duration as the outcome, with different levels of 
adjustment for covariates. (1) Adjusted for age, sex, wealth, ethnicity and baseline 
sleep duration; (2) Basic model + physical activity, smoking status, alcohol 
consumption, baseline sleep duration; (3) Basic model + long-standing illness, 
depressive symptoms, baseline sleep duration; (4) Basic model + physical activity, 
smoking status, alcohol consumption, long-standing illness, depressive 
symptoms, baseline sleep duration; B (Unstandardized coefficient) = change in 
sleep duration (minutes) per unit change in BMI (kg/m2) or WC (cm), 95% CI 
=95% confidence interval, P= regression p-value. 
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Table 3.5 Prospective associations between sleep duration at Wave 4 (baseline) and 
change in adiposity at Wave 6 (follow-up) of ELSA (N=5,015) 
Note. This table presents the prospective association between baseline sleep 
duration (exposure) and follow-up BMI/WC (outcome), with increasing levels of 
adjustment for covariates. (1) Adjusted for age, sex, wealth and baseline BMI or 
WC; (2) adjusted for age, sex, physical activity, smoking status, alcohol 
consumption, baseline BMI or WC; (3) adjusted for age, sex, long-standing 
illness, depressive symptoms, baseline BMI or WC; (4) adjusted for age, sex, 
wealth, physical activity, smoking status, alcohol consumption, long-standing 
illness, depressive symptoms, baseline BMI or WC; B (Unstandardized 
coefficient) = change in BMI (kg/m2) or WC (cm) per change in sleep duration 
(minutes), 95% CI= 95% confidence interval, P= regression p-value. 
 
 
 
 
 
 
 
 
 
Sleep duration (baseline) 
BMI (follow-up) B (kg/m2) 95% CI P 
Basic model (1) 0.005 -0.039 – 0.053 0.755 
Adjusted for health behaviours 
(2) 
0.008 -0.038 –0 .054 0.725 
Adjusted for health problems (3) 0.009 -0.044 – 0.055 0.712 
Fully-adjusted model (4) 0.009 -0.037 – 0.055 0.696 
Sleep duration (baseline) 
Waist circumference (follow-up) B (cm) 95% CI P 
Basic model (1) -0.06 -0.195 – 0.082 0.426 
Adjusted for health behaviours 
(2) 
-0.05 -0.189 – 0.089 0.480 
Adjusted for health problems (3) -0.06 -0.197 – 0.082 0.416 
Fully-adjusted model (4) -0.05 -0.194 – 0.085 0.447 
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Figure 3.1 Baseline and follow-up sleep duration, by BMI category at baseline  
 
Note. Underweight <18.5 kg/m2 (n=31), Normal weight≥18.5 kg/m2 & ≤24.9 kg/m2 
(n=1,317), Overweight ≥25 kg/m2 & <30 kg/m2 (n=2,154), Obese≥30 kg/m2 
(n=1,513).  
 
Figure 3.2 Baseline and follow-up sleep duration, by WC category at baseline 
 
Note. Not-at-risk <80 cm (females) and <94 cm (males) [n=1,031], At increased 
risk>=80 cm, but <88 cm (females) and >=94 cm, but <102 cm (males) [n=1,267], 
Substantially increased risk >=88 cm (females) and >=102 cm (males) [n=2,717].  
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3.5 DISCUSSION 
3.5.1 Key findings 
In this large, nationally representative study of older adults, findings suggest that 
cross-sectionally, while both BMI and WC are inversely associated with sleep 
duration, these relationships are largely accounted for by variations in health 
status and health behaviours. Prospectively, greater BMI and WC at baseline 
were associated with sleep duration over a 4-year period, independently of 
adjustment for a variety of covariates.  In contrast, sleep duration at baseline was 
not associated with changes in BMI or WC over the follow-up period. The 
richness of the available dataset enabled analyses that accounted for a number of 
factors, including wealth, illness and depressive symptoms, and health 
behaviours.  
3.5.2 Cross-sectional findings 
Cross-sectional results indicate that adiposity measures (BMI and WC) are not 
associated with self-reported sleep duration, after adjustment for a wide range of 
covariates. This finding is consistent with two earlier large-scale studies, which 
did not find an association between adiposity and sleep duration117,229. However, 
this result does not accord with evidence in favour of this cross-sectional 
relationship in older adults 210,230. One of these studies, which found a significant 
association of BMI and WC with sleep duration in older adults made no 
adjustment for physical long-standing illness or socioeconomic position in their 
analysis230, which could in part explain the discrepancy between the current 
findings and theirs. The authors also used a measure of self-reported sleep 
duration by which respondents were only asked to report how many hours they 
had slept on the two nights prior to the interview230 rather than the more general 
sleep duration question in ELSA which asked about the number of hours sleep on 
an average weeknight. The other study, mentioned above210 also differed 
regarding inclusion of covariates in comparison to the present findings. 
Covariates that these authors adjusted for that were not included in the current 
study were the following: coffee consumption, educational level, social network 
(not online, but ascertained from data on social links), perceived health status, 
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waking up during the night and whether participants were taking anxiolytic 
medication. The authors observed that their cross-sectional relationship of sleep 
duration and adiposity remained robust to this wide range of adjustments. 
However, the present study included adjustment for physical activity, wealth and 
ethnicity, which were not adjusted for in the study by Lopez-Garcia and 
colleagues210. A further disparity was the mean age, as well as age range in this 
sample (72 years) as compared to the present study (65 years). Also, the current 
study included respondents aged 50 or older, whereas Lopez-Garcia et al.’s study 
included only those who were 60 or older.   
Furthermore, as mentioned above, health behaviours also impacted the 
association between BMI and sleep duration at baseline. Specifically, the cross-
sectional models that examined whether BMI/WC were associated with sleep 
duration adjusting only for demographics (wealth, ethnicity, age and sex) 
revealed a significant effect (Appendix 8.1, Table 8.1). However, subsequent 
models that adjusted for health behaviours (PA, smoking and alcohol 
consumption) in addition to demographics, showed a clear attenuation of the 
association between sleep duration and adiposity such that it was no longer 
significant (Appendix 8.1, Table 8.2). On closer inspection, it was apparent that 
PA attenuated the relationship between adiposity (BMI and WC) and sleep 
duration, as associations were observed between PA and sleep duration (p=0.005 
for BMI and p=0.006 for WC), whilst this was not the case for alcohol 
consumption or smoking status (Appendix 8.1, Table 8.2). It is possible that this 
represents mediation by PA, such that respondents with higher BMIs, or shorter 
sleep durations may engage in lower levels of PA, which could lead to shorter 
sleep duration. Evidence suggests that in older adults, PA may protect against 
developing insomnia, for example231.  
Associations in these data concur with several reports that associations exist 
between disadvantaged socioeconomic position and sleep duration64,216–219 
(Appendix 8.1, Table 8.1), and depression and sleep duration60,220 (Appendix 8.1, 
Table 8.3). There is also previous evidence for an association between 
socioeconomic position and obesity221,222, as well as BMI and depression223.  
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When tested there was no statistically significant evidence of a cross-sectional U-
shaped relationship between BMI and sleep duration. However, the finding of 
longest sleep duration in those with BMI between 18.5 and 24.9 kg/m2 agrees with 
previous research71,106,107,112,133. This may reflect reverse causation, as long-standing 
illness is prevalent in older age groups and may lead to weight loss. These 
findings support this notion because adjustment for health problems attenuated 
observed associations.  
Interactions between BMI/WC and sleep duration, and both age and sex were 
tested, but were not significant. The rationale for investigating these potential 
effect modifiers stemmed from some previous literature, which suggests that this 
association changes with age and that there may be sex differences. A handful of 
previous studies found that the relationship between BMI and sleep duration 
diminishes with age111,121,122.  
An early study in this area showed that there was an interaction between age and 
sleep duration, and their association with adiposity, such that after age 34 years 
there was no association between sleep duration and adiposity121. Gangwisch and 
colleagues122 also found that the ORs for obesity in short sleepers (<4 hours) in 
comparison with those who slept seven hours substantially decreased with age: 
the OR for ages 32-49 was 3.21, whilst at ages 68-86 it was 1.71. These findings 
emerged from stratified regression analyses, after the authors found a significant 
age-by-sleep duration interaction and its association with obesity. However, this 
was not apparent in ELSA as no significant age-by-adiposity, or age-by-sleep 
duration was found, thus suggesting that across all ages (range of 50 to 90 years 
and over) the magnitude of association appeared to be the same.  
In ELSA, there was also no evidence of an interaction between sex and adiposity 
and the effect on sleep duration, nor was there an interaction between sex and 
sleep duration and the effect on adiposity. A Japanese study suggested that at 
one-year follow-up sleep duration was associated with increased weight and 
increased risk of obesity in men, but not in women134. Another study, by Mezick 
et al.110 found that sex moderated the effect of objectively measured sleep 
duration on BMI, such that there was only an association in females. However, 
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this was not the case for self-reported sleep duration, as there appeared to be no 
effect modification by sex. Thus, the lack of any significant sex interactions in 
ELSA is in agreement with this earlier study, as self-reported sleep duration was 
also used.    
3.5.3 Prospective findings I: BMI and WC, and changes in sleep duration 
This study was the first to perform bidirectional analyses of adiposity and sleep 
duration in a large sample of older adults. Longitudinal analyses of adiposity at 
baseline with change in sleep duration between baseline and follow-up revealed a 
negative association, such that higher BMI and WC were associated with 
decreased length of sleep. However, it is important to note that these effect sizes 
were very small and are unlikely to be clinically meaningful. Also, on average, no 
change between baseline and follow-up sleep duration was observed, which 
might explain why the magnitude of effect was small. 
Finding that adiposity and sleep duration were associated in a prospective 
analysis accords with previous research, which found evidence of an association 
between average changes in weight gain and average change rates in sleep 
duration121,232. The present study found that both BMI and WC were associated 
with future sleep duration in a sample whose average age was 65 years, but it is 
important to note that this effect size was very small (0.42 minutes). This result is 
in line with a study in younger adults, which suggests that the association 
between adiposity and changes in sleep duration was stronger than the opposite 
relationship, which examined sleep duration and changes in adiposity121.   
In linear models, despite a small effect, both BMI and waist circumference 
remained associated with change in sleep independently of a wide range of 
covariates (measured at baseline), including health and health behaviours. 
However, these effects were small and residual confounding cannot be 
discounted, as it was not possible to examine all other factors that might explain 
the observed association between adiposity and sleep duration.  
For example, an important factor that the analyses were not able to account for 
was napping. A recent study found that both longer sleep duration and prolonged 
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midday napping of greater than or equal to ninety minutes, are potential risk 
factors for incidence of metabolic syndrome233, compared to their counterparts 
who napped for less than, or equal to thirty minutes and reported night time 
sleep durations of between 6 to 7 hours. A recent study in the UK Biobank found 
that, interestingly, the relationship between a genetic risk score of BMI and BMI 
and WC, is moderated by sleep duration and daytime napping 234. These effects 
were observed independently of diet, socio-demographic factors and 
comorbidities234.     
As some previous research has shown that the association between adiposity and 
sleep duration may be U-shaped, prospective quadratic modelling was performed 
for both BMI and WC in relation to sleep duration. Quadratic models showed 
that there was no significant U-shaped association between adiposity and 
changes in sleep duration in ELSA and therefore suggest that this relationship is 
linear in nature.   
3.5.4 Prospective associations II: sleep duration and changes in BMI and 
WC 
In ELSA, there was no evidence of an association between sleep duration and 
change in BMI from baseline to follow-up, nor between baseline sleep duration 
and change in WC at follow-up. That sleep duration was not associated with 
change in BMI or WC specifically in older adults, accords with some235,236, but not 
all previous reports210. One potential explanation for this may relate to the 
stability of adiposity in this age group, as neither average BMI nor WC changed 
greatly in 4 years. This was confirmed by a paired samples t-test, which showed 
that there was no significant difference between BMI at baseline and follow-up in 
the analytic sample (p=0.33). Thus, perhaps further follow-up of the participants 
could reveal associations with BMI that were not yet apparent. WC showed 
greater change over the follow-up period (baseline vs. follow-up, p<0.001), such 
that, on average, WC decreased from 96.49 cm (SD=13.21) at baseline to 96.09 cm 
(SD=13.54) at follow-up, yet evidence suggests that the WCs of older adults tend 
to increase, rather than decrease, over time237. However, there was still no effect 
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of sleep duration on WC and both adiposity measurements yielded consistent 
findings.  
Secondly, it is suggested that the magnitude of the association between sleep 
duration and changes in adiposity measures declines with age121,122. This may 
explain why the results presented here, where mean age is 65 years, and in other 
studies such as the Whitehall II111, are null.  Thus, these data suggest that obesity 
may be a target to ameliorate co-morbidities that occur due to poor sleep, but 
that sleep duration is not a target to prevent obesity in older age groups. This 
non-significant prospective association between sleep duration and two adiposity 
measures is an important one, particularly as the majority of previous research in 
this area has yielded positive findings. It is possible that differences in inclusion 
of covariates may have contributed to this discrepancy in results, and/or that 
these effects have disappeared by the time data are collected from individuals in 
later life (for example, ELSA and WHII). In comparing the present results with 
those of the WHII paper111 the authors also adjusted their analyses for a list of 
covariates that are similar to those adjusted for in ELSA. There were small 
differences in adjustments, for example in ELSA ethnicity and long-standing 
illness were included, whilst in WHII adjustment was made for medications, such 
as cardiovascular drugs and hypnotics. Also, notably, in ELSA and WHII the sleep 
duration question asked is identical, whilst other studies included in the most 
recent meta-analysis of prospective studies in adults238 shows that in the other 10 
studies sleep duration was asked slightly differently, which may affect the results.  
For example, three of these studies239–241 asked participants to report their average 
daily sleep duration, two asked about both weekday and weekend sleep duration 
and then took a weighted average134,242, two studies asked for average sleep 
duration in a 24 hour period124,243 and the remaining studies asked participants to 
report average night time duration of sleep244–246. Also, of these studies, only two 
included ethnicity as a covariate243,246 and only two, besides the WHII paper111, 
included adjustments for medications124,244. Notable is that the study which had 
the fewest covariates (age, sex, baseline BMI, length of follow-up and SES) and 
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the smallest sample size (n=151), had the largest effect size (OR=2.97) for sleep 
duration and risk of obesity at follow-up239. 
Also, a quadratic sleep duration term was included in separate models, adjusted 
for covariates, the results of which were not significant. Thus, there was no U-
shaped relationship between sleep duration and changes in BMI or WC.  
3.5.5 Potential unexplored mechanisms for the association between 
adiposity and sleep duration in older adults  
In this section, potential mechanisms that might underlie the relationship 
between adiposity and sleep duration are explored. However, the magnitude of 
effect between baseline BMI/WC and changes in sleep duration was miniscule, 
which is important to note.  
3.5.5.1 Sleep apnoea as a possible explanation 
In Chapter 1, shared genetic aetiology was discussed as a potential explanation for 
the association between BMI and sleep duration. Additionally, it is possible that 
obstructive sleep apnoea (OSA) is another plausible explanation for the 
prospective associations of adiposity measures and sleep duration in older adults 
OSA is a condition that causes the airways to collapse or become blocked whilst 
sleeping and is markedly prevalent in obese adults247. Older people with higher 
BMIs and/or WCs may have a higher percentage of visceral fat than their leaner 
counterparts, which has been found to be a significant risk factor for OSA247,248. 
Therefore, they may develop OSA, which could subsequently affect their sleep 
duration.  
Evidence suggests that when objectively measuring sleep duration, very short 
sleep (mean duration of 3 hours) is associated with greater OSA severity249, which 
could also be applicable to self-reported sleep duration. Another recent study 
found self-reported short sleep duration and OSA to be independently associated 
with visceral obesity, in adults aged between forty and sixty-nine years250. Meta-
analytic evidence also finds that OSA is predictive of CVD and all-cause 
mortality251. However, in ELSA waves 4 (baseline) and 6 (follow-up) there are no 
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questions asked about sleep apnoea, thus it was not possible to perform analyses 
to investigate this further.  
3.5.6 Study strengths 
This study has several strengths. As both adiposity (BMI and WC) and sleep 
duration data were collected at two time points in ELSA, it was possible to 
investigate changes in both adiposity and sleep duration by incorporating these 
baseline measures as covariates in all prospective, bidirectional modelling.  
It was also important to analyse two measures of adiposity, particularly WC, 
which is deemed better for measuring adiposity in older adults, as BMI can be 
less accurate in this population, mainly due to sarcopenia88,90. Thus, the fact that 
WC and sleep duration were related in an identical way to BMI and sleep 
duration also strengthens the study conclusions. However, no relationship was 
observed between baseline sleep duration and changes in BMI or WC, thus this 
association is likely to be weak in comparison in older adults. This is in line with 
literature reviewed in Chapter 1, which suggests that the prospective relationship 
between sleep duration and changes in adiposity in fact weakens with age.  
 A further strength is that BMI and WC were measured by a nurse, rather than 
self-reported, which reflects an improvement on some earlier studies in this 
area71,252. Large-scale epidemiological studies suggest that BMI calculated from 
self-reported height and weight may overestimate values at the lower end of the 
scale (<22 kg/m2) and underestimate values at the upper end of the scale 
(particularly for BMI values >28 kg/m2)253. Adults over the age of 55 are also more 
likely to underestimate their BMI, in comparison to those aged between 42 and 
55253.  
A further strength is that ELSA is broadly representative of the English 
population aged 50 years and older254 , which is important, as it allows 
generalisability of the findings. The richness of the available dataset enabled 
analyses that accounted for a number of factors, including wealth, illness and 
depressive symptoms, and health behaviours. 
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3.5.7 Study limitations 
Sleep duration was self-reported, which may be prone to error and bias130. In 
older adults, it may not be optimal to rely on self-reports of sleep duration, as 
sleep disruptions due to OSA and insomnia are common and can lead to 
erroneous estimates of time spent asleep154. For example, research within the 
same ageing sample showed an association between objective sleep duration and 
obesity, but no relationship was found when self-report measurements were 
analysed in relation to obesity130.  It is important to note that for a within-person 
analysis it may be less important that self-reported sleep duration may be error-
prone, as the associated measurement error terms remain consistent. However, 
this does not rule out that for example, there could be a differential effect of 
adiposity (BMI, WC) on how respondents report their sleep durations.  
Data were only available from waves 4 and 6 of ELSA; hence there were only four 
years between baseline and follow-up, which may have contributed to the trivial 
change observed in sleep duration and adiposity. This could perhaps be related to 
findings that usual sleep parameters do not significantly change in adults after 
the age of sixty255. It was also not possible to examine all potential mediators of 
the prospective association between adiposity measures and sleep duration. For 
example, respondents might sleep poorly due to their own or partner’s snoring or 
other symptoms of sleep apnoea, as mentioned above. Additionally, information 
on daytime napping was not available, which is particularly pertinent in older 
adults. Despite ELSA’s representativeness of the English ageing general 
population, these findings may not be entirely applicable to non-white ethnic 
groups and to adults below the age of 50. It is also possible that the restriction of 
sleep duration to between 2 and 12 hours may have impacted the results, 
although there were only 12 respondents whose durations of sleep were outside of 
this range.  
3.5.8 Future directions 
The present study was the first to examine the association of adiposity and sleep 
duration using bidirectional analyses. However, there are some important 
directions to consider for future research.  
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These findings should be replicated with objective sleep duration, perhaps by 
means of actigraphy, as it is rapidly becoming less expensive. For example, since 
this work was completed, the UKB have released wrist actigraphy data collected 
from approximately 100,000 individuals, which will enable large-scale analyses of 
objective sleep duration and BMI. This is important, as it has been reported that 
the agreement between objective and subjective sleep duration is at best, 
modest96.  
Evidence suggests that length of average sleep is unlikely to change drastically in 
healthy adults over the age of sixty. However, to confirm the results from this 
study it may be important to carry out a similar study using a longer follow-up 
time. This could potentially be done using the ELSA sample, as wave 8 data is 
newly available and includes sleep duration, as well as crucial questions about 
shift work and napping, for example. Thus, it would be possible to investigate 
whether factors such as these do in fact, mediate the association between 
adiposity and changes in sleep duration. However, as the amount of change in 
both BMI and sleep duration over the 4-year follow-up period was very small, it 
would have been difficult to use other methods to examine this bidirectional 
relationship.  
In relation to an earlier point, in future it would also be of interest to further 
explore the interrelationship between BMI, socioeconomic position, depression 
and sleep duration.  
3.6 CHAPTER SUMMARY 
 Analyses were performed to investigate the cross-sectional and 
bidirectional prospective relationship of BMI and WC with self-reported 
sleep duration in older adults.  
 Using data from waves 4 and 6 of ELSA linear and non-linear regression 
analyses were performed to establish the direction of this association.  
 After adjustment for a wide range of covariates, there was no evidence of a 
significant cross-sectional association between adiposity and sleep 
duration. 
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 Prospective models indicated that there was a significant relationship 
between BMI at baseline and very small changes in sleep duration, but the 
opposite relationship was not significant.  
 Although some potential explanations for this association were proposed, 
such as sleep apnoea and share genetic aetiology, it is unlikely that we 
would need to target adiposity in order to promote longer sleep duration 
in older adults, as these effects are very small. 
4 INVESTIGATING THE BIDIRECTIONAL 
ASSOCIATION OF BMI AND SLEEP DURATION IN 
EARLY LIFE 
4.1 BRIEF INTRODUCTION AND OVERVIEW OF CHAPTER 
CONTENTS 
Chapter 1 introduced and provided a review of the literature to date, on the 
relationship between adiposity (typically measured by BMI, waist circumference 
or another inexpensive method of data collection) and sleep duration (usually 
measured by means of self-report, with the exception of a small number of 
studies which have used objective sleep duration). Whilst reviewing this 
literature, several systematic reviews and meta-analyses of cross-sectional and 
prospective studies predominantly suggest that shorter sleep is related to 
changes in BMI and increased risk of obesity106,107,139,140,151–153. However, all of these 
studies examined whether sleep duration might predict changes in BMI or 
increased risk of obesity, whilst there appear to have been only two studies 
(described below), to date, to examine both processes in a single sample137,138.   
Hiscock and colleagues137 were the first to investigate the bidirectional 
association of BMI with sleep duration in children. They found that BMI did not 
predict changes in sleep duration, nor did they observe that sleep duration was 
associated with changes in BMI, in a large sample of Australian children.  
More recently, another study provided support for Hiscock’s findings138. These 
researchers found that BMI did not predict changes in sleep duration, nor did 
sleep duration predict changes in BMI, in White children from the Born in 
Bradford Study. However, they observed associations in both directions in South 
Asian children.  
It is important to investigate the direction of this association further, using a 
distinct approach from previous studies. Both the Hiscock et al. and Collings et 
al. studies analysed subjective measures of sleep duration and thus, no research 
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has yet investigated the bidirectional relationship of BMI with objective sleep 
duration in a paediatric sample. The sample used in this chapter has prospective 
data available in children, as well as carefully-measured actigraphically assessed 
sleep duration and measures of height and weight. Thus, it provided a unique 
opportunity to investigate the bidirectional, prospective association of BMI and 
objective sleep duration at three time points. Establishing the direction of effect 
between BMI and objective sleep duration in children is important, as this could 
be different from the relationship between BMI and subjective duration of sleep 
because objective sleep is likely to be measured with more precision.  
As mentioned in Chapter 1, the remainder of this thesis focuses on understanding 
the association between BMI and sleep duration in adults and therefore, this is 
the only study in a paediatric sample. Funding was provided by the ESRC for an 
Overseas Institutional Visit (OIV) and due to an existing collaboration with Dr 
Clare Llewellyn, I visited the Department of Psychology at the Norwegian 
University of Science and Technology (NTNU) for three months (March 2017 – 
June 2017) to work with Dr Silje Steinsbekk and Prof. Lars Wichstrom. Data were 
available from the comprehensively-phenotyped study that this research group 
houses: the Trondheim Early Secure Study (TESS), and enabled the investigation 
of the prospective relationship of BMI with objective sleep duration, for the first 
time, in a paediatric sample. 
4.2 AIMS OF THIS CHAPTER  
The study presented in this chapter had three aims:  
 Examine the cross-sectional associations between BMI and objectively 
measured sleep duration at ages 6 and 8y.  
 Examine the association between BMI at age 6y and changes in sleep 
duration between 6 and 8y, as well as the association between BMI at age 
8y with changes in sleep duration between 8 and 10y.  
 Examine the association between sleep duration at age 6y with changes in 
BMI between 6 and 8y, and the association between sleep duration at age 
8y and changes in BMI between 8 and 10y.   
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4.3 METHODS 
For the work carried out in this chapter I designed the study, derived BMI-SDS 
for the age 10 data and performed all statistical analyses.  
4.3.1 Sample 
The Trondheim Early Secure Study (TESS) comprises a community sample of 
Norwegian children born in 2003 and 2004 (see Chapter 2 for more detailed 
information about TESS). Data have been collected at ages 4, 6, 8 and 10 years, to 
date. From these two birth cohorts, 1250 (97.2%) children were recruited into 
TESS at wave 1 (age 4) by means of a letter of invitation, which included the 
Strengths and Difficulties Questionnaire (SDQ), version 4-16203. The SDQ is a 
screening tool for behavioural and emotional problems, which was one of the 
primary focuses of TESS. Therefore, due to the oversampling of children with 
such problems, sample weights are needed in all analyses of the TESS data. 
Ethical approval for TESS was granted by the Regional Committee for Medical 
and Health Research Ethics, Mid-Norway and written informed consent was 
obtained from parents. Here data were analysed from waves 2 (baseline), 3 
(baseline + first follow-up) and 4 (follow-up) and there was a total of 794 children 
included in the study. Thus, two separate cross-sectional and prospective studies 
were carried out, as children develop and may change (in terms of weight and 
sleep duration) between the ages of 6y and 10y. For this reason a 2-year follow-up 
period was used, rather than a single, 4-year follow-up.  
4.3.2 Measures 
4.3.2.1 Body Mass Index (BMI) 
Height (metres) and weight (kg) at ages 6y, 8y and 10y were collected by a health 
nurse, using digital scales (Heightronic digital stadiometer: QuickMedical, 
Model 235A and Tanita BC420MA). BMI was then calculated with the standard 
formula: weight (kg) divided by height (m2). BMI standard deviation scores (SDS) 
were derived in TESS using the British growth curve reference for children aged 
from birth to twenty-three years87. The British reference data were used because 
they are deemed to be more reliable than the Norwegian reference data and are 
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therefore used in TESS published studies (for example, Steinsbekk et al256.). 
Further details on BMI, BMI-SDS and how weight status categories were derived 
in TESS are provided in Chapter 2. 
4.3.2.2 Sleep duration  
Sleep duration was objectively measured using the ActiGraph™ GT3X 
accelerometer (Manufacturing Technology Incorporated, Fort Walton Beach, FL, 
USA). Participants wore the actigraphs on their hip for 7 consecutive days, 
including whilst asleep, and were only required to remove them whilst showering 
or bathing. More details on this measure are provided in Chapter 2. 
4.3.2.3 Covariates 
Covariates included in the analyses were demographics: age (continuous), sex 
(0=male, 1=female), a measure of socioeconomic status (SES), ethnicity and 
season. Parental occupation was used as a measure of SES, coded as 0=skilled 
professionals and leaders, 1=unskilled. This was recoded from the International 
Classification of Occupations, which is measured on a 6-point scale (1=Manual 
workers, 6=Leaders)257. If participants’ parents were living together the parent 
with the highest occupation was selected. Ethnicity was originally coded from 1 to 
12 (1=Norway, 2=Nordic countries, 3=Western Europe, USA, Canada, New 
Zealand, Australia, Israel, 4=Eastern Europe, 5=Balkans (Former Yugoslavia, 
Romania, Bulgaria), 6=Turkey, 7=North Africa, 8=South Africa [country], 9= Rest 
of Africa, 10= Central and South America, 11=Asia/Rest of Oceania, 12= Sami 
(indigenous Norwegian population). However, as there were only n=11 across all 
categories that did not fall into either 1 or 2 the ethnicity variable was recoded as 
1=Nordic and 2=Non-Nordic.    
A season variable was created from the month when the sleep duration data were 
collected at both waves 2 and 3 (ages 6y and 8y). The rationale for including 
season as a potential covariate was that there is some evidence to suggest that 
children’s sleep duration varies between seasons, particularly in Northern Europe 
and Scandinavia. A recent study in 730 Danish children, aged 8-11y found that 
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objective sleep duration was approximately 2% longer during winter, compared 
to spring258. 
The variable was originally coded as a number between 1 and 12 to indicate the 
month of assessment, which was subsequently recoded into an ordinal measure 
with 4 categories, one per season. In creating these categories a similar approach 
to that of Kolle and colleagues259 was used, who defined the Norwegian seasons 
as: Autumn (September, October, November); Winter (December, January, 
February); Spring (March to mid-June); and summer was not included, as they 
did not collect data in July or August. However, in TESS data were collected 
during July and August and were thus, also categorised as Summer. The season 
variables for ages 6y and 8y were coded as: 1=spring, 2=summer, 3=autumn, 
4=winter. Season was included as a covariate, as linear regressions showed that 
there was a significant cross-sectional association between both season and sleep 
duration at age 6y (B= 0.10, 95% CI= 0.011; 0.190, P=0.027), and season and sleep 
duration at age 8y (B=0.21, 95% CI=0.122; 0.292, P<0.001). Both of these regression 
models were adjusted for age, sex, ethnicity and SES.  
4.3.3 Statistical analyses 
4.3.3.1 Power calculations 
Using G*Power post-hoc power was calculated for cross-sectional and 
bidirectional prospective analyses, by using the following parameters: effect size 
F2, % error probability, total sample size, number of tested predictors and total 
number of predictors. F2 for the effect size was calculated as: R2 / 1 - R2, by taking 
the R2 from an unadjusted (no covariates included) cross-sectional and 
prospective models from the results of the ELSA study (Chapter 3). The alpha 
level was set at 0.05, the total n was 794 and the number of tested predictors was 
1 for cross-sectional and prospective analyses. Power calculations indicated that 
there was limited power to observe similar effects to those in the ELSA study in 
Chapter 3 (Table 4.1), which was unsurprising, given the very small effects found 
in ELSA.  
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Table 4.1 Power calculations for cross-sectional and bidirectional prospective 
analyses in TESS 
Model Effect 
size F2* 
% error 
probability 
N No. tested 
predictors 
Power 
Cross-sectional 0.0025 0.05 794 1 29% 
Prospective  
BMI on sleep 
duration 
0.0046 0.05 794 1 48% 
Prospective Sleep 
duration on BMI   
0.0046 0.05 794 1 48% 
Note. *For cross-sectional models this (F2) was calculated as: R2/ 1 – R2 = 0.0025 / 1 
– 0.0025 = 0.0025; for prospective models of BMI on sleep duration this was 
calculated as:  R2/ 1 – R2 = 0.0046 / 1 – 0.0046 = 0.0046; for prospective models of 
sleep duration on BMI this was calculated as: R2/ 1 – R2 = 0.0021 / 1 – 0.0021 = 
0.0021 . All of these R2 values were taken from results of the simple linear 
regression (unadjusted) models in the ELSA study in Chapter 3.  
4.3.3.2 Full Information Maximum Likelihood (FIML) estimation 
Statistical analyses were all performed in STATA, version 14. Due to the limited 
sample size for a complete case analysis (CCA) of n=452, analyses were performed 
using full information maximum likelihood (FIML), yielding an analysis sample 
of n=794. Maximum likelihood estimation is a powerful method for handling 
missing data and is less biased than ad hoc techniques such as pairwise deletion, 
mean imputation and list wise deletion260. FIML is sometimes also preferred over 
multiple imputation (MI) for various reasons, one particularly important reason 
being that MI produces different results for the same data every time because it 
involves random draws260. FIML does not suffer from this limitation. 
Furthermore, analyses were all weighted using sample weighting in STATA to 
ensure representativeness of the general population, due to the oversampling of 
children with emotional and behavioural problems in TESS. Associations 
between BMI and sleep duration were tested separately for cross-sectional 
associations at both ages 6 years and 8 years and subsequently, separate models 
were run to try to establish the direction of effect.  
  134 
4.3.3.3 Comparison of sample characteristics across sleep duration 
categories 
To compare baseline characteristics, the sample at age 6y was divided into two 
categories of sleep duration. These sleep categories were defined in line with the 
latest recommendations from the American Academy of Sleep Medicine, which 
state that, for every 24 hours, sleep duration should be between 9 and 12 hours 
for children aged 6 to 12 years old261. Thus, <9 hours was defined as “short sleep” 
and ≥9 hours as “typical sleep”. 
One-way ANOVAs were then used to compare participants on age and BMI (and 
BMI-SDS), whilst Chi-squared tests were used to compare sex, ethnicity, SES and 
weight status across sleep duration categories (Table 4.2).  
4.3.3.4 Change in BMI and sleep duration between ages 6 and 8, and 8 
and 10 
To examine whether BMI and sleep duration changed substantially between ages 
6 and 8 years, and 8 and 10 years, Pearson’s correlations were calculated and 
subsequently, paired samples t-tests were also performed. In STATA, first, 
weighted means for both BMI and sleep duration were obtained using the sample 
weight that is applied to all TESS analyses and then linear combinations of these 
variables (for example, BMI at age 8 – BMI at age 6) were estimated to compute 
the respective t-and p-values.  
4.3.3.5 Linear models 
Linear regression models were performed to examine the cross-sectional 
relationship between BMI SDS with sleep duration, separately, at both ages 6 and 
8 (waves 2 and 3, respectively). As mentioned above, these models were all 
adjusted for age, sex, ethnicity, parental SES and season. 
Then linear regressions were performed to examine the prospective bidirectional 
associations between BMI and BMI SDS, and sleep duration. To investigate the 
relationship between BMI and changes in sleep duration, first sleep duration was 
regressed on BMI and BMI SDS using age 6y (wave 2) 6 as the baseline and age 8y 
(wave 3) as follow-up, followed by age 10y (wave 4) sleep duration regressed on 
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BMI and BMI SDS at age 8y (wave 3). These models were adjusted for age, sex, 
SES, ethnicity, season and baseline sleep duration.  
To examine the opposite relationship age 8y BMI and BMI SDS were regressed on 
age 6y sleep duration, followed by age 10 BMI and BMI SDS regressed on age 8y 
sleep duration. These regression models were adjusted for age, sex, SES, 
ethnicity, season and baseline BMI or BMI SDS.  
4.3.3.6 Non-linear models  
A quadratic term was included for exposures in both cross-sectional and 
bidirectional prospective analyses. Thus, in cross-sectional regressions a BMI-
squared (BMI2) was included, as well as in prospective associations to examine 
the change in sleep duration from baseline BMI. In prospective analyses to 
examine changes in BMI from baseline sleep duration, a sleep duration-squared 
(sleep duration2) term was included. Subsequently, one cross-sectional linear 
regression model was performed, adjusted for age, sex and parental SES. 
Additionally, the interactions between sex and baseline BMI and sleep duration 
(ages 6y and 8y) were tested, as some previous research has found differences 
between boys and girls.  
4.4 RESULTS  
4.4.1 Sample characteristics  
Table 4.2 presents time-invariant characteristics in TESS. There were no 
significant differences between these groups in terms of sex, SES, ethnicity (all 
p>0.05). Tables 4.3, 4.4 and 4.5 present descriptive statistics for age, season, BMI, 
BMI-SDS and weight status at ages 6, 8 and 10 years. At 6y there was a small but 
significant difference in age between shorter and longer sleepers in TESS at age 
6y, such that children who slept for longer were younger. However, there were no 
differences between the two sleep duration groups across any other time-varying 
characteristics at age 6y. At age 8y (Table 4.4) there was a nominally significant 
difference in mean age between the two sleep categories. There was a significant 
difference in the percentage of children who slept for <9 hours vs. ≥9 hours 
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across the four seasons (spring, summer, autumn, winter) at age 8y. There was no 
difference in BMI, BMI-SDS or weight status categories between the two sleep 
groups at age 8 (all p>0.05). At age 10y (Table 4.5) the two sleep duration groups 
differed significantly in terms of BMI and BMI-SDS, such that those who slept <9 
hours had a higher mean BMI/BMI-SDS than those who slept for ≥9 hours. 
Similarly to age 8y, there was a significant difference in the number of children 
who slept <9 hours in comparison. ≥9 hours across the four seasons at age 10y.  
Table 4.2 Sample characteristics in TESS by sleep duration category, at age 6y 
 <9 hours 
(n=108) 
≥9 hours 
(n=686) 
Total (Max. 
N=794) 
P 
Sex – n (%) 
Boys  
Girls 
 
62 (57.41) 
46 (42.59) 
 
329 (48.03) 
356 (51.97) 
 
391 (49.31) 
402 (50.69) 
 
0.070 
SES – n (%) 
Skilled 
Unskilled 
 
81 (77.14) 
24 (22.86) 
 
502 (74.93) 
168 (25.07) 
 
583 (75.23) 
192 (24.77) 
 
0.625 
Ethnicity  
White 
Non-white 
 
104 (98.11) 
2 (1.89) 
 
637 (98.62) 
9 (1.39) 
 
741 (98.54) 
11 (1.46) 
 
0.695 
Mean age (SD) 6.05 (0.21) 6.01 (0.16) 752 0.044 
Season – n (%) 
Spring  
Summer   
Autumn  
Winter   
 
31 (32.39) 
32 (33.33) 
18 (18.75) 
15 (15.63) 
 
190 (31.61) 
135 (22.46) 
124 (20.63) 
152 (25.29) 
 
221 (31.71) 
167 (23.96) 
142 (20.37) 
167 (23.96) 
 
 
0.058 
BMI – mean (SD) 15.49 (1.55) 15.59 (1.47) 15.54 (1.51) 0.523 
BMI-SDS – mean (SD) -0.30 (0.90) -0.11 (0.85) -0.14 (0.86) 0.506 
Weight status – n (%) 
Underweight 
Normal weight 
Overweight/obese 
 
13 (16.05) 
63 (77.78) 
5 (6.17) 
 
45 (9.34) 
399 (82.78) 
38 (7.88) 
 
58 (10.30) 
462 (82.06) 
43 (7.64) 
 
 
0.173 
Note. Overweight + obese weight status categories were collapsed as there were 
only n=3 overweight and n=2 obese participants. 
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Table 4.3 Descriptive statistics for exposure/outcome measures at ages 8y and 10y 
in TESS 
 Sleep duration (age 8) 
 <9 hours 
(n=205) 
≥9 hours 
(n=481) 
Total (Max. 
N=686) 
P 
BMI – mean (SD) 16.72 (1.99) 16.55 (1.96) 628 0.297 
BMI-SDS – mean (SD) 0.15 (0.94) 0.07 (0.88) 509 0.298 
 Sleep duration (age 10) 
BMI – mean (SD) 17.76 (2.59) 17.40 (2.36) 686 0.028 
BMI-SDS – mean (SD) 0.22 (1.05) 0.06 (0.99) 686 0.038 
 
4.4.2 Cross-sectional linear and non-linear associations of BMI and 
sleep duration at ages 6 and 8 
Cross-sectional linear regressions yielded no significant associations between 
BMI and sleep duration, at either ages 6y and 8y (Table 4.4). These models were 
adjusted for age, sex, SES ethnicity and season, and were performed for both BMI 
and BMI SDS. There was no evidence of a U-shaped (quadratic) relationship 
between BMI and sleep duration at either age (p>0.05).  
Table 4.4 Cross-sectional associations of BMI and BMI SDS with sleep duration at 
ages 6 and 8 
Sleep duration B (minutes) 95% CI P 
Age 6 
Model 1 - BMI (age 6) 0.01 -0.067; 0.095 0.724 
Model 2 - BMI-SDS 
(age 6) 
0.02 -0.067; 0.012 0.590 
Age 8 
Model 3 - BMI (age 8) -0.03 -0.124; 0.060 0.500 
Model 4 - BMI-SDS 
(age 8)  
0.03 -0.070; 0.129 0.560 
Note. Models 1 and 2= adjusted for age, sex, SES, ethnicity and season (age 6); 
Models 3 and 4= adjusted for age, sex, SES, ethnicity and season (age 8); exposure 
in Models 1 and 3 = BMI, exposure in Models 2 and 4= BMI SDS; B 
(Unstandardized coefficient) = difference in sleep duration (minutes) per 
difference in BMI, 95% CI =95% confidence interval, P = regression p-value. 
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4.4.3 Bidirectional prospective linear and non-linear associations of BMI 
and sleep duration  
In prospective analyses using age 6 as a baseline and age 8 as follow-up, there was 
no significant relationship between BMI (and BMI SDS) and changes in 
actigraphic sleep duration, in unadjusted models that included only the exposure, 
outcome and baseline outcome (p>0.05). In further models adjusted for age, sex, 
SES, season, ethnicity and baseline sleep duration (Table 4.5). Furthermore, there 
was no significant association between sleep duration assessed at age 6y and 
changes in BMI, in a model adjusted for the same covariates as mentioned above, 
but with baseline BMI rather than sleep duration. The pattern of results for BMI-
SDS in relation to sleep duration was identical to BMI and thus, there was no 
association between BMI-SDS at age 6y and change in sleep duration at age 8, 
nor was there any relationship between sleep duration at age 6y and change in 
BMI-SDS at age 8y. 
There was also no significant U-shaped association between BMI at age 6y and 
sleep duration at age 8y, in either direction (p>0.05). Although Pearson’s 
correlations showed that BMI was largely stable between the ages of 6y and 8y, 
r=0.85, p<0.001, a paired samples t-test indicated that there was also change over 
time, with a difference of 1.15 kg/m2 (15.56 kg/m2 at age 6y vs. 16.58 kg/m2 at age 
8y), which was, in fact, significant (p<0.001).  
Duration of sleep was much less stable between these ages, r=0.27, p<0.001. Mean 
sleep duration at age 6y was 9.62 hours, whilst at age 8y it decreased to 9.09 and 
a paired samples t-test confirmed that this difference of approximately 28 
minutes, was significant (p<0.001).  
Results from linear regressions which used age 8y as a baseline and age 10y as 
follow-up, were identical to the previous bidirectional analyses (age 6y to 8y). 
Thus, BMI at age 8y did not predict changes in sleep duration at age 10y, nor did 
sleep duration at age 8y predict changes in BMI at age 10y, irrespective of level of 
adjustment for covariates (Table 4.6). Results also showed no significant 
quadratic associations between BMI and sleep duration in either direction 
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(p>0.05). Again, Pearson’s correlations indicated that participants’ BMIs were 
fairly stable between ages 8y and 10y (r=0.86, p<0.001), but a paired samples t-test 
suggested that there was nevertheless change over time and the difference in 
mean BMIs (16.60 kg/m2 at age 8 vs. 17.49 kg/m2 at age 10) was significant 
(p<0.001). The correlation between age 8y and age 10y sleep duration was much 
smaller, indicating less stability over this developmental period (r=0.32, p<0.001), 
although a paired samples t-test revealed that this difference (average decrease of 
3.56 minutes between age 8 and age 10 sleep duration) was not significant 
(p=0.088).  
Table 4.5 Bidirectional prospective models of BMI and sleep duration from age 6 to 
8 
BMI (age 6)  Sleep duration (age 8)  
 B (minutes) 95% CI P 
Model 1  0.02 -0.07; 0.11 0.694 
Model 2  0.03 -0.057; 0.129 0.451 
BMI-SDS (age 6)  sleep duration (age 8) 
Model 3  0.02 -0.08; 0.13 0.685 
Model 4   0.02 -0.086; 0.121 0.737 
Sleep duration (age 6)  BMI (age 8)  
 B (kg/m2) 95% CI P 
Model 5  -0.02 -0.06; 0.03 0.467 
Model 6  -0.01 -0.058; 0.030 0.527 
Sleep duration (age 6)  BMI-SDS (age 8) 
Model 7  -0.03 -0.08; 0.01 0.148 
Model 8  -0.01 -0.092; 0.065 0.736 
Note. Model 1= baseline sleep duration (age 6); Model 2= adjusted for age, sex, 
SES, ethnicity, season and baseline sleep duration (age 6); Model 3= baseline 
sleep duration (age 6); Model 4= adjusted for age, sex, SES, ethnicity, season and 
baseline sleep duration (age 6); Model 5= adjusted for baseline BMI (age 6); 
Model 6= adjusted for age, sex, SES, ethnicity, season and baseline BMI (age 6); 
Model 7= adjusted for baseline BMI (age 6), Model 8= adjusted for age, sex, SES, 
ethnicity, season and baseline BMI (age 6; B (unstandardised coefficient in 
minutes) = change in sleep duration per unit change in BMI (Models 1 and 2), 
outcome in Models 1 to 4= sleep duration at age 8y, outcome in Models 5 and 6 = 
BMI at age 8y, outcome in Models 7 and 8 = BMI-SDS at age 8y.  
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Table 4.6 Bidirectional prospective models of BMI and sleep duration from age 8 to 
10 
BMI (age 8)  sleep duration (age 10)  
 B (minutes) 95% CI P 
Model 1  -0.04 -0.12; 0.04 0.318 
Model 2  -0.04 -0.120; 0.040 0.332 
BMI-SDS (age 8)  sleep duration (age 10) 
Model 3 -0.00 -0.09; 0.08 0.997 
Model 4 0.07 -0.016; 0.160 0.107 
Sleep duration (age 8 )  BMI (age 10) 
 B (kg/m2) 95% CI P 
Model 5 0.00 -0.07; 0.07 0.998 
Model 6  0.00 -0.068; 0.074 0.934 
Sleep duration (age 8)  BMI-SDS (age 10) 
Model 7 0.02 -0.04; 0.09 0.449 
Model 8  -0.03 -0.133; 0.071 0.547 
Model 1= baseline sleep duration (age 8); Model 2= adjusted for age, sex, SES, 
ethnicity, season and baseline sleep duration (age 8); Model 3= baseline sleep 
duration (age 8); Model 4= adjusted for age, sex, SES, ethnicity, season and 
baseline sleep duration (age 8); Model 5= adjusted for baseline BMI (age 8); 
Model 6= adjusted for age, sex, SES, ethnicity, season and baseline BMI (age 8); 
Model 7= adjusted for baseline BMI (age 8), Model 8= adjusted for age, sex, SES, 
ethnicity, season and baseline BMI (age 8); B (unstandardised coefficient in 
minutes) = change in sleep duration per unit change in BMI (Models 1 and 2), 
outcome in Models 1 to 4= sleep duration at age 10y, outcome in Models 5 and 6 = 
BMI at age 10y, outcome in Models 7 and 8 = BMI-SDS at age 10y. 
4.5 DISCUSSION 
4.5.1 Summary of findings  
In this study, analyses were performed to examine the cross-sectional, as well as 
the bidirectional, prospective association between BMI and actigraphic sleep 
duration in a Norwegian sample. The purpose of this study was to understand the 
nature of the direction of this relationship in children, which has only been 
investigated by two previous studies137,138, but never with objectively measured 
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sleep duration. This study in TESS yielded no significant cross-sectional 
associations between BMI and actigraphic sleep duration at ages 6y or 8y. There 
was also no evidence of a prospective relationship in either direction between 
BMI and actigraphic sleep duration, using age 6y as a baseline and age 8y as 
follow-up, or using age 8y as a baseline and age 10y as follow-up. There was also 
no evidence of U-shaped relationships between BMI and actigraphic sleep 
duration in TESS.  
Correlations between BMI at ages 6y and 8y, and ages 8y and 10y in TESS were 
very strong, indicating that there was very little change in children’s BMIs over 4 
years. This was not the observation for actigraphic sleep durations, which 
changed to a greater extent, as expected, between ages 6y and 8y, and 8y and 10y.  
4.5.2 Evaluation of findings in relation to previous research  
4.5.2.1 Cross-sectional findings 
As mentioned earlier, large-scale meta-analyses on BMI and sleep duration in 
children have predominantly concluded that shorter sleep is associated with 
higher BMI and increased risk of obesity106,107,135,151,153,157. The findings in this study 
accord with one study from another Scandinavian population, in which 
Klingenberg et al.148 observed no cross-sectional association between parent-
reported sleep duration and BMI in 211 Danish children. One reason for this null 
finding could be that the families recruited are mostly of high SES and live in the 
capital city region, thus these children are less likely to become obese and have 
poor sleeping habits. The TESS sample possesses important similarities to the 
Danish sample used in the earlier study, as for example, 86.4% of the children 
slept for ≥9 hours, which is in line with the recommendations for the amount of 
sleep in this age group261. There is some evidence to support this notion of social 
differences in children’s sleep patterns. Findings from 11,500 ALSPAC children 
showed that those who were more likely to go to bed later and wake up later 
were those in low-income homes, yet there was little difference in total sleep 
duration with children from higher income homes262. However, it was also 
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observed that children of older mothers (>35 years) had shorter sleep durations, 
and that children in larger families were more likely to have later bedtimes262.  
BMIs did not differ across the sleep duration categories in the TESS sample and 
the prevalence of overweight/obesity was only 7.6% at age 6y and 6.77% at age 
8y. It is therefore a possibility that no association was observed between BMI and 
sleep duration in TESS, as participants are largely lean and also had healthy sleep 
durations, on average, with approximately one in eight children slept for less 
than 9 hours at age 6y. In order to observe an effect between BMI and sleep 
duration it may be necessary to have greater variation in weight and sleep 
duration. In particular, the proportion of overweight/obese children in TESS is 
very different from that of the UK paediatric population. Statistics from the 2016-
17 National Child Measurement Programme show that at ages 4/5y one in three 
children are overweight/obese and at ages 10/11y one in three are 
overweight/obese263.  
Thus, it is possible that the TESS sample is somewhat too homogenous and 
healthy to have observed a cross-sectional association between BMI and sleep 
duration. This work adds to a small body of null research on the cross-sectional 
relationship between BMI and sleep duration in childhood.  
4.5.2.2 Bidirectional prospective findings 
This study is not the first to find a non-significant prospective association 
between BMI and sleep duration in children. For example, the only two previous 
studies to investigate the bidirectional relationship between BMI and sleep 
duration in children yielded non-significant findings137,138. Hiscock and 
colleagues137 observed that BMI did not predict changes in sleep duration, or vice 
versa, in a large sample of Australian children. This was supported by a more 
recent study on the bidirectional association of BMI and sleep duration, which 
found no significant effects in either direction, in a sample of 562 White children, 
who were followed up at ages 12, 18, 24 and 36 months138. Importantly, both of 
these studies used parent-reported sleep duration, in the form of sleep duration 
diaries. Thus, this is a fundamental difference between the analyses in TESS and 
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earlier studies, yet similar findings were observed across studies. This is 
important because if an association truly exists in either direction in childhood, it 
would have likely emerged using objective measurement of sleep duration, due to 
its improved precision over subjective measures (self or parent-reported).  
Another study, which analysed both parent-reported, as well as accelerometer-
estimated sleep duration in 311 young Danish children, found that neither 
measure of sleep was associated with BMI148. These authors found that parent-
reported sleep duration at 9 months of age was not related to BMI at 18 months 
or 3 years of age, nor was accelerometer-measured sleep duration was associated 
with BMI cross-sectionally, at age 3. A recent Chinese study also found no 
significant relationship between risk of being overweight or obese and weekday 
sleep duration150 in 3,086 children, which could be due to ubiquitous insufficient 
weekday sleep amongst Chinese children. 
Overall, given that the present findings alongside results from the two earlier 
bidirectional studies, conducted in samples across three different countries (UK, 
Australia and Norway) suggest a null association (in White children), irrespective 
of sleep duration measurement (objective vs. subjective), it is possible that earlier 
non-bidirectional studies have overestimated the size of this effect.  
4.5.3 Could sleep dimensions, other than duration be more important in 
relation to childhood obesity? 
Jarrin and colleagues166 found that other sleep dimensions, such as quality, 
pattern and disturbances may in fact be more important in relation to obesity. 
They reached this conclusion, as in their study the association between sleep 
duration with BMI was attenuated following adjustments for covariates, whereas 
this was not the case for the other sleep dimensions. Recently, researchers also 
observed that, in a sample of 236 children aged between 6 to 10 years, it was 
bedtime and sleep timing that were significantly associated with weight, rather 
than sleep duration264. Specifically, children classed as ‘late sleepers’ were 
significantly heavier than their ‘normal sleeper’ counterparts. In a Chinese sample 
of more than 5,000 children aged between 9 to 12 years findings suggest that 
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although sleep duration is related to BMI, later bedtime is also associated with a 
higher BMI265, which provides some support for the previously described study by 
Thivel and colleagues264. Furthermore, evidence from 11,945 children from the 
Millenium Cohort Study (MCS) found that at age five, those who had irregular 
bedtimes were also the most likely to be obese266.   
The underlying mechanisms for how phenotypes such as bedtime and sleep 
timing may impact BMI are not fully understood. However, evidence suggests 
that children who have later bedtimes, compared to those with earlier bedtimes, 
are more likely to have higher BMIs, be inactive and have longer screen times166. 
Thus, it is possible that delaying sleep in children may mean that they spend 
more time exposed to an obesogenic environment and may for example, not have 
breakfast and be overall, more sedentary.   
It is important, however, to acknowledge that studies have mainly focused on the 
relationship between sleep duration and BMI and thus, little is known about the 
association between other sleep parameters with BMI, which could also be 
important. However, this could be partly due the fact that self-reported sleep 
duration, in particular, is very easy to measure. The majority of large-scale studies 
collect this type of measure, as it can usually be captured with a single question 
asking how long participants usually sleep for, or by asking them the time they 
usually go to sleep and wake up and then deriving a proxy for duration of sleep. 
This was also the case in the TESS study, in which data on sleep quality, pattern, 
timing, etc were not available at waves 2, 3 and 4. If these data are collected in 
future waves it would be important to test the association between BMI and these 
other sleep parameters, using a bidirectional approach, similarly to the present 
analyses.  
4.5.4 Study strengths 
The study reported here has important strengths. It was the first to investigate 
the bidirectional relationship between BMI and objectively measured sleep 
duration in children, using actigraphic data; similar previous studies have only 
employed subjective sleep duration137,138. Actigraphic sleep duration can provide 
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more accurate estimates of sleep duration in comparison to subjective 
measures97. Van den Berg and colleagues97 examined the agreement between 
actigraphic and self-reported sleep duration in adults from the Rotterdam Study. 
They observed that in 34% of participants, actigraphic and subjective sleep 
duration differed by more than an hour and thus recommended that multiple 
indicators of sleep duration be used in research. However, this is not always 
possible, mainly due to costs and time constraints when collecting data from 
large samples.  
As indicated by the power calculations in the Methods section, there was 
sufficient power to detect associations between BMI and sleep duration of at least 
the size observed in ELSA (Chapter 3). Further, as TESS participants have been 
followed throughout childhood, it was possible to perform both cross-sectional 
and longitudinal analyses, using a robust approach, FIML, which maximised all 
data points available in the study.  
4.5.5 Study limitations 
The TESS sample is a particularly homogenous one, as indicated in the sample 
characteristics of the Results section. The proportion of overweight/obese 
children in TESS was only 7.6% at age 6 and 6.77% at age 8, with 92% of 
participants in the normal weight category at age 6 and 93.23% at age 8. It is 
likely that these low overweight/obesity prevalence estimates contributed to the 
null finding of a relationship between BMI and objective sleep duration in this 
study. Participants’ BMIs only changed by 1.15 kg/m2 from ages 6y to 8y and 0.89 
kg/m2 from ages 8y to 10y, and t-tests showed that these differences were 
significant. Mean durations of sleep did change, by approximately 28 minutes, 
over the 2-year follow-up period between ages 6 and 8, which was shown with t-
test analyses.  
Furthermore, there was no measure of parent-reported sleep duration available at 
these ages in TESS, which would have enabled a direct comparison with the 
actigraphic sleep duration measures. Also, there is some evidence to suggest that 
waist actigraphy may overestimate sleep duration in children, compared with 
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wrist actigraphy167. The present findings may not be applicable to children of 
non-Nordic backgrounds, which is supported by a previous study of the 
bidirectional association of BMI and sleep duration in South Asian children, as 
the authors found a prospective relationship in both directions. It is also 
important to mention that power to detect similar effects to those observed in 
ELSA (Chapter 3) was limited.  
4.5.6 Future directions 
There are some important considerations for future research in this area. In order 
to confirm, or refute emerging evidence that other sleep parameters are related 
to adiposity and an increased risk of obesity166,264, future research could involve 
similar bidirectional analyses to those performed here, but with a focus on other 
such sleep measures, as well as longitudinal data, larger sample sizes and other 
ethnic groups.  
Further research could also be performed using the TESS cohort, as data 
collection is on-going and the team plan to follow participants throughout 
adolescence and early adulthood. It might be of interest to repeat these 
bidirectional analyses at slightly older ages, as meta-analytic evidence also 
suggests a link between sleep duration and BMI in adolescents267. This is 
important, as sleep patterns, weight and body composition can change as 
participants enter puberty and adolescence. As part of this, analyses could also be 
performed to examine the relationship of other adiposity indicators, available in 
TESS, in relation to sleep parameters. Also, given the potential discrepancies 
between wrist and waist actigraphy in measuring sleep duration, future research 
should use wrist actigraphy, where possible. 
It is also important that future studies use a more efficient analytical approach 
than the present study. For example, a parallel process latent growth curve model 
may be more appropriate for studies in which repeated measurements are 
available because it would allow the modelling of outcomes (in this case, BMI 
and objective sleep duration), as a function of both time and 
exposures/covariates. This kind of approach is also particularly effective to 
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investigate change and potential inter-individual variation in any observed 
change.   
4.6 CHAPTER SUMMARY  
 In this chapter, data were analysed from a Norwegian paediatric cohort to 
investigate the bidirectional relationship between BMI and actigraphic 
sleep duration at ages 6, 8 and 10.  
 Both linear and non-linear analyses and found that there was no cross-
sectional association between BMI and sleep duration at age 6 or 8.  
 Prospective, bidirectional analyses also yielded non-significant results in 
both directions, at ages 6 to 8, and 8 to 10.  
 Future studies ought to investigate the bidirectional association of other 
sleep dimensions (pattern, quality, bedtime, timing) with adiposity 
measures in children.  
 
5 GENOME-WIDE ASSOCIATION STUDY (GWAS) 
OF SELF-REPORTED SLEEP DURATION  
 
Results from the GWAS analyses performed in ELSA and UKHLS contributed to 
the following publication: Garfield, V., Fatemifar, G., Dale, C., Smart, M., Bao, Y., 
Llewellyn, C., Steptoe, A., Zabaneh, D. & Kumari, M. Assessing Potential Shared 
Genetic Aetiology between Body Mass Index (BMI) and Sleep Duration in 142,209 
individuals. Under review in Scientific Reports.  
5.1 BRIEF INTRODUCTION AND DESCRIPTION OF CHAPTER 
CONTENTS 
As outlined in Chapter 1 (section 1.7: Genetic determinants of sleep duration) 
there have only been a handful of GWAS of sleep duration, with only one 
replicated SNP to date78. As mentioned in Chapter 1, undertaking a large GWAS 
of self-reported sleep duration is important, given the current molecular genetic 
literature on this phenotype. Also, to potentially investigate the causal 
relationship between self-reported sleep duration and BMI, more robustly 
associated SNPs (with sleep duration) are needed, as this is a core assumption 
underlying Mendelian randomisation (more details in Chapter 6) – a genetic 
epidemiological method, which enables the use of genetic variants as 
instrumental variables (IVs) to examine causation between an exposure and 
outcome of interest. This chapter presents findings of a meta-genome-wide 
association (GWA) study, which was performed across three large-scale UK 
studies, in collaboration with a researcher from the University of Bristol.  
5.2 AIMS AND OBECTIVES  
The main aim of this chapter was to perform a large-scale meta-GWAS of self-reported 
sleep duration.  
The specific objectives were fourfold:  
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 Identify novel common genetic variants (SNPs) associated with self-
reported sleep duration by performing a meta-analysis of three large-scale 
population-based studies. 
 Replicate previously reported loci associated with sleep duration. 
 Investigate whether any genome-wide suggestive SNPs were significant 
expression quantitative trait loci (eQTL). An eQTL is a genomic locus that 
explains a portion of the variance of a gene expression phenotype. 
 Estimate the SNP heritability of sleep duration.  
5.3 METHODS 
For the work carried out in this chapter, I performed all of the data cleaning and 
analyses, with the exception of the GWAS in ALSPAC, which was performed by 
Dr Gibran Hemani (University of Bristol). I did not, however, carry out the initial 
genotype QC or the imputation for any of the studies included in this meta-
GWAS. 
5.3.1 Samples 
Across the ALSPAC, ELSA and UKHLS samples, inclusion of participants in the GWAS 
analyses was dependent on them having genotypic data, as well as self-reported sleep 
duration (phenotypic) and all covariate data. Within ALSPAC, only genotyped and 
phenotyped mothers were included. See Table 5.1 in the Results section for sample 
characteristics.  
5.3.2 Phenotype 
For detailed descriptions of the sleep duration phenotype QC and preparation, 
see Chapter 2. Data from ALSPAC mothers were analysed for this GWAS, with an 
analytical sample of n=4,914; an analytical sample of 6,028 was used in the ELSA 
and data from n=8,608 individuals from UKHLS were analysed in the GWAS.  
5.3.3 Covariates 
Association tests and genome-wide complex trait analyses (GCTA) were adjusted 
for age, sex and the first 10 principal components (PCs) in ELSA and UKHLS.  
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Age and sex were included as covariates to ensure that associations between 
SNPs and sleep duration would not be due to variance explained by age and sex. 
These covariates were included because, although genotypes are unconfounded 
by factors such as age and sex, they were included in the genetic association 
analyses to account for any additional variance, which will in turn, ensure that 
the GWAS signals are less confounded.   
The first 10 PCs were used as covariates to adjust for any residual population 
structure during the association tests between SNPs and sleep duration, by 
minimising the chances of detecting spurious associations that might be due to 
genetic ancestry268. Principal component analysis (PCA) is the most commonly 
implemented approach for identifying related individuals in genetic association 
studies269. A multivariate statistical approach, PCA produces uncorrelated 
variables (principal components) from a data matrix that contains observations 
from several supposedly correlated variables. PCs are calculated so that PC1 
explains as much as possible variance in the data in a single component, which is 
followed by PC2, etc. In its application to the detection of genetic ancestry, 
observations are individuals and genetic markers are the potentially correlated 
variables269. These PCs are usually created for each sample, using genome-wide 
genetic data from common reference panels, such as the HapMap or 1000 
Genomes genotype data, for which ancestry is already known. These common 
panels enable the detection of continental-level ancestry, as it contains genotype 
data from Europe, Asia and Africa. Due to the fact that these ancestral groups are 
very divergent, the first two PCs will sufficiently cluster individuals in these 
populations. This model can also be applied to individuals in GWAS to predict 
their PC scores and therefore, enable them to be clustered ancestrally, alongside 
samples from the reference panel, such as HapMap or 1000 Genomes.   
5.3.4 Statistical Analysis 
Across all three studies the minor allele frequency (MAF) filter was set at 1% and 
a threshold of P <5x10-8 was used to identify SNPs reaching genome-wide 
significance. This MAF threshold is used in GWAS to identify common genetic 
variants associated with a trait of interest and >1% is recommended, as GWAS has 
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low power to detect rare variants270. The significance threshold of P<5x10-8 has 
become the most widely used in GWAS and applies a Bonferroni correction that 
accounts for multiple testing in GWAS, under the assumption that there are a 
million independent SNPs in the human genome268. However, SNPs that were 
associated with sleep duration at P <5x10-6 as ‘suggestive’ of significance in this 
study.  
Genomic inflation factor (Lambda genomic control= GC) and quantile-quantile 
(Q-Q) plots were used to examine whether there is inflation due to population 
stratification.  
The Q-Q plot ranks p-values for each genetic variant from smallest to largest and 
plots these against expected values from a chi-squared distribution. GC was 
obtained for each study separately (see Appendix 8.1 for individual study Q-Q 
plots) and for the meta-analysis, using LD score regression (described in more 
detail below in section 5.3.4.4), implemented in LD Hub. Also, within each study, 
phenotypic variance (in sleep duration) explained by single top SNPs was 
calculated using the following formula, as previously reported by271: 
𝑅2  ≅  
2?̂?2𝑀𝐴𝐹(1 − 𝑀𝐴𝐹)
2?̂?2𝑀𝐴𝐹(1 − 𝑀𝐴𝐹) + (𝑠𝑒(?̂?))22𝑁𝑀𝐴𝐹(1 − 𝑀𝐴𝐹) 
 
Whereby, R2 for a given SNP based on the effect estimate for its association with 
self-reported sleep duration (beta or ?̂?), respective standard error (𝑠𝑒(?̂?)), minor 
allele frequency (MAF), and sample size (N). 
5.3.4.1 ALSPAC association analysis 
The GWAS analysis in ALSPAC was performed by a collaborator, Dr Gibran Hemani 
(University of Bristol). Linear association tests were performed using the frequentist 
method in SNPTEST between genotyped and imputed SNPs, and untransformed sleep 
duration. Dr Hemani then sent the ALSPAC summary estimates. A Manhattan plot of 
ALSPAC results is presented in Appendix 8.1.  
5.3.4.2 ELSA and UKHLS association analyses 
The analytical approach adopted in ELSA and UKHLS was identical: linear regressions 
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(as sleep duration was measured in hours, as a continuous trait), which assumed 
additive effects between (genotyped and imputed) SNPs and untransformed sleep 
duration were implemented in the snpStats R package272. An additive model was chose 
for this GWAS study because it is powered to detect additive and dominant effects, but 
might be underpowered for the detection of recessive effects21. Individual Manhattan 
plots from ELSA and UKHLS GWASs are presented in Appendix 8.1.  
5.3.4.3 Meta-analysis of ALSPAC, ELSA and UKHLS 
An inverse-variance fixed effects meta-analytical approach273 was adopted using 
METAL274, as the phenotype was very similar across the three studies (N=19,550) and 
individuals were all of European ancestry. Underlying this model is the assumption that 
studies included in the meta-analysis have a common genetic effect, thus any 
differences in study findings are due to sampling variation. When performing the 
analysis, this approach weights the effect sizes according to the inverse of their standard 
errors. In total, 9,498,728 SNPs were included in the meta-analysis. 
5.3.4.4 Genome-wide Complex Trait Analysis (GCTA) and LD Score 
(LDSC) regression 
The Genome-wide Complex Trait Analysis (GCTA) package19 was used to perform 
restricted maximum likelihood (REML) analysis to estimate the amount of phenotypic 
variance (SNP heritability) in sleep duration explained by all the genotyped SNPs in 
each study separately. Prior to running the REML analyses it was necessary to estimate 
the genetic relationship matrix (GRM) between pairs of individuals. Power was 
calculated using the online GCTA GREML Power calculator275 for different heritability 
estimates (Table 5.1). 
LDSC regression is an alternative method, which uses GWAS summary statistics to 
estimate the SNP heritability of complex traits28. This method involves regressing 
summary statistics from GWAS (from millions of SNPs) and measures to what extent 
each SNP is able to tag other variants locally (or, its ‘LD score’). The slope of the LDSC 
regression model can then be rescaled to provide a heritability estimate of a trait, 
accounted for by all SNPs used in the estimation of the LD scores 28. LD Hub is a web 
interface, which allows the uploading of summary statistics from association analyses 
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(from each study separately, as well as results from the meta-analysis) in order to 
automate the LD score regression analytical process20. SNP heritability of sleep duration 
was estimated using this method in addition to GCTA for two reasons: 1) to compare the 
results and 2) to calculate the heritability of sleep duration across all three studies using 
the meta-analysis results.  
Table 5.1 Power calculations for different heritability estimates of self-reported 
sleep duration using GCTA GREML  
Study Sample size Heritability estimate (h2) Power 
 
ALSPAC 
 
4,914 
20% 
15% 
10% 
7%* 
87% 
64% 
34% 
19% 
 
ELSA 
 
6,028 
20% 
15% 
10%* 
7% 
97% 
82% 
48% 
27% 
 
UKHLS 
 
8,608 
20% 
15% 
10% 
7%* 
99% 
98% 
78% 
48% 
Note. *indicates actual h2 obtained from GCTA GREML analyses. 
5.4 RESULTS  
5.4.1 Main results 
5.4.1.1 Sample characteristics  
As per Table 5.2 below, the mean sleep duration across the samples included in 
the current meta-GWAS (ALSPAC, ELSA and UKHLS) were largely comparable to 
those included in the earlier CHARGE meta-GWAS.   
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Table 5.2 Characteristics of current GWAS samples vs. samples included in the 
CHARGE sleep duration GWAS 
Study  N Mean age (SD) Sex, %Female Mean sleep duration, 
hours (SD) 
ALSPAC   4,914 39.4  100% 7.61 (0.95) 
ELSA  6,028 67.09 (9.90) 54.66% 6.61 (2.41) 
UKHLS 8,608 53.67 (16.15) 56.42% 6.61 (1.30) 
Samples in the CHARGE GWAS 
ARIC 3578 62.6 (5.6) 53.20% 7.4 (1.1) 
CHS 1515 77.9 (4.6) 62.10% 7.3 (1.3) 
FHS 7531 51.3 (13.2) 54.10% 7.9 (1.3) 
HABC 1661 73.8 (2.8) 47.00% 7.0 (1.2) 
HBCS 1175 69.0 (2.7) 60.70% 8.2 (1.1) 
HPFS 3542 56.0 (8.7) 0.00% 7.2 (0.9) 
InCHIANTI 1205 68.3 (15.5) 55.40% 6.8 (1.5) 
MrOS 2354 76.7 (5.7) 0.00% 7.0 (1.2) 
NHS 6638 54.4 (6.7) 100.00% 7.0 (0.9) 
QFS 865 41.1 (15.4) 56.30% 7.7 (1.1) 
QIMR 2286 34.5 (14.3) 74.20% 7.7 (1.0) 
RS I 2834 76.1 (6.3) 59.50% 6.8 (1.3) 
RS II  1425 68.9 (7.6) 57.60% 6.9 (1.3) 
SHIP 2859 49.4 (16.5) 57.90% 7.5 (1.3) 
SOF 3303 77.0 (5.1) 100.00% 7.0 (1.2) 
TwinsUK 1531 53.1 (12.6) 86.10% 6.8 (0.8) 
WiSC 850 55.7 (7.5) 45.60% 7.1 (0.9) 
YFS  2028 37.7 (5.0) 54.90% 7.4 (0.8) 
Note. Sample characteristics were not available in the UKB GWAS paper78 and are 
therefore not presented.  
5.4.1.2 Main results  
In the analyses, there appeared to be little evidence of population stratification, as 
shown in the Q-Q plot in Figure 5.1 and the calculated Lambdas: GC ALSPAC= 1.00, GC 
ELSA= 1.00, GCUKHLS= 1.00, GC Meta-analysis= 1.02. In the case of these studies, the 
Q-Q plot showed that the majority of the variants are distributed along the null line, 
with 15 SNPs towards the top end at p<10-7.  
No novel or previously reported genome-wide significant SNPs associated with self-
reported sleep duration emerged in the meta-analysis, thus associations are presented 
where p<5*10-6, resulting in 34 ‘suggestive’ SNPs in Table 5.3. Of these loci presented in 
Table 5.3, 25 are located on chromosome 19, 4 on chromosome 14, 2 on chromosome 12, 
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and one each on chromosomes 3 and 5, respectively, which can also be seen in the 
Manhattan plot in Figure 5.2. Taken together, these variants explained a modest 
proportion of the phenotypic variance in self-reported sleep duration: ALSPAC= 3%, 
ELSA = 3%, UKHLS= 4%. Therefore, in ALSPAC and ELSA the percentage of variance 
explained by these SNPs was less than half the size of the SNP h2 estimate of 7%, whilst 
in UKHLS the variance explained by these 34 SNPs was slightly larger (4%), which was 
expected due to the larger sample size. 
The top SNP as presented in Table 5.3 was rs72781084 on chromosome 5 
(p=8.49*10-7), an intron within the Polymerase (RNA) III (DNA Directed) 
Polypeptide G (POLR3G) gene, which was associated with a 4-minute decrease in 
sleep duration. In these data, this variant had minor allele frequencies of between 
0.23 in ALSPAC and ELSA, and 0.24 in UKHLS, and explained 0.12%, 0.19% and 
0.09% of the phenotypic variation in sleep duration in each study, respectively. 
No variants within this gene have previously been associated with any sleep 
phenotypes in a GWAS.  
Twenty-four of the SNPs on chromosome 19 are intronic variants whilst rs855632 is an 
exonic synonymous variant, within the Signal-induced proliferation-associated 1 like 3 
(SIPA1L3) gene. All of these SNPs have MAFs of between 0.42 and 0.45 across the three 
studies. Using the SNP Annotation and Proxy Search tool (SNAP: 
http://www.broadinstitute.org/mpg/snap/ldsearchpw.php) and applying a threshold of 
R2=0.8, pairwise LD was obtained for these SNPs, the results of which are in Appendix 
8.1 and show that 19 of these variants are in high LD (R2= 0.93 - 1.00). The effect allele for 
each of the 25 SNPs on chromosome 19 was associated with a 3-minute increase (17 
SNPs) or decrease (8 SNPs) in sleep duration, effect sizes which are comparable to SNPs 
significantly associated with this phenotype in recently published in large-scale 
studies74,78.   
rs118167883 and rs117831282 on chromosome 12 are both intergenic variants, which are 
not in LD. The former is located between the PDZ Domain Containing Ring Finger 4 
(PDZRN4) and the Glucoside Xylosyltransferase 1 (GXYLT1) genes, whilst the latter is 
between the Ethanolamine Kinase 1 (ETNK1) and Sex Determining Region Y – Box 5 
(SOX5) genes. In these data, rs118167883 was associated with a 20-minute increase in 
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sleep duration, whilst rs117831282 was associated with a 14-minute decrease in sleep 
duration; however, the MAFs of these variants are low at 0.01 and 0.02, respectively. 
These small MAFs indicate that, whilst such variants are considered to be ‘common’ and 
appropriate for inclusion in genome-wide analyses, rs118167883 was only present in 195 
individuals and rs117831282 in 391 individuals in this study and thus, their effect sizes 
should be interpreted with caution.  The potential implication of this is that these 
particular analyses may not have been the most suitable for SNPs with low MAFs and 
perhaps a more appropriate test would be one for analysis of rare variants. These SNPs 
explained 0.15% and 0.17% of the phenotypic variance in sleep duration within ALSPAC, 
0.12% and 0.11% in ELSA, and both explained only 0.08% in UKHLS.  
On chromosome 3, it appeared that rs116728846, an intergenic variant located 
between the Vent Homeobox Pseudogene 7 (VENTXP7) and the SGOL1 Antisense 
RNA 1 (SGOL1-AS1) was associated with a 15-minute increase in sleep duration. 
Similarly to the variants on chromosome 12 the minor allele frequencies for this 
SNP were low: 0.01 in ALSPAC and UKHLS, and 0.02 in ELSA, and it only 
explained between 0.01% and 0.12% of the phenotypic variance in sleep duration 
in these samples. Thus, this effect size of 15 minutes should be interpreted 
cautiously, as this SNP was only present in ~281 individuals out of the 19,500 in 
the meta-GWAS (49 individuals in ALSPAC, 60 individuals in ELSA and 172 
individuals in UKHLS). 
Of the four SNPs on chromosome 14, rs138098759, rs2749493 and rs1958962 were 
associated with a 6-minute decrease in sleep duration per allele, whilst rs1953188 
was associated with a 6-minute increase in sleep duration. Only rs1958962 and 
rs1953188 are in high LD, R2=1.00. These SNPs all have MAFs of 0.08 in these 
samples, indicating that they are present in 1,564 individuals from the overall 
meta-analytic sample, and explained between 0.08% and 0.16% of the variation in 
sleep duration. All of these SNPs are intergenic variants located between the F-
Box Protein 33 (FBXO33) and the (uncharacterised) LOC644919 RNA gene.  
The meta-analysis also found an intergenic variant on chromosome 16, 
rs55950229 to be associated with a 4-minute decrease in sleep duration. This 
SNP’s minor allele frequency is 0.20 in ALSPAC and ELSA, and 0.21 in UKHLS; 
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and it explained between 0.05% and 0.23% of the phenotypic variance in sleep 
duration. rs55950229 lies between the MicroRNA 4719 (MIR4719) and MON1 
Secretory Trafficking Family Member B (MON1B) genes.  
The Co-expression database (COXPRESdb)276 was used to examine which genes 
are co-expressed with the SIPA1L3 and POLR3G genes, which are presented in 
two network diagrams in Appendix 8.1. There is an enrichment of genes in 
adhesion processes and RNA modification. 
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Table 5.3 34 ‘top’ SNPs associated with sleep duration in meta-analysis of ALSPAC, 
ELSA and UKHLS (N=19,550) at suggestive p-value threshold of <5x10-6 
       Meta-analysis 
SNP Functional class Gene/locus Chr Position A1* A2 Effect SE P-value 
rs118167883 intergenic PDZRN4,GXYLT1 12 42149726 T C 0.329 0.070 2.78E-06 
rs117831282 intergenic ETNK1,SOX5 12 23497814 T C -0.233 0.051 4.47E-06 
rs116728846 intergenic SGOL1-
AS1,VENTXP7 
3 21051974 C G 0.249 0.055 6.41E-06 
rs138098759 intergenic FBXO33,LOC6449
19 
14 40171948 A G -0.104 0.023 4.87E-06 
rs2749493 intergenic FBXO33,LOC6449
19 
14 40176497 A G -0.103 0.023 4.23E-06 
rs1953188 intergenic FBXO33,LOC6449
19 
14 40187953 A G 0.104 0.023 6.60E-06 
rs1958962 intergenic FBXO33,LOC6449
19 
14 40179804 T C -0.104 0.023 3.94E-06 
rs55950229 intergenic MIR4719,MON1B 16 76930106 T C -0.072 0.015 3.51E-06 
rs72781084 Intronic POLR3G 5 89789454 A G -0.072 0.015 8.49E-07 
rs8112798 Intronic SIPA1L3 19 38661228 A G -0.055 0.012 4.95E-06 
rs8109799 Intronic SIPA1L3 19 38661480 A G -0.054 0.012 5.09E-06 
rs9941474 Intronic SIPA1L3 19 38658607 A G -0.054 0.012 3.73E-06 
rs332849 Intronic SIPA1L3 19 38629126 T C -0.054 0.012 9.57E-06 
rs6508765 Intronic SIPA1L3 19 38644528 T C -0.054 0.012 6.05E-06 
rs855632 exonic 
(synonymous) 
SIPA1L3 19 38652993 T C -0.054 0.012 3.97E-06 
rs332850 Intronic SIPA1L3 19 38629630 A T -0.053 0.012 8.63E-06 
rs332848 Intronic SIPA1L3 19 38630160 A G -0.053 0.012 8.46E-06 
rs8101826 intronic SIPA1L3 19 38631193 T C 0.053 0.012 4.56E-06 
rs332851 intronic SIPA1L3 19 38634474 T C 0.053 0.012 7.48E-06 
rs8100144 intronic SIPA1L3 19 38645276 T C 0.054 0.012 6.87E-06 
rs2099340 intronic SIPA1L3 19 38647545 A G 0.054 0.012 6.69E-06 
rs2384778 intronic SIPA1L3 19 38637945 T C 0.054 0.012 6.93E-06 
rs8109695 intronic SIPA1L3 19 38637746 A G 0.054 0.012 4.05E-06 
rs2569412 intronic SIPA1L3 19 38639903 T C 0.054 0.012 7.66E-06 
rs332864 intronic SIPA1L3 19 38642874 T C 0.054 0.012 6.39E-06 
rs332855 intronic SIPA1L3 19 38638176 A T 0.054 0.012 7.62E-06 
rs4802251 intronic SIPA1L3 19 38643951 A G 0.055 0.012 6.27E-06 
rs332856 intronic SIPA1L3 19 38639940 A C 0.055 0.012 6.69E-06 
rs332858 intronic SIPA1L3 19 38641264 T C 0.055 0.012 6.61E-06 
rs2005055 intronic SIPA1L3 19 38642044 T C 0.055 0.012 6.58E-06 
rs10404957 intronic SIPA1L3 19 38634020 T C 0.055 0.012 3.87E-06 
rs8111180 intronic SIPA1L3 19 38627138 A G 0.055 0.012 4.62E-06 
rs332843 intronic SIPA1L3 19 38603259 C G 0.056 0.012 8.26E-06 
rs332844 intronic SIPA1L3 19 38601728 A G 0.056 0.012 9.41E-06 
Note. *A1= effect allele, A2= alternative allele, SE= standard error, p-value= 
association p-value.   
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Figure 5.1 Q-Q plot of p-values for meta-analysis of ALSPAC, ELSA and UKHLS 
 
Note. Q-Q plot depicts the observed –log10 p-values on the Y-axis and the 
expected –log10 p-values on the X-axis.  
 
Figure 5.2 Manhattan plot for meta-analysis of sleep duration in ALSPAC, ELSA 
and UKHLS 
 
Note. Manhattan plot depicts –log10 p-values on the Y-axis, with the blue line set 
at p<5x10-5 and along the X-axis are chromosomes (1-22).   
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Figure 5.3 Locus zoom plot of GWAS results 
 
 
5.4.2 Previously associated loci in CHARGE and UK Biobank: how are 
they associated with sleep duration in the present GWAS? 
As mentioned in the Introduction of this chapter, the most recently published GWAS in 
127,573 UK Biobank participants78 was the first to replicate a signal (rs62158211) for self-
reported sleep duration. rs62158211 is in high LD with rs1823125 (R2=0.95) and rs1807282 
(R2=1.00), which were previously reported in the CHARGE consortium GWAS74. An 
intron within the PAX8 gene, rs62158211 was present in the ELSA and UKHLS samples 
and in the present meta-analysis a similar effect size was observed, albeit with a very 
large standard error (UKBiobank effect =-2.34 minutes, SE=0.30 minutes vs. present 
meta-analysis effect = -1.80 minutes, SE=1.14). Proxies for rs62158211 (rs1823125 and 
rs1807282) were identified but were not present in the ALSPAC dataset. 
Further, the two novel loci reported by Jones and colleagues78, rs17190618 and rs1380703 
are both introns in the Vaccinia Related Kinase 2 (VRK2) gene and were associated with 
a 2-minute decrease and a 1.5-minute increase in self-reported sleep duration, 
respectively. In the current meta-analysis these SNPs were associated with a 2-minute 
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decrease and a 1.4-minute increase in sleep duration, but not significantly (p=0.061 and 
p=0.087, respectively).  
Previously, Gottlieb et al., 201474 performed a genome-wide association analyses in 
~47,000 individuals in the CHARGE consortium and found seven novel loci associated 
with self-reported sleep duration, four of which are on chromosome 2 and 3 on 
chromosome 6. In CHARGE, the four SNPs on chromosome 2, rs1191685, rs1823125, 
rs1807282 and rs1964463 were all associated with a 3-minute increase in self-reported 
sleep duration. The present meta-analysis found that rs1191685 was associated with a 2-
minute increase in sleep duration, whilst rs1823125, rs1807282 and rs1964463 were 
associated with increases in sleep duration of 1.44, 2 and 1 minutes, respectively. 
However, these combined effects were only for ELSA and UKHLS, as none of these SNPs 
or any proxies in LD of R2>0.80 were present in ALSPAC, with the exception of 
rs1964463, for which no proxies were available. Minor allele frequencies (MAFs) for 
these variants were comparable between CHARGE and the present samples.  As the 
effect alleles for these three variants in CHARGE were the opposite allele to those in 
these data the signs of the coefficients were changed here for the purposes of reporting 
and comparing the results.  
In addition, the three loci of interest on chromosome 6 (rs4587207, rs4248149, 
rs2394403) were looked up in this study and they were not present. The Single 
Nucleotide Polymorphisms Annotator (SNiPA: http://snipa.helmholtz-
muenchen.de/snipa/index.php) was used to search for proxies for these variants. 
The best proxy (with the highest r2= 1), which was in high LD with all three of 
these SNPs was rs147772769 (Appendix 8.1). This variant was present in ALSPAC 
and ELSA, but not in UKHLS. However, the effect of rs147772769 in these two 
studies was in the same direction as in Gottlieb’s74 study: in ALSPAC this effect 
was -0.02, in ELSA it was -0.001 and in the previous GWAS it was -0.05.  
5.4.3 Do the ‘top’ (suggestive) 34 SNPs from the present meta-analysis 
replicate in the latest UKB GWAS? 
The summary statistics from the latest UKB GWAS by Jones and colleagues78 
were freely available alongside the publication and were therefore downloaded to 
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look up the suggestive loci from the current meta-GWAS. However, none of these 
SNPs were significantly associated with self-reported sleep duration in UKB at 
either genome-wide or suggestive significance. The lowest p-value was 0.042 for 
rs72781084, which had a directionally consistent effect in UKB in comparison to 
the present study, -0.004 vs. -0.072, respectively.   
5.4.4 Expression quantitative trait loci (eQTLs) associated with ‘top’ SNPs 
The Genotype-Tissue Expression portal (http://www.GTEXportal.org) was used to 
search for significant expression quantitative trait loci (eQTLs) in tissue for each of the 
top SNPs. rs72781084, on chromosome 5, which was the most strongly associated SNP 
with sleep duration, was significantly associated with expression levels in the following 
tissues: colon, thyroid and adrenal gland.  
Fourteen of the SNPs on chromosome 19 were significantly associated with expression 
levels in the pancreas, whilst 2 variants were associated with expression levels in the 
tibia nerve. No significant eQTLs for any of the other top SNPs were found. 
5.4.5 SNP heritability in ALSPAC, ELSA and UKHLS 
Restricted maximum likelihood (REML) analyses in GCTA showed that the SNP 
heritability of self-reported sleep duration in these samples was low and not statistically 
significant. This was further confirmed by estimating SNP heritability using LD score 
regression (see Table 5.4) in each sample. However, the heritability estimate from LD 
score across all three samples albeit low at 7%, was significant. The recent UK Biobank 
GWAS found the SNP heritability of sleep duration to be 7% in a sample that was 
approximately 10 times greater than the GWAS reported here. This is therefore, 
consistent with what was found in the present study.  
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Table 5.4 Heritability of self-reported sleep duration in ALSPAC, ELSA and UKHLS 
samples 
Method ALSPAC  
 
ELSA  
  
UKHLS  
  
All 3 studies  
 
h2 SE P-
value 
h2 SE P-
value 
h2 SE P-
value 
h2 SE P-
value 
GCTA*  0.07 0.0564 0.17 0.103 0.067 0.058 0.075 0.108 0.238 N/A N/A N/A 
LD score 0.188 0.107 0.57 0.055 0.076 0.080 0.041 0.055 0.064 0.074 0.021 0.0005 
Note. There are no GCTA estimates for h2 in all 3 studies combined, as it requires 
IPD.  
5.5 DISCUSSION 
5.5.1 Summary of findings 
In a genome-wide meta-analysis of 19,550 individuals of European ancestry, no 
novel genetic variants associated with self-reported sleep duration were found, 
nor were any SNPs published in recent large-scale GWA studies of sleep 
duration74 replicated at genome-wide level. These analyses were relevant at the 
time they were performed, as the UKB sleep duration GWAS78 had not been 
published (date of publication: August, 2016) and one of the main aims of this 
project was to carry out bidirectional Mendelian randomisation analyses in 
Chapter 6. 
An intron (rs72781084) in the POLR3G gene was the most strongly associated 
SNP with a 4-minute decrease in sleep duration (p=8.49x10-7). This variant was 
also found to be significantly associated with expression quantitative trait loci 
(eQTLs) in the colon, the thyroid and the adrenal gland. A further 33 SNPs were 
suggestively (p<5x10-6) associated with sleep duration, albeit not at the genome-
wide significance level (p<5x10-8). Of these variants, twenty-five are introns in the 
SIPA1L3 gene on chromosome 19; four are on chromosome 14, two on 
chromosome 12, and one each on chromsomes 3, 5 and 16. Aside from the introns 
in the SIPA1L3 and POLR3G genes, the other SNPs found are all 
intergenic. Significant associations with expression quantitative trait loci (eQTLs) 
in the pancreas were found for twenty-two of the introns in the SIPA1L3 gene. 
Most of the variants on chromosome 19 are in high linkage disequilibrium and 
the lead SNP was identified as rs332858. Of the additional one-hundred and 
  164 
twenty genetic variants that were suggestively associated with sleep duration 
(P<5x10-6), there were another four intronic SNPs in the SIPA1L3 gene.  
As mentioned above, rs72781084 is an intronic variant which was suggestively 
associated with a decrease in sleep duration in the present GWAS, yet it has not 
previously been associated with sleep duration. The POLR3G gene has not 
previously been linked to any sleep phenotypes. The SIPA1L3 gene has not been 
related to any aspects of sleep in the GWAS literature. Located on chromosome 
12, rs118167883 is an intergenic variant between the PDZRN4 and GXYLT1 genes, 
whilst rs117831282 is found between the ETNK1 and SOX5 genes, yet neither of 
these SNPs has been associated with any sleep phenotypes. rs55950229 lies 
between the MIR4719 (a microRNA gene) and MON1B (protein coding) genes on 
chromosome 16. To date, this variant has not been associated with any sleep 
phenotypes in GWAS. 
It is important to note that it can be problematic to interpret GWAS results that 
are below the significance threshold of p<5x10-8. This may mean that SNPs 
detected to be associated with sleep duration at this less stringent threshold are 
more likely to be spurious signals and these usually require further validation. In 
the present meta-GWAS this is a plausible explanation for the loci that were 
suggestively associated with sleep duration, as upon closer inspection of these 
signals, it emerged that none of them had been related to any sleep mechanisms 
or pathways in the literature.  
5.5.2 Significant eQTLs in the SIPA1L3 and POLR3G genes 
Several genetic variants in the SIPA1L3 were significant eQTLs in the pancreas. 
Evidence from a recent review of over one-hundred thousand individuals, suggests 
that duration and quality of sleep are both significant predictors of type 2 
diabetes187, a condition in which individuals build up insulin resistance, causing 
the pancreas to work harder to produce higher than normal levels of insulin.  
  165 
5.5.3 Heritability of self-reported sleep duration 
Across the samples included in this study, self-reported sleep duration was only 7-
10% heritable, but these were not significant when using GCTA, which is likely due 
to the limited power. Using the LD Score method heritability across all three 
studies was still low at 7%, but was significant. However, twin studies have 
previously reported that genetic factors explain between thirty to fifty per cent of 
the variance in sleep duration69–71. One reason for this could be the fact that the 
CTM assumes a lack of, or minimal gene*environment interactions and that 
therefore, all genetic risk is additive, which can in turn, produce inflated 
heritability estimates277. It is also possible that the CTM estimates include rare, as 
well as common variants. 
In a sample of approximately 120,000 individuals from the UK Biobank78 SNP 
heritability of self-reported sleep duration was 7%, which accords with what was 
found in the present study. However, this estimate reached statistical significance 
in the UK Biobank, which is not surprising as their study had a much larger sample 
size and thus, more power.  
There are some key points to be noted in relation to the heritability of self-reported 
sleep duration. Firstly, the present estimates accord with the very limited number 
of genome-wide significant loci that have been found to date in GWAS. If genetic 
factors only explain a very small proportion of the variation in a phenotype then it 
is plausible that we fail to detect a large number of common variants associated 
with this phenotype. Secondly, it is likely that the genetic component of self-
reported sleep duration is highly complex with potentially many variants of very 
small effect sizes (polygenic trait) and that they may still not have been discovered 
using GWAS. Thirdly, it is also possible that rare genetic variants account for a 
proportion of the heritability of self-reported sleep duration and/or that there may 
be epigenetic factors that play a role in sleep duration, but they have not yet been 
described. Therefore, even though the present GWAS did not have substantial 
power to detect SNP heritability using GCTA, the results of GCTA REML analyses 
appear to suggest that the genetic component of this phenotype might not be 
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accounted for by common variants of small effect size. Fourthly, finding that self-
reported sleep duration is not highly heritable does not rule out the fact that 
objectively measured sleep duration, using methods such as actigraphy or 
polysomnography, might yield higher estimates of SNP heritability, in comparison 
to self-reported sleep duration. To date, research into the molecular genetics of 
objective sleep measures remains limited. However, a candidate polymorphism 
study found a significant association between a specific polymorphism (rs324981) 
and objective sleep duration, as measured by actigraphy, in a sample of four-
hundred and thirty-six individuals over the age of sixty278. In the present meta-
analysis this variant was associated with a -0.5-minute decrease in sleep duration, 
although not at the GWAS significance level. Fifthly, the study reported here, 
alongside other large-scale GWA studies of self-reported sleep duration to date, 
have focused on examining heritability in individuals of Northern European 
ancestry. Therefore, it cannot be assumed that in populations of different ancestry 
heritability estimates of sleep measures are equal. For example, Americans of 
African descent reportedly have shorter sleep durations compared to European 
Americans279, and a recent review suggests that being of African American, or sub-
Saharan African descent may predispose to shorter sleep duration280.  
5.5.4 Issues with self-reported sleep duration as a phenotype 
Self-reported sleep measures are widely used in observational and genetic 
epidemiological research as they are inexpensive and easy to administer. Within 
the context of GWAS, obtaining both objective sleep duration as well as genotype 
data from large samples of participants remains on the whole, financially 
unfeasible, and only one, small-scale GWAS of objective sleep measures has been 
published, to date. Across the majority of studies, sleep duration is assessed by 
asking respondents how many hours and/or minutes they sleep on an average 
night, or they are asked to report the times that they go to bed and wake up, from 
which sleep duration is estimated. The only GWAS of actigraphic sleep duration 
to date found one novel SNP in the Zinc Finger MYM-Type Containing 4 
(ZMYM4) gene281. However, this study’s sample size was only 956 individuals, 
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aged between 40 to 79 years and thus, requires stringent replication in future 
studies.  
5.5.5 Study strengths 
This study possesses important strengths. The sleep duration phenotype definition 
was almost identical across the three samples included in this meta-GWAS, whilst 
for example, Gottlieb et al., 2014 282 meta-analysed data from eighteen studies that 
did not ask about sleep duration in the same manner. The fact that it was possible 
to meta-analyse data from three studies is also a strength; each study on its own 
had extremely limited power, as single GWA studies only have the ability to detect 
large effects 283. Also, genotypes were imputed to the same reference panel (1000 
Genomes), and all of the same covariates were available across all three studies.  
5.5.6 Study limitations 
However, there are also methodological limitations concerning this GWAS. As 
discussed earlier in more depth, the phenotype was self-reported across ALSPAC, 
ELSA and UKHLS. Crucially, this study also had limited statistical power to both 
detect novel, and replicate existing loci associated with self-reported sleep 
duration, particularly as previous larger GWAS of 47,000282 and 127,573 
individuals78 have only detected a total of nine independent variants for sleep 
duration. Thus, due to the lack of genome-wide significant hits further analyses 
were limited, such as pathway analyses, gene enrichment analyses, genetic 
correlations with other brain phenotypes of interest, amongst others. 
Furthermore, given the markedly low and non-significant SNP heritability, a 
polygenic risk score was not created, as this is commonly done when the variance 
can be at least partially explained by genetic factors. Also, the only study in which 
individuals were removed due to reporting the use of sleep medication was 
ALSPAC, but exclusions based on taking sleep medication were not made in ELSA 
or UKHLS. The ELSA participants also had a different age and sex distribution from 
the other two studies, which makes the findings somewhat less representative of 
the general population. Another limitation is the use of different cut-offs for sleep 
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duration ALSPAC, as compared to ELSA and UKHLS, which introduced noise to 
the phenotype.  
5.5.7 Future directions 
Future studies should aim to perform genome-wide analyses using objective sleep 
duration in large samples. Furthermore, it is important to perform larger genetic 
association studies to potentially identify common variants; novel and/or 
previously-identified, associated with other self-reported sleep parameters. For 
example, there have yet to emerge SNPs related to sleep quality, as measured by 
validated self-report scales. This is particularly significant, as evidence suggests 
that for example (and of interest to the wider research carried out in this thesis), it 
is sleep quality, rather than sleep duration, that is linked to higher BMI and 
increased risk of obesity166,284.  
Finally, a newer method for estimating SNP heritability has recently emerged285. 
This technique is able to describe the variation of heritability, dependent on 
genotype certainty, MAF and LD. The authors re-estimated the SNP heritability for 
19 traits and observed that their method yielded estimates that were on average, 
43% higher than GCTA. The application of this novel approach may be important 
to confirm heritability estimates of self-reported sleep duration, as the present 
study, as well as other published studies have shown that SNP heritability is 
currently estimated to be approximately 7%.  
5.6 CHAPTER SUMMARY 
 A meta-GWAS of self-reported sleep duration was performed across three 
population-based studies. 
 No novel genome-wide significant loci associated with sleep duration 
emerged. 
 This GWAS did not replicate any previously reported sleep duration loci. 
 SNP-based heritability of self-reported sleep duration was low in these 
samples. 
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 Due to all of the above, the decision was made that it would not be 
feasible to perform a Mendelian randomization study of sleep duration on 
BMI, as one of the core assumptions was not met (lack of robustly 
replicated SNPs associated with the exposure of interest, in this case 
sleep).  
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6 IS THE ASSOCIATION BETWEEN BMI AND SELF-
REPORTED SLEEP DURATION CAUSAL? A 
MENDELIAN RANDOMISATION STUDY 
 
Results from analyses performed in this chapter contributed to the following 
publication: Garfield, V., Fatemifar, G., Dale, C., Smart, M., Bao, Y., Llewellyn, 
C., Steptoe, A., Zabaneh, D. & Kumari, M. Assessing Potential Shared Genetic 
Aetiology between Body Mass Index (BMI) and Sleep Duration in 142,209 
individuals. Resubmitted to Genetic Epidemiology.   
6.1 BRIEF INTRODUCTION AND OVERVIEW OF CHAPTER 
CONTENTS 
In Chapter 3, observational regression analyses were performed to investigate the 
nature of the direction of the relationship between BMI and self-reported sleep 
duration in a community sample of older English adults. These findings 
suggested that the direction was from BMI and WC to very small decreases in 
sleep duration over a 4-year follow-up period: BMI [B = -0.42 minutes, (95% CI = 
-0.013; -0.002), p = 0.013] and WC [B = -0.18 minutes, (95% CI = -0.005; -0.000), p 
= 0.016], independently of several demographic, health behaviour and 
problematic health covariates. Though, one crucial limitation of these analyses, 
even when they are performed using prospective data, is their limited ability to 
allow the inference of causation, due to confounding and possible reverse 
causation (discussed in more detail in Chapter 1 and below). Also, despite the fact 
that the effects observed between adiposity and changes in sleep duration in 
ELSA (Chapter 3) were small, these analyses were performed only in an ageing 
sample and thus, it is important to investigate causality using data from a sample 
of a wider age range.  
Mendelian Randomisation has been proposed as a method to address causality 
using genetic markers as instruments.  When these analyses were planned, there 
had been no previous attempt to investigate the causal relationship between BMI 
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and sleep duration. Then, the first MR of BMI and self-reported sleep duration 
was published78, but the analyses presented in this chapter differ somewhat from 
the previous study.  
Briefly, in this chapter the causal relationship between BMI and self-reported 
sleep duration was investigated, using genetic data. This chapter begins by asking 
why we would want to use genetics to investigate causation, followed by an 
overview of Mendelian randomisation and polygenic risk scoring (PRS) and the 
aims of this chapter. Then, there is a detailed account of the methodologies and 
statistical analyses used, followed by results, which are divided into observational 
and genetic. Subsequently the main findings are discussed, in light of previous 
evidence and cover relevant strengths and limitations. The chapter ends with a 
summary of what has been presented.  
6.2 MENDELIAN RANDOMISATION: A GENETIC TOOL FOR 
ASSESSING CAUSALITY  
Mendelian randomisation (MR) was proposed to investigate causation between 
two traits, which have been consistently associated in the observational 
epidemiological literature286. This method has been increasingly used in the last 
decade with 1,060 publications indexed under ‘Mendelian randomization’ and 151 
under ‘Mendelian randomisation’ in PubMed Central (as of October 2017). MR 
has been called ‘nature’s randomised trial’287, as it provides an alternative to the 
RCT and enables researchers to exploit large-scale studies in which participants 
have undergone detailed genotyping.  
6.2.1 A brief overview of Mendelian randomisation (MR) 
MR – the random assortment of genes, passed on from parents to offspring 
during conception and gamete formation286 – exploits the unique properties of 
genetic variants. What makes genetic variants unique is that they are unlikely to 
be associated with common confounders and we have them from birth 
throughout the life course286. Due to these properties, MR uses common genetic 
variants (SNPs) from published GWAS as proxies for an exposure, to investigate 
cause and effect between said exposure and an outcome of interest288. Through 
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Mendel’s second law – the law of independent assortment – genotypes 
transferred from parent to child are independent of one another, making MR 
analogous to the randomized controlled trial (RCT), as one allele (out of a 
possible two) is randomly allocated during meiosis  and passed on during gamete 
formation288. This has been called ‘nature’s randomised trial’287, as genotypes are 
unlikely to be confounded in the same way that phenotypes are. For example, 
BMI and sleep duration may be associated because they are both associated with 
physical activity (PA). Therefore, it is possible to use genetic variants associated 
with BMI, rather than BMI itself, to examine its association with sleep duration, 
whilst removing PA (the confounder) from the equation. With the aid of MR in 
the last decade, genetic epidemiology has contributed to furthering our 
understanding of modifiable risk factors of disease, as evidenced by >1000 
published MR studies, and can be seen in the directed acyclic graph (DAG) in 
Figure 6.1.  
Figure 6.1 Directed acyclic graph (DAG) of MR with BMI and sleep duration, 
showing how all parts of the model are interlinked 
 
Figure 6.1 illustrates how Mendelian randomisation enables analyses to 
investigate causal association between BMI and sleep. In both cases, the genetic 
instruments – SNPs – (Z) are specific to the exposure (X) and not associated with 
confounders (U). This implies that any association observed between the genetic 
score (Z) and the outcome (Y) is due to the exposure (X).  
6.2.1.1 Principles of MR 
Two core underlying principles are fundamental to the MR technique:  
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I. Eliminating reverse causation and II. randomisation286,289. These two principles 
enable genetic epidemiology to go a step further than traditional observational 
epidemiology. 
I. Eliminating reverse causation 
Longitudinal studies provide only a partial solution to the problem of reverse 
causation – which implies that observational studies cannot confirm that the 
outcome in fact precedes the exposure, rather than the other way around and 
thus, the direction of association is unclear290,291. However Mendelian 
randomisation is able to overcome this hurdle by using genes as instrumental 
variables. The observed association between a genetic variant and a phenotype is 
a result of the specific effect of the said genetic variant. In line with the ‘Central 
Dogma’ of molecular biology292 – genomic DNA is transcribed to messenger 
ribonucleic acid (mRNA) and then translated to a protein – the reverse 
association (phenotype causes the genotype) is not possible.  
II. Randomisation 
A confounder is a third factor that is associated with both the exposure and 
outcome of interest. Therefore the confounder (for example, depression may 
confound the BMI-sleep duration relationship) exerts the actual effect on the 
outcome, rather than the measured exposure291. Through Mendel’s second law 
(see above) it is possible to exploit the random assignment of genes in a bid to 
reduce and potentially eliminate confounding. In this context, randomisation 
serves to overcome the problem of confounding, in a similar way to the 
randomised control trial (RCT) design, as genotypes are randomly distributed in 
the population and theoretically, should only be associated with a specific trait 
(although, in practice, the majority of complex traits in fact, follow a model of 
polygenic inheritance). In practice, when examining genetic markers, association 
analyses are performed to confirm that they are not associated with confounders.  
6.2.1.2 Assumptions of MR 
Three core assumptions underlie the Mendelian randomisation approach to 
ensure a reliable causal association. First, there should be a sufficiently robust 
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association between the specific genetic variant and the exposure of interest. To 
investigate causality between BMI and sleep duration there should be robustly-
associated SNPs with BMI, which come from the most recent meta-GWAS of 
BMI293. Second, the chosen genetic variant should be unrelated to typical 
confounding factors. Thus, in the case of BMI and sleep duration, this 
assumption implies that the BMI SNPs are not associated with common 
confounders of this association, such as PA. Third, there must be independence 
between the genetic variant and the outcome, i.e. there must be no horizontal 
pleiotropy288. This means that the BMI genetic variants should not be directly 
associated with sleep duration, but only indirectly (through the exposure: BMI).  
Assumption I implies that the relationship between the genetic variant and the 
exposure is reliable and can be quantified, but SNPs identified using GWAS 
usually only explain a small proportion of the variance. This is evidenced by the 
most recently published BMI meta-GWAS, in which 97 SNPs explain 2.7% of the 
variance in BMI293. However, published GWAS provide a basis for the selection of 
genetic variants. This assumption is tested by ensuring that the SNPs for the 
exposure of interest (in this case, BMI) are associated with the BMI phenotype in 
the data under study. As described further down (Methods section) in the 
present study a 2-sample summary-level MR was performed and thus, the effects 
of the BMI SNPs on BMI were taken from the latest published GWAS’293 summary 
statistics. As described below (6.2.1.3, under ‘Winners’ curse’), this was to ensure 
that a true 2-sample approach was used.  
For assumption II to be met there should be evidence, which suggests that the 
genetic variant is not affected by the usual confounders that are known to 
influence the exposure-disease association. This is tested by selecting common 
confounders of the relationship under study (for example, in the case of BMI  
sleep duration it may be that physical activity is a confounder) and examining 
whether the SNPs for the exposure (BMI) are associated with such confounders. 
If they are then this constitutes a violation of this assumption. Importantly, 
though, in the present study it was not possible to test this assumption, due to 
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the use of summary-level data, which were used to ensure that the sample size 
was large enough.  
Assumption III is met if the genotype does not directly affect the outcome 
(disease) of interest, nor should there be any mediating effect other than via the 
exposure. This assumption refers to what is known as ‘horizontal pleiotropy’ and 
can be tested and corrected for using different MR approaches, which are 
discussed below in section 6.2.1.3 and then in more detail in the Methods section. 
Related to the first assumption is an issue central to this doctoral research: a lack 
of published GWAS studies that have identified and replicated genetic variants 
associated with sleep duration. As mentioned above, investigation of the reverse 
relationship (from BMI to sleep duration) is possible, as published GWAS have 
now replicated and identified SNPs robustly associated with BMI86. However, the 
sleep duration GWAS literature is limited, making it difficult to perform a 
Mendelian randomisation to examine the causal association between sleep 
duration/disturbance and BMI. This was the rationale for the meta-GWAS 
performed in Chapter 5, but no previously-associated loci for self-reported sleep 
duration were replicated, nor did any novel associations emerge. Thus, genetic 
variants robustly associated with sleep duration have not been discovered, to 
date, and therefore, the decision was made not to perform MR analyses to 
investigate potential causality in the direction of sleep duration to BMI.   
 
 
 
 
 
 
  176 
Figure 6.2 Diagram illustrating violations of the assumptions described above  
 
Figure 6.2 illustrates a violation of the core assumptions of MR. Firstly, the ‘x’ 
between the BMI SNPs and X (BMI) indicates that these SNPs are not in fact 
associated with BMI (the exposure) and thus, a violation of this assumption. 
Secondly, the arrow from the BMI SNPs to sleep duration (the outcome) and 
thus, indicates that these variants are directly associated with sleep duration, 
rather than via BMI. Thirdly, the arrow between the BMI genetic instruments and 
physical activity depict another assumption violation, as these SNPs should not 
be related to confounders of the BMI-sleep duration association. The arrow from 
BMI to sleep duration is green because it indicates that it is the causal pathway 
that is under study.   
6.2.1.3 Potential problems when performing MR analyses 
i. Pleiotropy – is when a single gene influences more than one trait, thus if a 
genetic variant has a direct effect on the outcome it can invalidate the MR, as a 
core assumption is violated. A valid instrumental variable (IV) is one that meets 
the core MR assumptions: it is not associated with confounders of the exposure-
outcome association; it is associated with the exposure of interest; it is 
independent of the outcome under study, conditional on the exposure and 
unobserved confounders294.  
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MR Egger294 – is a modification of Mendelian randomisation and was adapted 
from meta-analysis. Its main aim is to detect horizontal pleiotropy between the 
genetic instruments and the outcome, whilst retaining its ability to provide an 
estimate of the underlying causal effect. Part of MR-Egger’s flexibility relates to 
the fact that it is able to estimate the causal relationship between two traits of 
interest, even in a scenario whereby 100% of the IVs under study are invalid (do 
not meet all three of the required MR assumptions). MR-Egger can also provide 
informative pleiotropy statistics, in the form of Cochran’s Q and Higgins’ I2. If the 
value of I2 is >75(%) then this indicates a cause for concern, as it implies that 
there is a high level of heterogeneity in a study (pleiotropy, in this case). 
Similarly, if the Cochran’s Q p-value is significant then this is also problematic 
and provides confirmation of heterogeneity.  
Weighted median295 – this is a further methodological development that can help 
with the issue of with pleiotropy in MR studies. Bowden and colleagues295 
proposed that researchers now apply this as an additional MR sensitivity analysis, 
alongside MR-Egger. This technique is as efficient as the inverse variance 
weighted (IVW) method, yet it is flexible enough to allow the inclusion of up to 
50% of IVs with invalid weights and provide a causal estimate in the presence of 
balanced pleiotropy. IVW meta-analysis is used in MR to obtain an overall 
estimate of the causal estimates (SNP-outcome /  SNP-exposure) from each 
individual SNP and is also known as ‘conventional MR’296.  However, the 
Weighted median approach is different from MR-Egger, as the former allows only 
up to 50% IVs with invalid weights, whilst the latter allows all of the IVs 
themselves to be invalid and can still estimate the causal effect of X on Y. More 
details, including the mathematics behind the different methods (IVW, MR-
Egger and Weighted median) are explained below in the Methods section.  
ii. Linkage disequilibrium (LD) – defined as the non-random association between 
alleles at distinct loci across the population297. If the genetic variant is in LD with 
another variant associated with the outcome of interest the IV regression may 
produce a confounded estimate of the causal relationship between the exposure 
and outcome. This is because, for example, if a chosen genetic variant (SNP1) is in 
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LD with another genetic variant (SNP2) then it is possible that SNP2 has a direct 
or indirect effect on the outcome298. Another possibility is that SNP2 exerts an 
influence on a confounder of the exposure-outcome association298.  
iii. Population stratification – within a given population individuals’ ancestry is 
usually genetically heterogenous299. The relevance to MR is that population 
stratification might lead to confounded results, which is especially possible in a 
case where the genetic variant (IV)-modifiable risk factor association was 
collected in a sample population that is different from the genetic variant-
outcome association300. This is because population subgroups might have 
different rates of disease and different allele frequencies and thus this can 
produce spurious (confounded) associations between a genotype and 
disease/trait in the entire population300.  
iv. Winner’s curse – this refers to a situation whereby several of the genetic 
variants’ true effect sizes (for the exposure) are similar, the one with the strongest 
association in the dataset under analysis may be overestimated301. This is likely to 
occur if the SNPs for the exposure were discovered in the data under study301. 
Two-sample MR is an approach in which the associations between genetic 
variants (IVs) and the exposure and outcome of interest come from two separate 
non-overlapping data sources. As such, two-sample MR reduces potential 
‘winner’s curse’ that can underestimate a true causal effect in one-sample MR and 
it also diminishes weak instrument bias302. This method is described in more 
detail below in the Methods section.  
v. Dynastic effects – where the offspring’s outcome phenotype is also influenced 
by the parental exposure caused by the parent’s genotype and may thus, affect 
the magnitude of the causal estimate303. The effect may be inflated, as the child 
might have greater exposure, or it may be smaller if the parental genotype creates 
a hostile environment in utero, from which the foetus then develops to protect 
against303.  
vi. Canalisation – a compensatory mechanism for disruptive environmental or 
genetic factors304. This may occur for certain risk factors, whereby an individual 
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develops such compensatory mechanisms as a response to higher or lower levels 
of a specific risk factor304 (for example, increased or reduced BMI).   
6.2.2 The Polygenic Risk Score (PRS) 
The use of polygenic risk scores (PRS) is now a widely-used approach to 
aggregate data from GWAS, as a lot of complex traits appear to be polygenic. 
They are used to predict an individual’s genetic predisposition to a particular 
trait, as well as to uncover potential genetic overlap between two traits305. PRS 
analyses can now be performed using either individual-participant data (IPD) or 
summary-level data, due to recent advances in bioinformatics techniques.  
Until recent years, a PRS tended to include only SNPs that had been identified as 
GWAS significant (P<5x10-8) in a large-scale study and would then use their effect 
sizes as external weights when creating a PRS. However, effects have been 
observed between a PRS with an inclusion threshold as high as P<0.5 and thus 
this approach is now also widely used306. In PRS analyses, the aim is to examine 
whether two traits of interest possess underlying shared genetic factors. It differs 
from a genetic correlation (rg) analysis, as this includes all genotyped SNPs on a 
particular genotyping array or all SNPs from GWAS results. A PRS analysis, 
however, aims to investigate whether traits X and Y share underlying common 
genetic variants, using a high-resolution best-fit approach307.  
6.3 AIMS OF THIS CHAPTER 
The aims of the research carried out in this chapter were fourfold: 
 Perform cross-sectional, observational analyses to examine the association 
between BMI and self-reported sleep duration in two UK population 
studies. 
 Perform 2-sample Mendelian randomisation analyses in a large sample of 
UK adults, exploiting both individual participant data (IPD) and 
summary-level data from published GWAS.  
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 Examine potential horizontal pleiotropy between BMI and sleep duration, 
using multiple methods, such as MR-Egger regression and a weighted 
median.  
 If substantial horizontal pleiotropy is detected using the methods 
mentioned in iii) then perform additional analyses to investigate this 
relationship, by means of polygenic risk scoring.  
6.4 METHODS 
For the work carried out in this chapter, I designed the study, performed all of 
the phenotypic data cleaning and all observational and genetic analyses in ELSA 
and UKHLS. However, as the UKB data used were only summary-level data, I was 
not involved in any phenotype or genotype cleaning or any other individual-level 
data handling of this sample.  
6.4.1 Samples  
This study included summary-level data from 127,573 UK Biobank participants, as 
well as IPD from 2 population studies. For observational purposes, data were 
analysed from 5,296 individuals from the English Longitudinal Study of Ageing 
(ELSA) and 6,811 participants from the UK Household Longitudinal Study 
(UKHLS) (see Table 6.1). For genetic analyses, data were used from individuals 
included in the ELSA and UKHLS sleep duration GWAS analyses from Chapter 5, 
which were 6,028 and 8,608, respectively. The reason for this was that for 
observational analyses the sample sizes were slightly reduced, data were required 
from participants who had data on BMI, sleep duration, covariates and genotype 
data (see Table 6.1). These inclusion criteria were so that in ELSA and UKHLS, both 
observational and genetic analyses were performed on the same individuals.  
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Table 6.1 Details of samples included in this study, with respective n for different 
analyses 
Study Type of data GWAS N* Observational analysis 
n** 
ELSA IPD 6,028 5,296 
UKHLS IPD 8,608 6,811 
UKB Summary*** 127,573 N/A 
Note. *Individuals GWAS of sleep duration, due to available genotype, sleep 
duration phenotype and covariate data; **summary statistics from sleep duration 
GWAS by Jones et al78 downloaded from: http://www.t2diabetesgenes.org/data/; 
***individuals included in the observational analysis of BMI and sleep duration, 
due to availability of BMI and sleep duration phenotypic data, as well as genetic 
data.  
6.4.2 Exposure and outcome 
The main exposure was researcher-measured BMI (kg/m2) (in ELSA, UKHLS and 
UKB) and the single outcome was self-reported sleep duration. ELSA respondents 
were asked: ‘How many hours of sleep do you have on an average week night?’. 
UKHLS participants were asked: ‘How many hours of actual sleep did you usually 
get at night during the last month? This may be different than the actual number 
of hours you spent in bed.’ More details on the sleep duration measures are in 
Chapter 2. Briefly, in for the UKB sleep duration (from which GWAS summary 
statistics were used here) was ascertained by asking participants for the average 
number of hours that they slept in a 24-hour period. More details of the 
phenotype derivation for Jones et al.’s sleep duration GWAS are in Chapter 2. 
6.4.3 Genotyping  
Full genotyping details for ELSA and UKHLS are in Chapter 2. Studies were 
genotyped using a genome-wide, Metabochip or Exome array (see Chapter 2). 
6.4.4 Statistical analyses   
Analyses were performed using a combination of R, version 3.3.2, PRSice, version 
1.25307 and PLINK, version 1.9 (www.cog-genomics.org/plink/1.9)308. 
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6.4.4.1 Observational analyses 
Firstly, in studies for which IPD (ELSA and UKHLS) were available, observational 
analyses were performed using linear regressions, with adjustments for age and 
sex. This was because the inclusion of multiple covariates can prove difficult in 
this type of observational analysis, as studies often measure demographic and 
lifestyle factors in different ways, and in an MR study it is more important to 
combine datasets to increase power.  These results were subsequently combined 
in a fixed-effects meta-analysis to obtain an overall observational estimate across 
studies. Heterogeneity between studies was assessed by means of Cochran’s Q 
and I2.  
6.4.4.2 Genetic analyses 
Selection of BMI SNPs and genetic instrument creation: 97 SNPs were selected 
from the published GIANT consortium GWAS (Appendix 8.3) which included up 
to 339,224 participants from 125 independent studies29. Where the target SNP was 
not available in IPD data, proxy SNPs in linkage disequilibrium (LD) with the 
target SNP were analysed, using a threshold of R2>0.8 (Appendix 8.3).    
Proxies were found using two online tools: SNP Annotation and Proxy Search 
(SNAP)309, and Single Nucleotide Polymorphisms Annotator (SNiPA)310. SNPs 
that did not contribute to the genetic instrument are in Table 6.2 below, along 
with the reason why. 
Table 6.2 BMI SNPs not included in MR study 
SNP Reason not included 
rs11057405 No proxy available in UKHLS 
rs10733682 UKHLS does not have this SNP or a proxy for it 
rs11727676 ELSA does not have this SNP or a proxy for it 
rs12016871 UKHLS does not have this SNP or a proxy for it 
rs13107325 ELSA does not have this SNP or a proxy for it 
rs13191362 UKHLS does not have this SNP or a proxy for it 
rs17001654 UK-Biobank does not have this SNP or a proxy for it 
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rs2075650 UK-Biobank does not have this SNP or a proxy for it 
rs2080454 UKHLS does not have this SNP or a proxy for it 
 
6.4.4.2.1 2-Sample MR analyses  
6.4.4.2.1.1 Associations between BMI SNPs and BMI (SNP-exposure 
association)  
Results were extracted for the association between 97 BMI SNPs and BMI (for 
both men and women) from the GIANT GWAS paper29. Linear regressions were 
also performed between each BMI SNP and BMI in the whole sample (n=142,209) 
and subsequently combined in a fixed-effects meta-analysis to obtain one 
estimate, the results of which are in Appendix 8.3. The percentage of variance 
explained in BMI by the BMI genetic instruments was obtained by performing a 
multivariable linear regression between the BMI SNPs and BMI and taking the R2 
value. I2 and a p-value for Cochran’s Q test were obtained to quantify the amount 
of heterogeneity of these associations between the studies (Appendix 8.3).  
6.4.4.2.1.2 Associations between BMI SNPs and sleep duration (SNP – 
outcome association)  
Using an additive model, linear regressions were performed between each 
individual SNP, and sleep duration in ELSA and UKHLS. To examine this 
association in UK Biobank summary statistics were downloaded from the latest 
sleep duration GWAS78 and the results extracted for up to 97 BMI SNPs.  
Subsequently, the results from the 3 studies were combined in a fixed-effects 
meta-analysis to obtain one estimate for each of the SNPs, for which I2 and 
Cochran’s Q were also obtained to quantify heterogeneity between studies 
(Appendix 8.3). In IPD the proportion of variance in sleep duration explained by 
the BMI genetic instruments was obtained by entering all of the SNPs into a 
multivariable linear regression with sleep duration as the outcome and 
multiplying the R2 by 100. 
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6.4.4.2.1.3 Instrumental variable (IV) analyses  
Three types of analysis were implemented to estimate the potential causal 
association of BMI on sleep duration in this study: Inverse-variance weighted 
(IVW) method, MR-Egger method and the weighted median, as detailed below. 
These analyses were performed in STATA version 14 using the mrrobust package 
(https://github.com/remlapmot/mrrobust). The final genetic instrument 
comprised 88 BMI SNPs, thus 9 variants were excluded for various reasons, which 
are detailed in Table 6.2 above. 
I. Inverse-variance weighted (IVW) analysis  
IVW is analogous to 2-stage least squares (2SLS). MR using IPD data, which 
was until recently, the most commonly employed MR. 2SLS estimates the 
causal effect (?̂?𝐺) of the exposure on the outcome with the following 
equation:  
𝑌 = 𝛼 + ?̂?𝐺  ?̂? +  𝜀      
where 𝛼  intercept term and 𝜀 the associated error term from the second 
stage regression. ?̂? represents the predicted value of the exposure (BMI) 
calculated in the first stage, as a result of 𝑋 on a weighted gene score 𝑍311.  
However, the IVW method was used here to calculate a combined estimate 
of the causal relationship between BMI and sleep duration for each variant: 
SNP – sleep duration / SNP – BMI.  IVW performs a weighted linear 
regression of the genetic associations with the outcome (BMI SNPs  sleep 
duration) on the associations between the genetic variants and the exposure 
(BMI SNPs  BMI) [𝜎𝑌𝑗
−2], under a fixed-effects meta-analysis. The intercept 
is constrained to equal zero in this model and it is assumed that all genetic 
variants are valid IVs and that they are not in LD (uncorrelated). Therefore, 
the causal estimate under an IVW model is calculated as:  
?̂?𝐼𝑉𝑊 =  
∑  ?̂?𝑌𝑗  𝑗 ?̂?𝑋𝑗
   2𝜎𝑌𝑗
−2
∑ ?̂?𝑋𝑗
   2
𝑗 𝜎𝑌𝑗
−2
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where ?̂?𝑥𝑗 is the coefficient from the regression of the exposure (BMI) on 
genetic variant j, ?̂?𝑦𝑗 represents the coefficient from the regression of the 
outcome (sleep duration) on genetic variant j312, alongside the respective 
standard error term, 𝜎𝑌𝑗.  
II. MR-Egger analysis  
MR-Egger was performed as a sensitivity analysis to account for potential 
horizontal pleiotropy, as it is still able to provide a valid causal estimate13. As 
per Burgess & Bowden311, the IVW causal estimate described above, can also 
be calculated using an identical weighted linear regression (?̂?𝑌𝑗 on ?̂?𝑋𝑗), but 
without an intercept term and instead uses the 𝜎𝑌𝑗
−2 term as weights. In this 
scenario, in which the intercept is not forced to be zero, an MR-Egger 
regression is performed, in which a causal estimate (?̂?𝐸) is obtained using 
the following equation:  
?̂?𝑌𝑗 =  ?̂?𝐸 + ?̂?𝐸  ?̂?𝑋𝑗    
where, as per the IVW equation described above, ?̂?𝑌𝑗 represents the 
coefficient from the regression of sleep duration on variant j and ?̂?𝑋𝑗 is the 
coefficient from regressing BMI on variant j, with a respective standard error 
term 𝜎𝑌𝑗. However, the new terms introduced in the MR-Egger equation are 
interpreted as: ?̂?𝐸 is the intercept term, which denotes average horizontal 
pleiotropy across all SNPs and its respective P-value indicates whether this 
form of pleiotropy exists in the causal relationship of exposure (BMI) and 
outcome (sleep duration). Under the null hypothesis ?̂?𝐸 = 0, but if this is 
not the case then it means that there is some degree of horizontal 
pleiotropy. If the accompanying P-value for the MR-Egger intercept is small 
(0.05) the implication is that horizontal pleiotropy is present, and that 
caution should be taken when drawing causal conclusions of the association 
under study. MR-Egger also makes an additional assumption, which is that 
associations between SNPs and the exposure (BMI SNPs  BMI), indicative 
of the strength of the instruments (BMI SNPs) are independent of the direct 
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associations between the SNPs and the outcome (BMI SNPs  sleep 
duration). This is referred to as the Instrument Strength Independent of 
Direct Effect (InSIDE) assumption295, under which it is assumed that 
stronger SNPs have more reliable estimates of the causal relationship, 
compared to weaker SNPs. As mentioned above, the average pleiotropic 
effect of SNPs is then accounted for via the Egger intercept term and any 
dose-response relationship in the SNP associations is evidential of a causal 
effect.  
III. Weighted median analysis 
The Weighted median estimator was also implemented in this study. The 
weighted median approach first estimates the causal effect ?̂? of each SNP j via 
the ratio method (?̂?𝑗 = ?̂?𝑌𝑗 ?̂?𝑋𝑗⁄ ). Weights are obtained by using the inverse 
variance of these ratio estimates, ?́?𝑗 = ?̂?𝑋𝑗𝜎𝑌𝑗
−2, where then 𝑠𝑗 =  ∑ 𝑤𝑘
𝑗
𝑘−1  
represents the sum 𝑠𝑗 (= 1) of the standardised weights 𝑤𝑗 up to and 
including the weight of the 𝑗th ordered ratio estimate. If 𝑘 represents the 
largest integer, whereby 𝑠𝑗 up to and including the 𝑘th ( 𝑠𝑘 =  ∑ 𝑤𝑗𝑗≤𝑘  ) 
estimate is <0.5, a causal effect  ?̂?𝑊𝑀 of the association between BMI and 
sleep duration will be interpolated between the 𝑘th and (𝑘 + 1 ) ratio 
estimates, as per the following equation: 
?̂?𝑊𝑀 =  ?̂?𝑘 + (?̂?𝑘+1 − ?̂?𝑘) ×  
0.5 − 𝑠𝑘
𝑠𝑘+1 −  𝑠𝑘
       
The main strength of the Weighted median is the ability to provide a valid 
causal estimate when up to 50% of the SNP weights under analysis are 
invalid295 and it is more robust than MR-Egger295. This is because MR-Egger 
has been shown to produce considerably less precise estimates (with very 
large standard errors) and has substantially reduced power to detect a 
causal effect295.  
Importantly, the mrrobust package also outputs pleiotropy statistics for 
each method (IVW, MR-Egger and Weighted median), which are 
interpreted alongside the main results from each approach. These statistics 
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include an I2 and a Cochran’s Q test p-value for heterogeneity. The higher 
the I2, the greater the degree of heterogeneity, whilst the Cochran’s Q test p-
value should be not significant (>0.05) if there is no heterogeneity.   
6.4.4.2.2 Further follow-up genetic analyses: polygenic risk scoring and 
genetic correlation 
Genetic correlation (rg) of BMI and sleep duration 
To estimate the rg between BMI and sleep duration  LD Score regression28 was 
used, implemented in LD Hub20, using summary statistics from GWA analyses of 
sleep duration in ELSA, UKHLS and UKB, to examine the underlying genetic 
correlation (rg) of BMI with sleep duration in the whole sample. A genetic 
correlation (rg) is the extent to which SNPs that contribute to variation in one 
trait (in this case, BMI) also contribute to variation in a second trait (here, self-
reported sleep duration). An rg is interpreted similarly to a Pearson’s correlation, 
as it ranges from 1 to -1, with values that are closer to 1 indicating that there is 
potentially a high proportion of overlap between two traits, whilst values closer 
to zero mean that the traits are unlikely to have a large amount of shared genetic 
aetiology. 
Briefly, LDSC regression involves regressing summary statistics from GWAS 
(from millions of SNPs) and measures to what extent each SNP is able to tag 
other variants locally (or, its ‘LD score’). The slope of the LDSC regression model 
can then be rescaled to provide a heritability estimate of a trait, accounted for by 
all SNPs used in the estimation of the LD scores28. LD Hub20 is a web tool where 
researchers can upload their GWAS summary statistics and obtain LDSC 
heritability estimates, as well  genetic correlations between their trait and dozens 
of other traits of interest.  
Polygenic risk scores (PRSs) of BMI and associations with sleep duration 
A PRS can be used to infer whether two traits possess shared underlying genetic 
factors and therefore, in the present study, whether the same genetic variants 
might influence BMI and self-reported sleep duration. To ensure that the most 
high-resolution PRS is produced, it is important to use a range of different p-
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value cut-offs, rather than merely GWAS significance (p<5x10-8). The aim of these 
PRS analyses was to find the best-fit model, or the highest possible proportion of 
variance in sleep duration, explained by BMI SNPs. This was achieved by not only 
selecting SNPs at the very stringent GWAS significance (p<5x10-8), but by using a 
range of p-value thresholds (Table 6.4).  
Sleep duration GWA analyses in ELSA and UKHLS were adjusted for the first 10 
principal components to account for population stratification, as well as age and 
sex (Chapter 5). The UKB sleep duration GWAS was adjusted for age, sex and 
study centre and these authors used linear mixed modelling in BOLT-LMM21, 
which is able to take into account potential relatedness between individuals, as 
part of the analysis. Then summary statistics were downloaded from the most 
recent large-scale consortium meta-GWAS of BMI15 from up to 339,224 
individuals and the  coefficients were used as external weights in the PRSs.  
PRSice307 software is implemented in R and also exploits specific PLINK (version 
1.9) functions, as well as the summary-statistic function from the Genetics 
ToolboX313 (gtx) R package. A total of 9 PRSs were created at p-value thresholds 
of 1.0, 0.5, 0.4, 0.3, 0.2, 0.1, 0.05, 0.01 and 0.001 (Table 6.2). At each threshold SNPs 
were clumped by LD using a cut-off of r2=0.1 and a window of 250kb, to ensure 
that only independent SNPs were included, as recommended by the creators of 
PRSice307.   
6.4.4.3 Power calculation 
Using the online MR power calculation tool: 
http://cnsgenomics.com/shiny/mRnd/314 power to detect causal estimates was 
calculated, given a sample size of 142,209, the proportion of variance in the 
exposure (BMI) explained by the genetic instruments (R2), βyx for the true 
underlying causal association (unstandardised coefficient (B) =0.84, taken from 
Jones et al.’s78 IVW causal estimate of BMI on sleep duration and multiplied by 
60 to convert it to minutes), BOLS for the observational association of BMI and 
sleep duration, variance of the exposure (BMI SD2 = 25.81) and variance of the 
outcome (sleep duration SD2= 1.64). The estimates for the observational 
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relationship, as well as SDs to calculate variance of the exposure and outcome, 
were taken from pooled ELSA and UKHLS results (Table 6.1). The power 
calculation indicated that with a sample size of 142,209 yielded 100% power to 
detect a potential causal association of β=0.8478, between BMI and sleep duration, 
assuming a type-1 error rate of 0.05.  
6.5 RESULTS 
6.5.1 Sample characteristics   
Table 6.3 shows sample characteristics for individuals from ELSA and UKHLS 
included in the observational analyses. Mean sleep duration and BMI was similar 
across both studies, with the highest mean BMI observed in ELSA. 
Table 6.3 Participant characteristics for IPD studies (N=12,107)  
Study Mean sleep duration* (SD) Mean BMI** (SD) Mean age (SD) 
ELSA 6.86 (1.27) 28.14 (5.11) 66.7 (9.16) 
UKHLS  6.63 (1.29) 28.01 (5.05) 52.76 (15.98) 
Both studies 6.74 (1.28) 28.07 (5.08) 59.73 (12.57) 
Note. *Hours, **kg/m2 
6.5.2 Cross-sectional, observational results    
The observational estimates presented in Figure 6.3 are adjusted for age and sex 
and depict a negative, cross-sectional association between BMI and self-reported 
sleep duration, such that for every SD increase in BMI (kg/m2) there is a mean 
sleep duration difference of 5 and 6 minutes in ELSA and UKHLS, respectively. 
The overall estimate showed that for every SD increase in BMI (5.08 kg/m2) there 
was a mean difference in sleep duration of 5.86 minutes. Cochran’s Q and 
I2 revealed that there were no issues with heterogeneity between the 2 studies 
(Cochrans’s Q p-value=0.70, I2=0). At first glance the ELSA cross-sectional 
finding appears to be completely inconsistent with the cross-sectional BMI-sleep 
duration result found in Chapter 3. However, the observational cross-sectional 
model tested here (Chapter 6) differed from that of the minimally-adjusted 
model in Chapter 3 and importantly, although the sample sizes were similar, this 
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was not a 100% overlapping sample. In a sensitivity analysis, an identical 
regression model to the present one (with standardised BMI as the exposure and 
sleep duration as the outcome and adjusted for age and sex only) was performed 
in the ELSA sample from Chapter 3 (n=5,015). The results of this model were β= -
3.72 minutes, 95%CI= -0.10; 0.03, p=0.001, an inconsistency (of approximately 1 
minute difference in effect sizes) which seemed plausible, given that the samples 
did not consist of exactly the same individuals.  
Figure 6.3 Observational association between (standardised) BMI and sleep 
duration in IPD studies (N=12,107) 
 
 
6.5.3 Genetic results  
6.5.3.1 Results of 2-sample MR 
The percentage of variance in BMI explained by the BMI SNPs was 1.15% (93 SNPs 
out of 97) in ELSA and 1.8% (86 SNPs out of 97) in UKHLS. Figure 6.4 presents 
the causal association between BMI (kg/m2) and sleep duration (minutes), as a 
result of IVW, MR-Egger and weighted median analyses.  
6.5.3.1.1 MR assumptions 
Assumption I – BMI SNPs should be robustly associated with BMI 
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It was ensured that this assumption was met by using summary statistics from 
the latest GIANT BMI GWAS to extract associations between the genome-wide 
BMI SNPs and BMI. This approach was taken because a 2-sample MR was 
implemented in this study.  
 
Assumption II – BMI SNPs should not be associated with common confounders of 
the BMI  sleep duration relationship  
As mentioned earlier in this chapter, it was not possible to test this assumption 
here, as this was a 2-sample summary-level MR study. This was because the 
majority of the data were contributed by summary statistics from the latest UKB 
sleep duration GWAS.  
 
Assumption III – BMI SNPs should not be directly associated with sleep duration, 
but should only be associated with sleep duration via BMI 
This assumption was tested by implementing three MR methods in total, namely 
IVW, MR-Egger and a weighted median. The IVW is the most ‘conventional MR’ 
approach, whilst MR-Egger and the weighted median are commonly-used 
sensitivity analyses that are able to (in different ways) correct for horizontal 
pleiotropy. This is described in more detail below.  
6.5.3.1.2 Main MR results  
Inverse-variance weighted (IVW) approach 
The IVW yielded a result that was consistent with a causal effect of BMI on sleep 
duration, such that for every additional kg/m2 sleep duration decreased by 3.23 
minutes (Figure 6.4). However, the I2 heterogeneity statistic for the IVW = 100% 
and the Cochran’s Q test p-value was <0.001, which indicated the presence of 
substantial balanced pleiotropy.   
 
Weighted median approach  
The weighted median estimate was smaller (by approximately 1 minute) than the 
IVW, at a decrease in sleep duration of 2.03 minutes per additional kg/m2 of BMI 
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and was also consistent with a significant causal effect of BMI on sleep duration 
(Figure 6.4).  
MR-Egger approach 
MR-Egger suggested there was substantial directional pleiotropy (I2>70% and 
Cochran’s Q test p-values <0.001), thus violating one of the core underlying 
instrumental variable assumptions. The MR-Egger intercept p-value also 
confirmed this (p=0.06, which is close to the threshold of 0.05) and the causal 
estimate yielded by MR-Egger was positive, whereas the weighted median and 
IVW estimates were negative, which is consistent with the observational results 
(Figure 6.4).  
Figure 6.4 Causal association between BMI and sleep duration using IVW, MR-
Egger and Weighted median analyses in IPD + summary-level data 
 
Note. Datasets include ELSA (n=6,028), UKHLS (n=8,608) (IPD) and UKB 
(summary-level data) (127,573).  
Additional graphical sensitivity checks 
To further examine the results of the three MR approaches, the plots below were 
created. Figure 6.4 presents a scatter plot of the BMI instruments – exposure 
(BMI) association and the BMI instruments – outcome (sleep duration) 
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association. As such, the MR-Egger, IVW and weighted median slopes are 
interpreted as the unit change in the outcome (hours of sleep duration) for every 
unit increase in the exposure (BMI) due to the BMI genetic variants. In this plot 
each BMI genetic variant is a data point and it shows that multiple variants 
violate MR assumption III and are therefore, subject to horizontal pleiotropy, 
which is also confirmed because the MR-Egger (solid line) intercept only just 
passes through zero. Also, in line with the description of results earlier, the MR-
Egger slope is positive, whilst the IVW and weighted median slopes are negative.  
Figure 6.5 Associations between BMI SNPs and BMI (X) and sleep duration (Y) 
 
Note. The main line represents the MR-Egger result and the other lines are the 
IVW (long dash) and the weighted median (short dash).  
Figure 6.5 presents a funnel plot of the IVW and MR-Egger causal estimates and 
similarly to the scatter plot above, each data point is a BMI genetic variant. The 
x-axis represents the estimate of the gene-outcome association divided by the 
estimate of the gene-exposure association (Wald ratio). The funnel plot is 
asymmetric, which is confirmatory of the fact that multiple BMI genetic variants 
have remarkably strong effects on sleep duration given that their precision is low. 
Also, as per the results description and the scatter plot above, the MR-Egger and 
IVW estimates are on opposing sides of zero and are thus, inconsistent with one 
another.  
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Figure 6.6 Funnel plot of MR-Egger and IVW causal estimates against the precision 
of each of these estimates 
 
 
Note. Line with longer dashes = MR-Egger, line with shorter dashes = IVW.  
6.5.3.2 Results of polygenic risk score (PRS) and genetic correlation (rG) 
analyses    
6.5.3.2.1 Genetic correlation (rG) of BMI and sleep duration 
To estimate the rG between BMI and sleep duration LDSC17 was used, 
implemented in LD Hub22, by using summary statistics from GWA analyses of 
sleep duration in ELSA, UKHLS and UKB. The rG between BMI and sleep 
duration was was -0.067, p=0.09.  
6.5.3.2.2 Polygenic risk scores (PRSs) of BMI and associations with sleep 
duration 
Of the 9 PRSs, a PRS of BMI at a p-value inclusion threshold of 0.01 explained the 
highest proportion of the variance in sleep duration (0.02%). This PRS was 
negatively associated with sleep duration (β=-1.75, p= 6.13x10-7) (Table 6.4). 
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Table 6.4 PRS analyses of BMI & sleep duration in 142,209 individuals after 
clumping SNPs by LD* 
P-val. threshold No. SNPs in model Coeff. 
(SE) 
P-val. (Pseudo) R2 N 
1.0 54,505  -0.62 
(0.18) 
0.0003 6.06x10-5 142,209 
0.5 36,688 -0.64  
(0.18) 
0.0003 6.94x10-5 142,209 
0.4 31,254 -0.59 
(0.19) 
0.0008 7.49x10-5 142,209 
0.3 25,196 -0.67 
(0.20) 
0.0003 8.16x10-5 142,209 
0.2 18,195 -0.62 
(0.21) 
0.002 8.22x10-5 142,209 
0.1 10,477 -0.80 
(0.24) 
0.0005 8.44x10-5 142,209 
0.05 6,006 -1.33 
(0.29) 
2.36x10-6 0.0001 142,209 
0.01** 2,024 -1.75 
(0.67) 
6.13x10-7 0.0002 142,209 
0.001 536 -2.07 
(0.43) 
0.004 4.83x10-5 142,209 
Note. *Clumping parameters are r2=0.1 and 250kb, Coeff. = unstandardized 
coefficient in minutes of sleep duration; **best threshold with 0.02% of the 
variance in sleep duration explained by this PRS. 
6.6 DISCUSSION 
6.6.1 Summary of findings 
A large-scale two-sample MR study was conducted to examine the potential 
causal relationship between general adiposity (BMI) and self-reported sleep 
duration. In doing so, three distinct MR methods were applied to obtain a 
complete picture of this complex, potentially causal association. Observationally, 
the cross-sectional pooled estimate of ELSA and UKHLS showed a mean 
difference in sleep duration of 6 minutes for every standard deviation increase in 
BMI (5.08 kg/m2).  
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However, the MR findings suggest that there is still a degree of uncertainty 
regarding the causal association between BMI and sleep duration and that future 
research should perform even more in-depth analyses. The IVW approach 
indicated that there was a large amount of heterogeneity. MR-Egger results 
suggested no causal association between BMI and sleep duration and indicated 
that there was likely to be a substantial proportion of directional pleiotropy. The 
Weighted median results were consistent with a causal effect of BMI on sleep 
duration and thus supported the IVW result. Importantly, the sensitivity analyses 
performed in the present study were able to test and correct for horizontal, but 
not vertical pleiotropy. Unmeasured horizontal pleiotropy violates a core MR 
assumption, in that the genetic variant(s) are associated with the outcome 
through more than one independent causal pathway (in the present case, via a 
pathway other than BMI). However, vertical pleiotropy would not confer a 
violation of MR assumptions and is present when the genetic variant(s) affect the 
outcome via a mediator (i.e. a factor that lies on the causal pathway).  
Subsequently, follow-up genetic analyses were performed to investigate whether 
BMI and sleep duration might have shared underlying genetic factors. The PRS 
that fitted the data best was at a p-value threshold of 0.01, which was negatively 
associated with sleep duration and explained only 0.02% of its variance. The 
genetic correlation between BMI and sleep duration was -0.067 and not 
significant (p=0.09), a result, which is in line with the small variance explained 
(0.02%) in the PRS analyses.  
6.6.2 Observational findings 
Only the two studies which had IPD available were included in the observational 
analysis. Cross-sectional analyses in ELSA and UKHLS showed that there was a 
negative relationship between BMI and sleep duration, after adjusting for age and 
sex. A subsequent fixed-effects pooled analysis yielded an overall negative cross-
sectional effect of BMI on sleep duration with a total sample size of 12,107 
individuals. This finding is also consistent with large epidemiological meta-
analyses106,107 of BMI and sleep duration.  
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6.6.3 MR findings 
Although there appeared to be a causal association, as suggested by the IVW and 
MR-Egger results there was a large proportion of horizontal pleiotropy. This was 
apparent from the heterogeneity statistics (I2 and Cochran’s Q test p-value) 
outputted by the IVW and MR-Egger methods. This metric was adapted from the 
meta-analysis literature315 to assess pleiotropy in the context of MR. MR-Egger 
requires that the effects of each instrument (SNP) on the exposure are 
independent of supposed pleiotropic effects on the outcome, which is known as 
the ‘InSIDE assumption’295, as mentioned earlier. Although this assumption may 
seem somewhat unintuitive, its plausibility has been supported by evidence from 
a study in which associations of SNPs with different phenotypes were largely 
uncorrelated316.  
Results from the IVW analysis showed that there was a significant negative causal 
effect of BMI on sleep duration in this sample of 142,209 individuals. However, 
the I2 produced alongside this result indicated that there was a high proportion of 
pleiotropy. Fundamentally, the IVW approach assumes that each SNP is a valid 
IV. Thus, if the three main assumptions hold (mentioned earlier) then the IVW 
can estimate the true causal effect of the exposure on the outcome. However, in 
this study it was not possible to test whether the BMI SNPs were associated with 
confounders, as these data were not available for the UKB study because 
summary data were used to maximise statistical power. A related and important 
point here is a potential violation of the InSIDE assumption (not possible to test 
in a 2-sample MR), whereby the pleiotropic effects of the SNPs on the outcome 
act via one particular confounder317 (for example, physical activity, in the case of 
BMI and sleep duration). Therefore, if this was tested in future and the BMI SNPs 
were associated with sleep duration, via physical activity this would mean that 
the InSIDE assumption is violated.  
To overcome some of the issues with IVW, both MR-Egger294 and the Weighted 
median295 were implemented as sensitivity analyses. If the IVW causal estimate of 
BMI on sleep duration is in fact true, results from the MR-Egger and Weighted 
median approaches should be almost indistinguishable from it. MR-Egger 
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calculates the average pleiotropic effect across SNPs; a small p-value (near or 
≤0.05) as well as an intercept that is different from zero indicate the presence of 
directional pleiotropy294. Results from MR-Egger analyses suggested no causal 
association between BMI and sleep duration (p=0.481) and the coefficient was 
positive, as opposed to the IVW and weighted median estimates, which were 
negative. The MR-Egger also revealed that there was likely to be directional 
pleiotropy underlying this relationship, as the intercept’s p-value was 0.06. It is 
important to note, though, that the 95% CI around the Egger estimate was 
particularly wide (-4.06; 8.60). This was not unexpected, as it is reliant on genetic 
variants having different effect strengths on the exposure317. Also, the MR-Egger 
has reduced power, compared to the other approaches, is more susceptible to a 
violation of assumption II (BMI SNPs should not be associated with common 
confounders of the BMI  sleep duration relationship) and may be more of a 
problem for weaker instrumental variables317. Therefore, it seems plausible that 
the Egger estimate in the present study may be biased, as it is inconsistent with 
the observational result, as well as the IVW and weighted median MR results.  
A Weighted median estimator295 was also used to ensure that the conclusions 
drawn from the results were robust and to assess the presence of potential 
balanced pleiotropy. The Weighted median is distinct from MR-Egger, as it is 
able to provide reliable causal estimates when up to fifty per cent of the IV 
weights are invalid. The Weighted median yielded a significant, negative causal 
estimate of the relationship between BMI and sleep duration. However, taken 
together, the three approaches showed that there is still uncertainty surrounding 
the causal relationship between BMI and self-reported sleep duration. Therefore, 
it may be unlikely that the BMI genetic variants exert their influence on self-
reported sleep duration via BMI. This was partially supported by an additional 
analysis in which associations between the BMI SNPs and sleep duration were 
tested in the IPD studies (ELSA and UKHLS, n=12,107), whilst adjusting for BMI 
and then IVW, MR-Egger and Weighted median MR analyses were performed. 
Results showed that none of the MR estimates were significant, which was not 
surprising, as this analysis was likely to be underpowered with such a small 
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sample size. Out of the 88 BMI SNPs, four were significantly associated with 
sleep duration in a model adjusted for measured BMI (Appendix 8.3). It is also 
important to note that findings from the only previous MR of BMI and self-
reported sleep duration differed from those of the present study. Specifically, the 
earlier study found, using IVW that there was no causal relationship between 
BMI and sleep duration, whereas the present study found the opposite. However, 
the MR-Egger analyses from both studies yielded an inverted effect in 
comparison to the IVW estimate.  
PRS and rG analyses were also performed to examine whether BMI and sleep 
duration were likely to have a shared common genetic aetiology.  After 
considering a few of the most well characterised BMI genes, it appeared that 
shared biological pathways could be a likely explanation for this relationship. For 
example, the fat-mass and obesity associated (FTO) gene is of interest here, as it 
is expressed in the hypothalamus29 and neurons in the ventrolateral preoptic 
nucleus (VLPO) are instrumental in promoting sleep, by shutting off other 
arousal centres in the brain318. Specifically, rs1558902, an intron in the FTO gene 
was included in our best-fit PRS and its association with sleep duration in the 
meta-GWAS of all three studies was -0.68 minutes. Thus, although this effect was 
not genome-wide significant it is consistent with the expected direction of effect, 
such that higher genetic risk of obesity is associated with less sleep.  
Results from PRS analyses showed that there was a negative association between 
a BMI PRS comprised of ~2,000 SNPs, and sleep duration, but it accounted for 
only 0.02% of its variance. LDSC findings were consistent with this, such that the 
non-significant rG of BMI and sleep duration was -0.067, a result which was very 
similar to the rG (-0.05) reported by Jones and colleagues78. These findings 
suggest that BMI and self-reported sleep duration might not possess shared 
genetic aetiology, but perhaps these results should be interpreted with some 
degree of caution. For example, although all three samples included in this study 
asked participants a very similar question on sleep duration, the UKB phenotype 
was derived distinctly from that of ELSA and UKHLS.  
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As summary statistics were included from the UKB sleep duration GWAS it was 
not possible to modify the phenotype for inclusion in the analyses. Briefly, Jones 
and colleagues78 excluded individuals who reported sleep durations greater than 
18 hours; they then adjusted for age, sex and study centre, obtained the model 
residuals and subsequently applied inverse-normalisation to ensure a normal 
distribution. Although it could be argued that the 2 to 12-hour range allowed for 
in ELSA and UKHLS is somewhat liberal, this was the result of restricting the 
original sleep duration phenotype to +/- 4 SDs. Thus, one possible explanation 
for the very small amount of variance explained in sleep duration could be that it 
is indicative of large variation in this phenotype, between the IPD samples (ELSA 
and UKHLS) and UK Biobank.  
6.6.4 Study strengths 
This study possesses important strengths. This was the largest Mendelian 
randomisation study of BMI and sleep duration in adults, to date. A 2-sample 
approach was employed, which decreases the chance of obtaining biased results. 
This is because in a 2-sample MR setting, no data from individuals who 
contributed to the latest BMI GWAS86  were analysed, none of these studies 
(ELSA, UKB and UKHLS) were part of this meta-GWAS.  
6.6.5 Study limitations 
One of the limitations of this study was the considerable overlap between the 
sample analysed and that of Jones and colleagues78. However, the present study 
also included data from two other general population samples and also 
performed comprehensive PRS analyses to assess shared genetic aetiology 
underlying BMI and sleep duration. Sleep duration was self-reported, which 
might suffer from measurement error and bias and has been shown to correlate 
only modestly with actigraphic sleep duration97. These analyses were conducted 
with data from White/European individuals and may therefore not be applicable 
to other ethnic groups. Also, as it was not possible to access to the UKB IPD 
observational analyses were not performed in this study. Jones et al did not 
report findings from observational analyses of BMI and sleep duration, which 
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meant it was not possible to make comparisons with the ELSA and UKHLS 
results.  
6.6.6 Future directions 
In future, it would be important to perform similar analyses in children and 
adolescents, as genetic effects can differ over the life course. Research suggests 
that some complex traits – including BMI – may be more heritable in younger 
people. For example, Evans and colleagues319 found that SNP heritability of BMI 
was higher in ALSPAC children, compared to an adult sample. Although an 
individual’s DNA remains unaltered throughout their life, differential levels of 
gene expression are linked to several disease states and cellular responses320 and 
it would be of interest to investigate this more in future.   
It is also important to investigate potential shared genetic aetiology between BMI 
and objectively measured sleep duration, as evidence suggests that there is at 
best, moderate agreement between subjective and objective measures98,130. 
Objectively measuring sleep duration in large samples is now possible, unlike a 
few years ago. For example, the UKB have recently released data on actigraphic 
sleep duration collected in 100,000 individuals.  
Shared genetic aetiology between BMI and other sleep phenotypes, such as 
pattern, bedtime, timing, quality and disturbance should also be investigated. 
Although it is likely that an individual’s sleep duration correlates with some, if 
not all other sleep measures, research suggests that each of these phenotypes 
should be treated independently56. There are some challenges to be considered 
when measuring sleep dimensions other than duration, particularly when 
combining multiple studies to increase statistical power. Studies are less likely to 
have administered the same measure of sleep quality, for example, compared to 
duration.  
Future research may also benefit from the inclusion of samples which have 
derived their sleep duration phenotype more similarly. As mentioned earlier, the 
present study used data from three samples, one of which used particularly 
  202 
unconventional exclusion criteria for hours of sleep (>18 hours)78, even though 
they subsequently applied inverse-normalisation to assure a normally distributed 
measure.   
Further MR studies that investigate the causal association between BMI and self-
reported sleep duration could also consider performing further sensitivity 
analyses. For example, if substantial heterogeneity is identified amongst BMI 
SNPs then it would be plausible to remove some of the more heterogeneous SNPs 
(i.e. have an I2 value of >75%).  
Finally, the UKB have recently released genetic data from 500,000 (the previous 
release was n=150,000) individuals and thus, these analyses could be repeated in 
this much larger sample in future.  
6.7 CHAPTER SUMMARY  
 Observational data in IPD revealed a negative relationship between BMI 
and sleep duration in 12,107 individuals.  
 A comprehensive set of 2-sample MR analyses in 142,209 individuals 
suggests that there is still a degree of uncertainty in terms of the causal 
association between BMI and self-reported sleep duration.   
 MR findings showed substantial pleiotropy between BMI and sleep 
duration. 
 A polygenic risk score of BMI was significantly related to sleep duration, 
but only explained a small proportion of its variance.  
 Future research should investigate shared genetic aetiology between BMI 
and other sleep phenotypes, use objective sleep duration and employ 
samples in which sleep duration is derived uniformly.
7 GENERAL DISCUSSION 
7.1 SYNTHESIS OF EVIDENCE GENERATED  
The obesity epidemic has coincided with a chronic reduction in sleep duration, 
largely, but not exclusively, in Western societies59. The work undertaken in this 
thesis used a combination of observational and genetic epidemiological methods, 
in an attempt to better understand the complex relationship between BMI and 
sleep duration. The majority of this work focused on adults, with one study that 
analysed data from a paediatric sample. Below are the specific objectives that 
were outlined in Chapter 1, followed by the key findings that addressed them:  
I. Establish the direction of effect between BMI/WC and self-reported 
sleep duration in older adults, by performing bidirectional, 
epidemiological analyses, with adjustment for a wide range of 
important covariates (Chapter 3). This research showed that in older 
adults, higher BMI leads to small decreases (<0.5 minutes) in self-
reported sleep duration over time but sleep duration was not associated 
with prospective changes in BMI. 
II. Ascertain the direction of effect between BMI and objectively-
measured sleep duration in childhood, by analysing data from a 
paediatric sample and using bidirectional modelling, with adjustment 
for important covariates (Chapter 4). This work was the first to examine 
the bidirectional association between BMI and objectively measured 
sleep duration in childhood and found no effect in either direction, from 
ages six to eight and eight to ten years. 
III. Perform genome-wide analyses to find novel, as well as replicate 
previous, common genetic variants associated with self-reported sleep 
duration, with the aim of using them in bidirectional MR analyses 
(Chapter 5). No novel genetic variants were identified in this meta-
GWAS, nor were previous sleep duration variants replicated. This was 
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likely due to limited statistical power, as the sample size was very 
modest compared to other meta-GWAS of self-reported sleep duration. 
IV. Use Mendelian randomisation to investigate whether there is a causal 
relationship between BMI and self-reported sleep duration in a large 
sample of adults (Chapter 6). MR analyses suggested that the 
association between BMI remains uncertain with respect to whether it is 
causal or not. Also, these phenotypes likely possess only a small amount 
of genetic overlap (genetic correlation was -0.067 and not significant and 
the variance in sleep duration explained by BMI SNPs was 0.02%). 
7.2 JUDGING THE EVIDENCE  
To draw definitive conclusions about the work that was carried out in this thesis, 
it is necessary to judge the findings in relation to the following limitations 
pertaining to measurement, design and generalisability: measurement of sleep 
duration; methods for assessing causality; confounding; and generalisability of 
the findings. General limitations that arose around these themes will be 
discussed; specific limitations pertaining to each study have been discussed in 
each chapter.   
7.2.1 Measurement of sleep duration 
In Chapters 3, 5 and 6 sleep duration was measured using self-report. Taken 
together, the analyses in this thesis that investigated the association between 
BMI and self-reported sleep duration (or self-reported sleep duration and BMI), 
whether observational or genetic, seemed to suggest that this association is likely 
to be very small, or absent.  
Importantly, in Chapters 3 and 6, observational cross-sectional models of BMI 
and sleep duration that were adjusted only for age and sex showed revealed a 
much larger effect size, as compared to models adjusted for other demographics, 
as well as health behaviours and health problems. This finding confirmed that 
the cross-sectional relationship between BMI and sleep duration became 
attenuated following the inclusion of these important covariates in the model.  
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The null (multiply-adjusted) cross-sectional findings are in support of at least 
three epidemiological studies of BMI and self-reported sleep duration in adults, 
which found no association between the two116–118. However, several studies in 
adults reveal a cross-sectional association between BMI and self-reported sleep 
duration71,106,107,110,113–115,235. One reason for this discrepancy in results across cross-
sectional studies in adults could be the age of participants. For example, in the 
early meta-analysis of adults by Cappuccio and colleagues107 the majority of the 
studies included were conducted in younger or middle-aged adults. Later studies 
were also largely carried out in younger adults, with mean ages of 37y71, 54y110, 
43y114,115 and 55y235, whereas the mean age of the ELSA participants used in this 
work was 65y. Prospectively, there have been no previous bidirectional studies of 
BMI and self-reported sleep duration in adults and earlier research largely 
focused on the prospective association between sleep duration and changes in 
BMI. However, a systematic review106, a Canadian population-based study109 and 
the most recent large-scale meta-analysis123 showed an association between short 
sleep and greater BMI/increased risk of obesity. Importantly, in the Canadian 
study participants were on average 41y of age, in the meta-analysis most studies 
were in younger or middle-aged adults and the studies in the review had samples 
with mean ages of ~40y. However, at least two previous longitudinal studies in 
adults found no relationship between sleep duration and BMI235,321, in line with 
evidence from this thesis. One of these studies321 used a fixed effects model to 
account for unobserved time-invariant covariates (for example, genetics) and it 
was the results of this analysis that, contrary to their generalised estimating 
equation analysis, completely attenuated the prospective association between 
sleep duration and BMI, even though the respondents were aged between 19y and 
39y. The other study found that sleep duration did not predict changes in BMI, 
which is important because at follow-up participants’s mean age was 56y at 
baseline, whilst at follow-up they were in their early to mid-sixties.  
The majority of paediatric cross-sectional studies also suggest an association 
between BMI and self-reported sleep duration106,107,135,140,141,143,144,146,147. 
Nevertheless, three cross-sectional studies in children produced null findings148–
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150, which are in agreement with the results in TESS. Three systematic reviews and 
four meta-analyses in children suggest that subjective (usually parented-
reported) sleep duration does predict changes in BMI and an increased risk of 
obesity106,135,151–153,157, but the paediatric work in this thesis used objectively-
measured sleep duration and thus, there is more detailed discussion below about 
the bidirectional findings in TESS and comparison to previous similar studies.  
Another important reason for discrepancies in findings could be the differences 
in adjustments for confounders across studies, which is discussed in more detail 
below (section 7.2.3).  
As mentioned earlier in this thesis, evidence suggests only modest agreement 
between subjective and objective sleep duration, when assessed in the same 
individuals96–98. Specifically, when asked, people are likely to overestimate their 
hours of sleep per night, as compared to actigraphy96–98.  Despite these issues, as 
mentioned in Chapter 1 of this thesis, there are several advantages of using self-
reported sleep measures. The main advantages of self-report sleep duration 
measures are: they are inexpensive and easy to administer, particularly in large 
studies, as one or two questions can usually be asked as part of a larger 
questionnaire; they are simple to code and to analyse, as a typical question asks 
about the number of hours an individual sleeps for, thus researchers can choose 
to use this or convert to minutes if they prefer. There have also not been any 
GWAS to date that have used large samples to find common genetic variants 
associated with objective sleep duration, but it is likely that these will become 
available in the near future (this is discussed in more detail in the section on 
Future directions below). It is also important to note, however, that when 
analysing within-person observational data, the poor agreement between 
subjective and objective sleep measures are likely to be less of a problem. This is 
because the error terms associated with the measurement remain consistent and 
thus, do not invalidate the findings.  
In Chapter 4, objective sleep duration was used to investigate the bidirectional 
association with BMI in children. The current findings are in agreement with the 
only two prior studies that examined the bidirectional relationship of BMI with 
  207 
(subjective) sleep duration and it therefore, appears that the association between 
BMI and sleep duration, and vice versa, may have previously been overestimated. 
The first of these by Hiscock and colleagues137 found no relationship in either 
direction between BMI and sleep duration, in an Australian sample of 
approximately 3,800 children. The second study showed no association in either 
direction between BMI and sleep duration in 526 children from the ethnically 
White component of the BiB study138.  
It was also not possible to check the correlation between parent-reported sleep 
duration and actigraphic sleep duration, as the former was not collected; nor 
were parents asked to log the children’s bedtimes and wake times, which may 
have improved and aided the estimation of sleep duration. More generally, 
actigraphy also has its own limitations when measuring sleep duration. For 
example, Spruyt and colleagues322 examined the concordance between wrist 
actigraphy and polysomnography (PSG) in a sample of 149 healthy children, aged 
between four years and nine years of age. Their findings suggested that the 
actigraph significantly underestimated sleep duration by approximately 30 
minutes, in comparison to PSG, further supported by only a modest correlation 
of 0.47 between these two measures.   
7.2.2 Approach taken to assess causality  
The RCT is widely accepted as the gold standard for causality, whereby 
participants in the treatment and control arms of the trial are not to differ on any 
parameter, other than the fact that they have been randomly assigned to either 
group. As detailed in the introduction in Chapter 6, MR can be thought of as 
‘Nature’s randomised trial’287, as alleles are randomly allocated at conception. 
Thus, this provides support for the application of MR in its ability to assess 
causality. 
The ELSA bidirectional study (Chapter 3), which found that BMI led to small 
changes in self-reported sleep duration in older adults over four-year follow-up 
formed the basis of the rationale for the MR study in Chapter 6. Findings from all 
of the three MR approaches performed in 142,209 adults suggested that we are 
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still uncertain about whether the relationship between BMI and self-reported 
sleep duration is causal. This was judged to be the case, after taking into account 
the whole picture from all of the MR methods (inverse-variance weighted, MR-
Egger and weighted median) that were implemented. MR results showed that 
there was a high proportion of horizontal pleiotropy. Then, follow-up analyses 
using genetic correlation and comprehensive polygenic risk scoring analyses 
revealed that the BMI SNPs (with inclusion of only independent SNPs) explained 
a very small amount of the variance in sleep duration.  
Also, it must be noted that, as mentioned earlier (Chapter 6), a core assumption 
of MR is that the genetic variants for the exposure (in this case, BMI) should not 
be associated with confounders of the relationship under study. It was not 
possible to test this in the MR analyses used in this thesis because a two-sample 
MR design was implemented and the majority of the data came from summary 
statistics from the UK Biobank GWAS study323. It was not possible to access the 
UKB IPD for this study.  
Triangulation of findings has been highlighted as crucial in aetiological 
epidemiology324. Triangulation means that different methods are applied in order 
to strengthen causal conclusions, particularly if various approaches point towards 
the same conclusion. In attempting to triangulate findings, Lawlor and 
colleagues324 suggest implementing some of the following methods to the same 
research question: multivariable regression modelling, cross-cohort comparisons, 
MR, instrumental variable (IV) analysis of intermediate (exposure) in an RCT, 
negative control studies, RCTs and within-sibship comparisons. Of these 
approaches, MR and multivariable regression modelling were used in this thesis, 
yet there is scope to apply some of the other methods to BMI and sleep duration.  
One suggestion could be performing a cross-cohort comparison. For example, the 
ELSA bidirectional results from Chapter 3 with results of the same analyses from 
another ageing cohort, but potentially from another ethnicity or culture. The 
cross-cohort comparison could be performed in for example, the Irish 
Longitudinal Study on Ageing (TILDA)325, as they have collected self-reported 
sleep duration and weight/height in a similar way to ELSA and also collect data in 
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Irish people who are over the age of 50. Specifically, TILDA administered a 
question about sleep duration that is very similar to the one in ELSA, as it asks 
about how many hours participants sleep on a weeknight. Participants in TILDA 
also undergo measurements of their height and weight by a research nurse, 
which is also how these measures are collected in ELSA. 
Another relevant approach could be a within-sibship comparison to compare 
outcome data (for example, sleep duration) from sibling pairs that are discordant 
for the exposure (for example, BMI), whilst controlling for observed and 
unobserved shared (familial) confounders. One such study in the G1219 
Longitudinal Twin Study cohort used a discordant twin design that investigated 
the relationship between BMI and sleep quality326. This study found that siblings 
who had a higher BMI reported poorer sleep quality, but the effect of sibling 
difference in BMI on sleep quality was attenuated (not significant) when 
adjusting for depression, anxiety and general health. Also, participants who had 
more symptoms of any of these three conditions were more likely to report 
poorer sleep quality. This study is an interesting example of how the discordant 
twin design removes confounding by all factors that are completely shared by 
twin pairs, yet it is unable to shed any light on causation if the data used are 
cross-sectional.  
7.2.3 Confounding 
As mentioned in Chapter 1, confounding remains an issue central to 
observational epidemiology. In Chapter 3, when investigating the bidirectional 
relationship of BMI and sleep duration, models were adjusted for a wide range of 
demographics, health problems and health behaviours, after which a small effect 
of BMI on sleep duration (over 4-year follow-up) remained. As with the majority 
of observational research, these analyses did not control for all possible 
confounding and therefore, there may be other unobserved factors that might 
affect the association between BMI and self-reported sleep duration in older 
adults. However, the MR analyses performed in Chapter 6 do not suffer from the 
same issues with confounding as observational methods, as MR uses genetic 
variants as instrumental variables and these are unlikely to be associated with 
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potential confounders of the relationship between BMI and sleep duration. 
Therefore, perhaps greater weight should be given to the MR findings. However, 
as mentioned above, it was not possible to examine associations between the BMI 
SNPs and confounders, given that summary-data was used in combination with 
IPD to maximise the sample size. This is because MR studies require large sample 
sizes to ensure precision of estimates327, as often genetic variants used in MR (as 
IVs for the exposure) do not have large effects, which results in a weak 
instrument and the need for very large samples327.  
Another important point is that in multiply adjusted models, no cross-sectional 
relationship was observed between BMI and sleep duration in ELSA (Chapter 3), 
which is in contrast to the large-scale systematic review106, and meta-analysis107 
published in 2008. One of the main reasons for this discrepancy in findings may 
be related to confounding. For example, of the studies included in this review, 
and meta-analysis, at least three made no adjustments for any covariates, but still 
found a cross-sectional association between BMI and sleep duration in 
adults64,328,329, whilst some other studies included only sex as a 
covariate116,328,330,331, with two others that adjusted for age and sex180,332, and one 
study adjusted for sex and sleep disorders120. Few studies included a more 
comprehensive list of covariates117,118,132,333,334 and in fact, these studies’ findings 
were generally less straightforward than those with an inferior set of covariates. 
Specifically, one of these studies found a relationship between BMI and sleep 
duration in one sex, but not the other; another of them observed an association 
between long sleep duration and BMI, as opposed to short sleep duration and 
BMI. Notable is also that in their pooled analyses of cross-sectional studies in 
adults, Cappuccio and colleagues107 included exclusively unadjusted estimates, 
due to such inconsistencies in covariates across studies. It was the result of this 
pooled analysis which led them to conclude that cross-sectional studies of BMI 
and sleep duration in adults show a robust association between the two. 
Therefore, it is possible that in several earlier published cross-sectional studies of 
BMI and sleep duration this relationship is confounded by important factors that 
have not been accounted for. 
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7.2.4 Generalisability  
It is important to consider the generalisability of the findings of this thesis, 
particularly in terms of the samples used. It has been suggested that findings 
from the ALSPAC mothers are generally applicable to the majority of UK women, 
as well as women in other high-income countries. However, the majority of 
families are White and there are slightly lower levels of deprivation as compared 
to the general population193. ELSA is broadly representative of the English 
population, when comparing socio-demographic characteristics with national 
census data200. UKHLS is an annual survey, which is representative of the UK 
population335. The UKB study comprises a very large sample of 500,000 UK 
adults, but it is important to acknowledge the potential selection bias that it 
suffers from. This is because, although the sample is large and was recruited both 
fast and efficiently, the response rate was only 5.5%, which is particularly low336. 
One of the main impacts that this has on health research is that due to selective 
probabilities that operate in drawing particular individuals to participate in this 
kind of study, diseases may appear to be associated when they are not336.  
In summary, from judging the evidence presented here, it should be concluded 
that the true relationship between BMI and sleep duration is small in magnitude 
in both children and adults, irrespective of whether subjective or objective sleep 
duration is used; it is unlikely to be causal in nature, and these phenotypes do not 
possess much underlying common genetic aetiology.  
7.3 RECOMMENDATIONS FOR POLICY AND PRACTICE 
7.3.1 Recommendations for adults 
 This work found no association between sleep duration and changes in BMI in 
adults over the age of 50. This finding is in line with at least two previous studies 
in older adults that found no relationship between sleep duration and changes in 
weight235,236.Thus, the suggestion that older people should sleep for longer to 
prevent weight gain, needs revisiting.  
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As results from this thesis suggest that the negative, prospective association 
between BMI and self-reported sleep duration was very small in older adults, on 
average, this age group may not benefit from interventions that target their 
weight in order to improve sleep duration. Since one of the potential underlying 
explanations for the association between BMI and sleep duration could be related 
to obstructive sleep apnoea (OSA) (discussed in Chapter 3), it is possible that 
individuals with OSA who are overweight/obese may benefit from interventions 
that target their weight with the aim of also improving their sleep duration. 
However, measures of OSA were not collected in waves 4 or 6 of ELSA and thus, 
not included in these analyses.  
7.3.2 Recommendations for children 
Meta-analyses of prospective studies to date largely suggest that public health 
strategies should recommend the following, for obesity prevention: sufficient 
sleep135,152,157; regular153 or earlier bedtimes and later wake-up times135; and/or 
behavioural interventions aimed at increasing duration of sleep151. Paediatric 
findings from this thesis are in support of the only two previous bidirectional 
studies of BMI and sleep duration in children137,138 and suggest that designing 
interventions to increase sleep duration to prevent obesity may be premature. 
Therefore, it would perhaps be more practical for public health efforts to focus on 
ensuring that health professionals are aware of up-to-date guidelines and 
recommendations on children getting sufficient sleep, as this comes with many 
other health benefits. It is important, however, to ensure that health 
professionals do not simply recommend longer sleep duration, as sleeping for too 
many hours has also been associated with poorer health outcomes in 
adulthood61,62,63. Findings from this work do not suggest that weight loss 
interventions would help prevent short sleep in children and as such, it is 
important to inform these children’s parents/caregivers that improvements in 
sleep are unlikely as a result of this kind of intervention. 
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7.4 FUTURE DIRECTIONS  
7.4.1 Future directions for observational epidemiology 
7.4.1.1 Further prospective analyses 
Bidirectional analyses in both Chapters 3 and 4 exploited all of the prospective 
data that were available for BMI and sleep duration in ELSA and TESS, 
respectively. Despite the fact that the TESS analyses yielded null findings in both 
directions, future research should also investigate this association with further 
prospective data as it becomes available in TESS. This is important because 
previous bidirectional studies have also failed to find these effects in children (of 
White ethnicity)137,138. Similarly, the analyses performed in Chapter 3 in ELSA, 
could be repeated using data from wave 8, which is now available and would 
provide an eight-year follow-up period from when sleep duration was first asked. 
This may help shed more light on the relationship between BMI and sleep 
duration in older age, as there was not a lot of change in either of these 
phenotypes over four years of follow-up, it is possible that greater change might 
be observed over a longer time period.  
7.4.1.2 Replication of findings 
In relation to the null findings in TESS (Chapter 4), these analyses should be 
performed in an independent cohort, as the two previous studies to perform 
bidirectional analyses of BMI and sleep duration used self-reported sleep 
duration and are thus, might not be completely comparable with the TESS 
findings, although the same conclusion was reached in all three studies. Also, 
future work ought to investigate the bidirectional association of BMI and 
objective sleep duration in children from other ethnic backgrounds, as well as in 
a sample that is perhaps less lean and healthy and in which the socioeconomic 
background of participants is more diverse (most participants were from affluent 
families). As Norway is a social democracy and thus, provides a lot of support for 
families in general, it may be that to observe an effect between BMI and sleep 
duration, we need to examine this relationship in samples from countries with a 
greater degree of inequity, such as the USA or the UK, for example.  
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Although one of the two previous bidirectional studies on BMI and sleep 
duration in children used data from a UK cohort including both Whites and 
South Asians and found only an association in the latter participants138, the BiB 
study is not representative of the entire UK population, as the city of Bradford 
has particularly high levels of poverty337. The other only paediatric bidirectional 
study of BMI and sleep duration to date, had null findings in both directions and 
analysed data from White Australian children137. 
 The findings in ELSA (Chapter 4) should also be replicated, perhaps using data 
from another ageing study, such as TILDA. These analyses should also be 
performed using data in older adults from other ethnic groups, as 98% of ELSA 
are White individuals.  For example, similar bidirectional analyses could be 
performed in for example, the Longitudinal Ageing Study in India338, as this study 
was designed to be comparable to HRS. Importantly, some evidence suggests that 
there are ethnic differences in adult sleep duration, with non-White ethnic 
groups at increased risk of being short/long sleepers, in comparison to White 
individuals339. 
7.4.1.3 The association of BMI with sleep parameters, other than sleep 
duration 
Future research should investigate other sleep parameters, such as quality, 
chronotype, bedtime, disturbance and latency and their potential effects on BMI 
and/or whether BMI might differentially affect any of these measures. For the 
work undertaken in this thesis it would have proved difficult to perform genetic 
analyses (Chapters 5 and 6) of other sleep measures apart from duration using 
the datasets for which access was granted. This is because studies do not measure 
these phenotypes uniformly, as there are at least a handful of validated 
questionnaires for the assessment of distinct sleep parameters. Thus, 
harmonisation of data across studies becomes difficult, which is necessary to 
have adequate power to perform both observational and genetic epidemiological 
analyses. However, studies such as the UKB provide a way to overcome some of 
these issues, as both genetic and phenotypic data are available on 500,000 
individuals from the general population. The UKB has also collected self-reported 
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sleep measures of chronotype, daytime napping, narcolepsy (daytime dozing), 
sleeplessness/insomnia, snoring and how difficult participants find it to get up in 
the mornings. Thus, it would be possible to perform MR analyses of BMI on these 
other sleep phenotypes, as to date, no papers have examined the potential causal 
associations using the entire UKB sample of 500,000 individuals.   
7.4.1.4 Self-reported vs. objective sleep duration  
As mentioned earlier, the use of self-reported sleep duration may not be optimal 
for several reasons. It is prone to measurement error, as individuals may not 
provide accurate reports of their average sleep duration, and agreement with 
objective measurements is only moderate96–98. Although the gold-standard 
method is PSG, this remains expensive and needs to be administered in a lab 
setting, which means that it is still not an option for large-scale epidemiological 
studies. Lab studies may also lack ecological validity340. However, waist and wrist 
actigraphy provide an alternative that is in between self-reported sleep duration 
and PSG, as they are not as costly as PSG, but are an improvement on subjective 
sleep reports. Some evidence suggest that actigraphy is in fact, more reliable than 
PSG, as data are collected over a period of several days and not just one or two 
nights in a laboratory102. However, both methods still only involve the collection 
of sleep data over limited periods of time, which might not be typical for that 
individual, but this is why usually a questionnaire is administered alongside 
actigraphy.  Another idea is whether in the near future it might be possible to 
gain access to objectively-measured habitual sleep patterns in the population, 
using data from for example, wrist-worn devices like the Apple Watch, or similar. 
This kind of device routinely measures people’s sleep patterns when worn during 
the night and is able to record and track trends in sleep.  
Thus, future work investigating BMI in relation to sleep duration should use 
objective measurements, where possible. Studies such as the the UK Biobank are 
beginning to collect actigraphic sleep duration from large numbers of individuals.  
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7.4.1.5 The association between sleep duration and other measures of 
adiposity 
Future work in this area should also ascertain whether sleep duration is also 
associated with other measures of adiposity. In Chapter 3, it was confirmed that 
in ELSA there was a prospective relationship between BMI and WC with sleep 
duration, which strengthened the findings, particularly as the magnitude of the 
effect was consistent for BMI and WC. However, the TESS analyses (Chapter 4) 
were performed using BMI only (TESS did not collect WC); thus, future work 
could involve analysing other measures of adiposity in relation to sleep duration 
in children, such as for example, body-fat percentage. This is important, as BMI is 
unable to distinguish muscle mass from fat mass. In terms of the relationship 
between BMI and sleep duration, one possibility is that there may be 
confounding by specific body composition measures, but not due to fatness. For 
example, having greater muscle mass increases BMI, but not because of fat. 
Longitudinal evidence in 244 children from New Zealand showed that 
objectively-measured sleep duration at ages 3y to 5y (an average of the two was 
taken) was negatively associated with fat mass index at age 7 in multiply-adjusted 
models (sex, maternal education, maternal BMI, income, ethnicity, birth weight, 
smoking during pregnancy, physical activity, TV viewing, fruit-vegetable intake 
and non-core foods intake)341. The authors also found a negative prospective 
relationship between sleep duration and BMI, but their findings suggested that 
these differences in body weight (between children with varying hours of sleep) 
were accounted for by increased fat mass deposition.  
7.4.2 Future directions for genetic epidemiology  
7.4.2.1 Advances in Mendelian randomisation methodology 
MR is constantly being developed by statisticians who have now been working 
with it for a number of years. Although the causal analyses conducted in this 
thesis employed three MR methods and findings are in line with those from the 
largest previous study, which found no causal effect of BMI on self-reported sleep 
duration, there is scope for future MR work.  
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Importantly, there have been recent advances in MR methods, which could be 
applied in the future. One recent area of development is a novel approach to 
dealing with horiztontal pleiotropy in MR342. Van Kipperslius and Rietveld342 call 
this method Pleiotropy robust Mendelian randomisation (PRMR), as it is able to 
estimate the degree of pleiotropy and also correct for it, whilst producing 
unbiased estimates of a causal effect between an exposure and outcome of 
interest. Thus, in addition to IVW, MR-Egger and the weighted median methods, 
future MR studies that estimate the causal effect of BMI on sleep parameters 
could also use the PRMR approach, as an additional sensitivity analysis with the 
aim of ensuring that all approaches lead to the same conclusion.   
Furthermore, future MR studies in this area could take into account potential 
mediators, which is another area of recent progress343,344. Of particular 
importance here is the distinction between the total effect and the direct effect, 
as the latter suggests that the potential causal pathway between the exposure and 
outcome may operate partly through a mediator (indirect effect)344. The validity 
of this approach has recently been shown using the example of age at menarche 
and risk of breast cancer, whereby BMI mediates this association, although a 
direct effect was also observed, independently of BMI344.  
This is potentially an important advance, as, of late, it has been suggested that 
MR may not be a valid causal analysis tool when the exposure that is 
instrumented is not closely related to a physiological phenotype345. This was 
recently argued in response to a large-scale MR study which found a causal 
relationship between educational attainment and CHD345. The argument put 
forward was that there must be mediators on the causal pathway from 
educational attainment causing CHD, thus the method discussed above provides 
a way of testing this. Therefore, it is recommended that future studies that use 
MR estimate the causal relationship between BMI and a sleep-related outcome 
potentially investigate relevant mediators that may lie on the causal pathway. For 
example, a recent study highlighted the importance of specific energy balance-
related behaviours in this context346. Using data from 5,900 adults from five 
European countries (including the UK), their findings showed that work-related 
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sedentary behaviour significantly mediated the relationship between self-
reported sleep duration and BMI. Although they found that dietary habits and 
physical activity were not significant mediators, an important limitation was that 
the questions asked about dietary habits were relatively simple and did not 
capture for example, caloric intake. Their data were also cross-sectional, which 
precluded any conclusions about temporality and of course, causation. Therefore, 
it would be of interest to test this using MR to examine whether BMI genetic 
variants are causally associated with sleep duration, via their effect on work-
related sedentary behaviours. The main hypothesis would be that a higher BMI is 
associated with increased work-related sedentary behaviour, which in turn leads 
to shorter sleep duration.   
In addition, future research in this area should consider a multivariable MR 
approach to further investigate the causal relationship between adiposity and 
sleep, and sleep and adiposity. This is important, due to the limitations of both 
BMI and sleep duration as phenotypes (as discussed earlier). Multivariable MR 
uses several genetic variants associated with multiple relevant risk factors of 
interest to simultaneously estimate the causal relationship between each risk 
factor and the outcome347. A future multivariable MR study in the context of this 
thesis’ topic may include multiple measures of adiposity, such as waist 
circumference, waist-hip-ratio and body fat percentage and simultaneously 
estimate their individual causal effects on a sleep phenotype of interest (other 
than duration). Similarly, a multivariable MR study in the other direction may 
investigate the causal effect of for example, sleep quality, timing and bedtime on 
a measure of adiposity.  
7.4.2.2 New developments in molecular methods to estimate heritability 
Recently, a new method for the estimation of SNP heritability was proposed. 
Speed and colleagues285 analysed imputed genetic data for 19 physical, 
neurological and psychiatric phenotypes. They derived a model that describes 
with more certainty how heritability may vary depending on MAF, LD and 
genotype uncertainty. Their model led to estimates of SNP heritability that were 
on average, 43% greater than those produced by GCTA. In future, it is important 
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that SNP heritability is estimated using this new method, as a standalone, or in 
addition to GCTA and LDSC.  
7.4.2.3 Using MR to investigate causality of BMI and sleep parameters 
other than duration  
Meta-analyses and systematic reviews that conclusively find a prospective 
observational association between BMI and other sleep parameters (timing, 
bedtime, disturbance, quality, latency) other than duration, and/or vice versa 
(how sleep parameters might influence BMI) are still needed. This is important, 
as MR studies are usually carried out once an observational relationship between 
a modifiable exposure and an outcome of interest, has been established. An 
interesting future direction could subsequently be to investigate whether there is 
a causal relationship between BMI and such sleep parameters. MR analyses in the 
opposite direction will prove difficult until replicated genetic variants for such 
sleep parameters have been found.  
7.4.2.4 Application of MR to investigate the causal effect of BMI on sleep 
duration in younger populations 
Although the findings from Chapter 4 suggested that BMI does not predict 
changes in sleep duration in children, these findings, using objective sleep 
measurements, should be replicated in a non-Norwegian paediatric sample, to 
draw definitive conclusions. It is also important that the causal effect of BMI on 
sleep duration is investigated in children, adolescents and young adults, as the 
MR analyses in this thesis were only performed in middle-aged and older 
individuals. An important rationale for this is that the effects of the BMI SNPs on 
BMI are stronger in younger age groups348,349.  This would be possible, given that 
there are now several paediatric cohorts with measures of sleep duration, BMI 
and GWAS data.  
7.5 OVERALL CONCLUSIONS 
This thesis performed a comprehensive investigation of the relationship between 
BMI and sleep duration. As the first study to investigate this bidirectional 
relationship in adults, findings revealed no prospective association of sleep 
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duration and BMI, in accordance with two earlier epidemiological studies235,236, 
yet BMI predicted very small changes in self-reported sleep duration over four 
years. There is no prospective relationship between BMI and objective sleep 
duration, in either direction, in middle childhood, in line with previous null 
bidirectional paediatric findings137,138. Common genetic variants implicated in 
sleep duration are likely to have very small effects and thus, can prove difficult to 
detect using GWAS. This work also suggested, via Mendelian randomisation 
analyses, that there is still a degree of uncertainty regarding whether the 
association between BMI and self-reported sleep duration is causal or not. Also, 
analyse showed that these phenotypes possess only a small amount of shared 
genetic aetiology. Overall, this thesis made novel contributions in dissecting this 
complex relationship and investigated it from a previously-unexplored 
perspective, by using observational epidemiology with complementary genetic 
epidemiological methods. Taken together, the results of this thesis suggest that 
the association of BMI with sleep duration is small in magnitude, if present at all. 
Therefore, these, and other earlier findings strongly suggest that the public 
health focus on improving sleep duration as an obesity prevention initiative 
might need reviewing.   
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8 APPENDICES  
8.1 ADDITIONAL TABLES FOR CHAPTER 3 
Tables 8.1 to 8.4 present the results of all cross-sectional associations between 
body mass index (BMI), waist circumference (WC) and sleep duration in ELSA, 
with varying levels of adjustment for covariates. As previously discussed in 
Chapter 3 of this thesis, these results show that health behaviours and health 
problems played a role in the attenuation of these associations between adiposity 
and sleep duration in ELSA.   
Table 8.1 Cross-sectional models of BMI/WC and sleep duration in ELSA, adjusted 
for demographics  
Sleep duration B (minutes) 95% CI P 
BMI -0.44 -0.014 – -0.000 0.033 
Age 0.23 -0.015 - -0.014 0.066 
Sex -5.21 -9.314 - -1.108 0.013 
Wealth 7.63 6.118 – 9.139 <0.001 
Ethnicity -15.10 -30.535 – 0.336 0.055 
    
Sleep duration B (minutes) 95% CI P 
WC  -0.18 -0.006 – -0.000 0.034 
Age 0.24 -0.350 - -0.014 0.050 
Sex -7.11 -11.567 - -2.659 0.002 
Wealth 7.63 6.117 - 9.136 <0.001 
Ethnicity -15.22 -30.660 - 0.211 0.053 
Note. These models were adjusted for age, sex, wealth and ethnicity; B 
(Unstandardized coefficient) = difference in sleep duration (minutes) per 
difference in WC (cm), 95% CI= 95% confidence interval, P= regression p-value. 
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Table 8.2 Cross-sectional models of BMI/WC and sleep duration in ELSA, adjusted 
for demographics and health behaviours 
    
Sleep duration B (minutes) 95% CI P 
BMI -0.39 -0.013 – -0.000 0.065 
Age 0.28 -0.797 – 0.040 0.026 
Sex -4.92 -9.098 - -0.743 0.021 
Wealth 6.91 5.317 – 8.509 <0.0001 
Ethnicity -15.29 -30.747 - 0.166 0.053 
Physical activity 4.19 1.257 - 7.126 0.005 
Alcohol consumption 0.41 -4.619 – 5.437 0.873 
Smoking status  -2.62 -5.760 - 0.518 0.102 
    
Sleep duration B (minutes) 95% CI P 
WC  -0.14 -0.005 – 0.000 0.087 
Age 0.30 0.047 - 0.547 0.020 
Sex -6.45 -11.015 - -1.888 0.006 
Wealth 6.94 5.344 – 8.531 <0.001 
Ethnicity -15.36 -30.816 – 0.100 0.051 
Physical activity 4.13 1.183 - 7.075 0.006 
Alcohol consumption 0.53 -4.497 - 5.553 0.837 
Smoking status  -2.50 -5.631 - 0.633 0.118 
Note. These models were adjusted for age, sex, wealth, ethnicity, physical activity, 
alcohol consumption and smoking status; B (Unstandardized coefficient) = 
difference in sleep duration (minutes) per difference in WC (cm), 95% CI= 95% 
confidence interval, P= regression p-value. 
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Table 8.3 Cross-sectional models of BMI/WC and sleep duration in ELSA, adjusted 
for demographics and health problems 
Sleep duration B (minutes) 95% CI P 
BMI -0.29 -0.012 – -0.002 0.167 
Age 0.31 0.067 – 0.557 0.013 
Sex -3.19 -7.291 - 0.904 0.127 
Wealth 6.38 4.855 - 7.907 <0.001 
Ethnicity -10.18 -25.535 -  5.178 0.194 
Longstanding limiting 
illness 
-4.15 -8.337 - 0 .036 0.052 
Depressive symptoms -19.37 -23.86 - -14.88 <0.001 
    
Sleep duration B (minutes) 95% CI P 
WC  -0.11 -0.005 – -0.000 0.198 
Age 0.32 0.077 – 0.567 0.010 
Sex -4.35 -8.817 - 0.105 0.056 
Wealth 6.39 4.870 -  7.919 <0.001 
Ethnicity -10.26 -25.620 -  5.089 0.190 
Longstanding limiting 
illness 
-4.09 -8.300 - 0 .106 0.056 
Depressive symptoms -19.35 -23.844 -  -14.864 <0.001 
Note. These models were adjusted for age, sex, wealth, ethnicity, longstanding 
limiting illness and depressive symptoms; B (Unstandardized coefficient) = 
difference in sleep duration (minutes) per difference in WC (cm), 95% CI= 95% 
confidence interval, P= regression p-value. 
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Table 8.4 Cross-sectional models of BMI/WC and sleep duration in ELSA, fully 
adjusted for demographics, health behaviours and health problems 
Sleep duration B (minutes) 95% CI P 
BMI -0.28 -0.012 – 0.002 0.190 
Age 0.32 0.090 – 0.589 0.008 
Sex -3.12 -7.294 -  1.048 0.142 
Wealth 6.03 4.428 -  7.626 <0.001 
Ethnicity -10.49 -25.88 - 4.893 0.181 
Physical activity 2.45 -0.506 -  5.401 0.104 
Alcohol consumption -0.04 -5.032 - 4.955 0.988 
Smoking status  -1.62 -4.749 - 1.506 0.310 
Longstanding limiting 
illness 
-3.59 -7.814 – 0.634 0.096 
Depressive symptoms -18.84 -23.357 -  -14.317 <0.001 
    
Sleep duration B (minutes) 95% CI P 
WC  -0.10 -0.004 – 0.001 0.270 
Age 0.35 0.099 - 0.597 0.006 
Sex -4.11 -8.672 - 0.454 0.078 
Wealth 6.05 4.455 - 7.648 <0.001 
Ethnicity -10.53 -25.921 - 4.856 0.180 
Physical activity 2.42 -0.537 - 5.388 0.109 
Alcohol consumption 0.05 -4.944 - 5.038 0.985 
Smoking status  -1.53 -4.651 - 1.588 0.336 
Longstanding limiting 
illness 
-3.58 -7.813 – 0.657 0.098 
Depressive symptoms -18.84 -23.358 - -14.318 <0.001 
Note. These models were adjusted for age, sex, wealth, ethnicity, physical activity, 
alcohol consumption, smoking status, longstanding limiting illness and 
depressive symptoms; B (Unstandardized coefficient) = difference in sleep 
duration (minutes) per difference in WC (cm), 95% CI= 95% confidence interval, 
P= regression p-value.   
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8.2 ADDITIONAL FIGURES AND TABLES FOR CHAPTER 5  
Figures 8.1, 8.3 and 8.5 present Manhattan plots of individual GWAS analyses in 
the ALSPAC, ELSA and UKHLS studies. It can be seen that no genome-wide 
significant SNPs were found to be associated with self-reported sleep duration in 
any of the three studies. Figures 8.2, 8.4 and 8.6 depict Q-Q plots of GWAS p-
values in each study and in line with the GC for each study (reported in Chapter 
5) there appear to be no issues with underlying population stratification in any of 
these studies. Figures 8.7 and 8.8 present network plots for genes that are co-
expressed with the SIPA1L3 and POLR3G genes, as the ‘top’ 34 SNPs that emerged 
as suggestive in the meta-GWAS were either in or nearby one of these genes. 
Table 8.5 presents proxy SNPs that are in high LD with the ‘top’ 34 SNPs in the 
meta-GWAS, at an R2 of 0.8 or above.  
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Figure 8.1 Manhattan plot of sleep duration GWAS results in ALSPAC 
 
 
Figure 8.2 Q-Q plot of GWAS p-values in ALSPAC 
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Figure 8.3 Manhattan plot of sleep duration GWAS results in ELSA 
 
 
Figure 8.4 Q-Q plot of GWAS p-values in ELSA 
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Figure 8.5 Manhattan plot of sleep duration GWAS results in UKHLS 
 
 
Figure 8.6 Q-Q plot of GWAS p-values in UKHLS 
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Figure 8.7 Network for genes co-expressed with SIPA1L3 gene 
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Figure 8.8 Network for genes co-expressed with POLR3G 
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Table 8.5 Pairwise LD for 'top' SNPs in meta-analysis of ALSPAC, ELSA and UKHLS 
SNP Proxy Distance  
(base pairs) 
R-squared Chromosome 
rs8109799 rs332849 4048 0.967 19 
rs8109799 rs4802251 5429 0.967 19 
rs8109799 rs8111180 9743 0.967 19 
rs8109799 rs332864 13090 0.901 19 
rs9941474 rs8111180 1034 1 19 
rs9941474 rs4802251 5348 1 19 
rs9941474 rs332849 14825 1 19 
rs9941474 rs332864 23867 0.934 19 
rs332849 rs4802251 9477 1 19 
rs332849 rs8111180 13791 1 19 
rs332849 rs332864 9042 0.934 19 
rs6508765 rs4802251 3702 1 19 
rs6508765 rs332849 5775 1 19 
rs6508765 rs8111180 8016 1 19 
rs6508765 rs332864 14817 0.934 19 
rs855632 rs8111180 26901 0.935 19 
rs855632 rs4802251 31215 0.935 19 
rs855632 rs332849 40692 0.935 19 
rs855632 rs332864 49734 0.87 19 
rs332848 rs332849 1077 1 19 
rs332848 rs4802251 8400 1 19 
rs332848 rs8111180 12714 1 19 
rs332848 rs332864 10119 0.934 19 
rs8101826 rs4802251 3471 1 19 
rs8101826 rs332849 6006 1 19 
rs8101826 rs8111180 7785 1 19 
rs8101826 rs332864 15048 0.934 19 
rs8100144 rs4802251 454 0.934 19 
rs8100144 rs8111180 3860 0.934 19 
rs8100144 rs332849 9931 0.934 19 
rs8100144 rs332864 18973 0.868 19 
rs2099340 rs8111180 1033 0.967 19 
rs2099340 rs4802251 3281 0.967 19 
rs2099340 rs332849 12758 0.967 19 
rs2099340 rs332864 21800 0.901 19 
rs8109695 rs332849 4011 0.935 19 
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rs8109695 rs4802251 5466 0.935 19 
rs8109695 rs8111180 9780 0.935 19 
rs8109695 rs332864 13053 0.87 19 
rs2569412 rs332849 3594 0.967 19 
rs2569412 rs332864 5448 0.967 19 
rs2569412 rs4802251 13071 0.967 19 
rs2569412 rs8111180 17385 0.967 19 
rs332864 rs332849 9042 0.934 19 
rs332864 rs4802251 18519 0.934 19 
rs332864 rs8111180 22833 0.934 19 
rs332855 rs332864 8487 0.967 19 
rs332855 rs332849 17529 0.967 19 
rs332855 rs4802251 27006 0.967 19 
rs332855 rs8111180 31320 0.967 19 
rs4802251 rs8111180 4314 1 19 
rs4802251 rs332849 9477 1 19 
rs4802251 rs332864 18519 0.934 19 
rs332856 rs332864 8235 0.967 19 
rs332856 rs332849 17277 0.967 19 
rs332856 rs4802251 26754 0.967 19 
rs332856 rs8111180 31068 0.967 19 
rs332858 rs332864 5614 0.967 19 
rs332858 rs332849 14656 0.967 19 
rs332858 rs4802251 24133 0.967 19 
rs332858 rs8111180 28447 0.967 19 
rs8111180 rs4802251 4314 1 19 
rs8111180 rs332849 13791 1 19 
rs8111180 rs332864 22833 0.934 19 
rs332843 rs332849 2687 1 19 
rs332843 rs4802251 6790 1 19 
rs332843 rs8111180 11104 1 19 
rs332843 rs332864 11729 0.934 19 
rs332844 rs332849 1907 1 19 
rs332844 rs4802251 7570 1 19 
rs332844 rs8111180 11884 1 19 
rs332844 rs332864 10949 0.934 19 
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8.3 ADDITIONAL FIGURES AND TABLES FOR CHAPTER 6  
Table 8.6 below lists all of the BMI SNPs used in the Mendelian randomisation 
analyses in Chapter 6, with details of proxies used where the target SNP was not 
available in ELSA, UKB or UKHLS.  Proxies were selected at an R2 threshold of at 
least 0.8 to ensure that they were in high LD with the target SNP. Table 8.7 
presents associations between BMI SNPs (from Locke et al. GWAS) and BMI in 
GIANT and for comparison, Table 8.8 shows the associations between BMI SNPs 
and BMI in ELSA and UKHLS (for which individual-level data were available), 
Table 8.9 presents the pooled associations between these BMI SNPs and BMI in 
the IPD samples used in the MR analyses (ELSA + UKHLS). UKB was not 
included, as only summary data were used. Figure 8.9 depicts a bar chart that 
shows the variance explained (R2) at different p-value thresholds between the 
chosen limits of 0.5 and 0.001 in the polygenic risk score (PRS) analyses.  
 
 
Table 8.6 GWAS SNPS associated with BMI from Locke et al., 2015 and proxies used 
in ELSA, UK Biobank and UKHLS Mendelian randomisation analyses 
SNP ID Chromosome Position Gene Proxy (r2 >0.8) 
    
ELSA UKB UKHLS 
rs657452 1 49,362,434 AGBL4 
   
rs11583200 1 50,332,407 ELAVL4 
   
rs2820292 1 200,050,910 NAV1 
   
rs11126666 2 26,782,315 KCNK3 
   
rs11688816 2 62,906,552 EHBP1 
  
rs2539984 
rs1528435 2 181,259,207 UBE2E3 
   
rs7599312 2 213,121,476 ERBB4 
   
rs6804842 3 25,081,441 RARB 
   
rs2365389 3 61,211,502 FHIT 
   
rs3849570 3 81,874,802 GBE1 rs7620240 
  
rs16851483 3 142,758,126 RASA2 
   
rs17001654 4 77,348,592 SCARB2 
   
rs11727676 4 145,878,514 HHIP 
   
rs2033529 6 40,456,631 TDRG1 
 
rs1579557 
 
rs9400239 6 109,084,356 FOXO3 
   
rs13191362 6 162,953,340 PARK2 
   
rs1167827 7 75,001,105 HIP1 
   
rs2245368 7 76,446,079 DTX2P1 
  
rs7804663 
rs2033732 8 85,242,264 RALYL 
   
rs4740619 9 15,624,326 C9orf93 
   
rs6477694 9 110,972,163 EPB41L4B 
   
rs1928295 9 119,418,304 TLR4 
   
rs10733682 9 128,500,735 LMX1B 
   
rs7899106 10 87,400,884 GRID1 
   
rs17094222 10 102,385,430 HIF1AN 
   
rs11191560 10 104,859,028 NT5C2 
  
rs5011520 
rs7903146 10 114,748,339 TCF7L2 
   
rs2176598 11 43,820,854 HSD17B12 
   
rs12286929 11 114,527,614 CADM1 
   
rs11057405 12 121,347,850 CLIP1 
   
rs10132280 14 24,998,019 STXBP6 
   
rs12885454 14 28,806,589 PRKD1 
   
rs3736485 15 49,535,902 DMXL2 
   
rs758747 16 3,567,359 NLRC3 
   
rs2650492 16 28,240,912 SBK1 
   
rs9925964 16 31,037,396 KAT8 
 
rs2288004 
 
rs1000940 17 5,223,976 RABEP1 
   
rs1808579 18 19,358,886 C18orf8 
   
rs7243357 18 55,034,299 GRP 
   
rs17724992 19 18,315,825 PGPEP1 
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rs977747 1 47,457,264 TAL1 
   
rs1460676 2 164,275,935 FIGN 
   
rs17203016 2 207,963,763 CREB1 
   
rs13201877 6 137,717,234 IFNGR1 
   
rs1441264 13 78,478,920 MIR548A2 
   
rs7164727 15 70,881,044 LOC1002875
59 
   
rs2080454 16 47,620,091 CBLN1 
   
rs9914578 17 1,951,886 SMG6 
   
rs2836754 21 39,213,610 ETS2 
   
rs492400 2 219,057,996 USP37 
   
rs16907751 8 81,538,012 ZBTB10 
   
rs9374842 6 120,227,364 LOC285762 
   
rs9641123 7 93,035,668 CALCR 
   
rs9540493 13 65,103,705 MIR548X2 
   
rs4787491 16 29,922,838 INO80E 
   
rs6465468 7 95,007,450 ASB4 
   
rs7239883 18 38,401,669 LOC284260 
   
rs3101336 1 72,523,773 NEGR1 
   
rs12566985 1 74,774,781 FPGT 
   
rs12401738 1 78,219,349 FUBP1 
   
rs11165643 1 96,696,685 PTBP2 
   
rs17024393 1 109,956,211 GNAT2 
   
rs543874 1 176,156,103 SEC16B 
  
rs506589 
rs13021737 2 622,348 TMEM18 
   
rs10182181 2 25,003,800 ADCY3 
   
rs1016287 2 59,159,129 FLJ30838 
   
rs2121279 2 142,759,755 LRP1B 
   
rs13078960 3 85,890,280 CADM2 
   
rs1516725 3 187,306,698 ETV5 rs10513801 
  
rs10938397 4 44,877,284 GNPDA2 rs13130484 
  
rs13107325 4 103,407,732 SLC39A8 
   
rs2112347 5 75,050,998 POC5 
   
rs205262 6 34,671,142 C6orf106 
   
rs2207139 6 50,953,449 TFAP2B 
   
rs17405819 8 76,969,139 HNF4G 
   
rs10968576 9 28,404,339 LINGO2 
   
rs4256980 11 8,630,515 TRIM66 
   
rs11030104 11 27,641,093 BDNF 
   
rs3817334 11 47,607,569 MTCH2 
   
rs7138803 12 48,533,735 BCDIN3D 
   
rs12016871 13 26,915,782 MTIF3 
   
rs12429545 13 53,000,207 OLFM4 
   
rs11847697 14 29,584,863 PRKD1 
   
rs7141420 14 78,969,207 NRXN3 
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rs16951275 15 65,864,222 MAP2K5 
   
rs12446632 16 19,842,890 GPRC5B 
   
rs3888190 16 28,796,987 ATP2A1 
   
rs1558902 16 52,361,075 FTO 
   
rs12940622 17 76,230,166 RPTOR 
   
rs6567160 18 55,980,115 MC4R 
   
rs29941 19 39,001,372 KCTD15 
   
rs2075650 19 50,087,459 TOMM40 
   
rs2287019 19 50,894,012 QPCTL 
   
rs3810291 19 52,260,843 ZC3H4 
   
rs7715256 5 153,518,086 GALNT10 
   
rs2176040 2 226,801,046 LOC646736 
   
rs6091540 20 50,521,269 ZFP64 
   
Table 8.7 Associations between BMI SNPs and BMI in GIANT  
SNP A1 A2 A1 Frequency N Beta SE L_95CI U_95CI P-value 
rs3101336 C T 0.65 316872 0.033 0.003 0.027 0.039 2.66E-26 
rs7243357 T G 0.87 322107 0.022 0.004 0.014 0.030 3.86E-08 
rs11030104 A G 0.8 322103 0.041 0.004 0.033 0.049 5.56E-28 
rs12446632 G A 0.87 316758 0.04 0.005 0.030 0.050 1.48E-18 
rs1516725 C T 0.91 320644 0.045 0.005 0.035 0.055 1.89E-22 
rs16951275 T C 0.78 322098 0.031 0.004 0.023 0.039 1.91E-17 
rs12885454 C A 0.63 320823 0.021 0.003 0.015 0.027 1.94E-10 
rs13021737 G A 0.88 318287 0.06 0.004 0.052 0.068       <1.0E-40 
rs9400239 C T 0.7 321988 0.019 0.003 0.013 0.025 1.61E-08 
rs2287019 C T 0.85 300921 0.036 0.004 0.028 0.044 4.59E-18 
rs16907751 C T 0.96 307752 0.035 0.007 0.021 0.049 1.25E-07 
rs2820292 C A 0.51 321707 0.02 0.003 0.014 0.026 1.83E-10 
rs1928295 T C 0.58 321979 0.019 0.003 0.013 0.025 7.91E-10 
rs12940622 G A 0.54 322032 0.018 0.003 0.012 0.024 2.49E-09 
rs17724992 A G 0.69 319588 0.019 0.004 0.011 0.027 3.41E-08 
rs2033732 C T 0.76 321406 0.019 0.004 0.011 0.027 4.89E-08 
rs9374842 T C 0.74 322008 0.019 0.004 0.011 0.027 9.67E-08 
rs17405819 T C 0.63 322085 0.022 0.003 0.016 0.028 2.07E-11 
rs16851483 T G 0.09 233929 0.048 0.008 0.032 0.064 3.55E-10 
rs6804842 G A 0.58 321463 0.019 0.003 0.013 0.025 2.48E-09 
rs2365389 C T 0.66 316768 0.02 0.003 0.014 0.026 1.63E-10 
rs10132280 C A 0.67 321797 0.023 0.003 0.017 0.029 1.14E-11 
rs1808579 C T 0.53 322032 0.017 0.003 0.011 0.023 4.17E-08 
rs7141420 T C 0.62 321970 0.024 0.003 0.018 0.030 1.23E-14 
rs7599312 G A 0.71 322024 0.022 0.003 0.016 0.028 1.17E-10 
rs2112347 T G 0.63 322019 0.026 0.003 0.020 0.032 6.19E-17 
rs29941 G A 0.67 321970 0.018 0.003 0.012 0.024 2.41E-08 
rs1167827 G A 0.54 306238 0.02 0.003 0.014 0.026 6.33E-10 
rs6091540 C T 0.73 321975 0.019 0.004 0.011 0.027 8.02E-08 
rs12429545 A G 0.1 312934 0.033 0.005 0.023 0.043 1.09E-12 
rs11688816 G A 0.46 322051 0.017 0.003 0.011 0.023 1.89E-08 
rs4740619 T C 0.53 321887 0.018 0.003 0.012 0.024 4.56E-09 
rs7903146 C T 0.75 322130 0.023 0.003 0.017 0.029 1.11E-11 
rs7164727 T C 0.78 321312 0.018 0.003 0.012 0.024 6.83E-08 
rs4787491 G A 0.61 267491 0.016 0.003 0.010 0.022 2.24E-06 
rs9925964 A G 0.61 318385 0.019 0.003 0.013 0.025 8.11E-10 
rs13201877 G A 0.08 322095 0.023 0.005 0.013 0.033 2.35E-07 
rs7239883 G A 0.32 321909 0.016 0.003 0.010 0.022 1.63E-07 
rs6465468 T G 0.33 307937 0.017 0.004 0.009 0.025 2.30E-06 
rs6477694 C T 0.36 322048 0.017 0.003 0.011 0.023 2.67E-08 
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rs3810291 A G 0.63 296261 0.028 0.004 0.020 0.036 4.81E-15 
rs11126666 A G 0.31 321979 0.021 0.003 0.015 0.027 1.33E-09 
rs11165643 T C 0.58 320730 0.022 0.003 0.016 0.028 2.07E-12 
rs4256980 G C 0.73 320028 0.021 0.003 0.015 0.027 2.90E-11 
rs2033529 G A 0.26 321917 0.019 0.003 0.013 0.025 1.39E-08 
rs1528435 T C 0.58 321924 0.018 0.003 0.012 0.024 1.20E-08 
rs3849570 A C 0.37 284339 0.019 0.003 0.013 0.025 2.60E-08 
rs13078960 G T 0.18 322135 0.03 0.004 0.022 0.038 1.74E-14 
rs492400 C T 0.33 321090 0.016 0.003 0.010 0.022 4.17E-07 
rs1000940 G A 0.23 321836 0.019 0.003 0.013 0.025 1.28E-08 
rs2836754 C T 0.65 320231 0.016 0.003 0.010 0.022 4.16E-07 
rs977747 T G 0.47 322086 0.017 0.003 0.011 0.023 8.65E-08 
rs17024393 C T 0.04 297874 0.066 0.009 0.048 0.084 7.03E-14 
rs1441264 A G 0.55 310286 0.018 0.003 0.012 0.024 6.04E-08 
rs9914578 G C 0.17 321126 0.02 0.004 0.012 0.028 8.99E-08 
rs17094222 C T 0.21 321770 0.025 0.004 0.017 0.033 5.94E-11 
rs2650492 A G 0.31 319464 0.021 0.004 0.013 0.029 1.91E-09 
rs3736485 A G 0.43 321398 0.018 0.003 0.012 0.024 7.41E-09 
rs12401738 A G 0.43 322070 0.021 0.003 0.015 0.027 1.14E-10 
rs10968576 G A 0.29 322061 0.025 0.003 0.019 0.031 6.61E-14 
rs12286929 G A 0.43 321903 0.022 0.003 0.016 0.028 1.31E-12 
rs7715256 G T 0.45 322084 0.016 0.003 0.010 0.022 1.70E-07 
rs17203016 G A 0.2 316466 0.021 0.004 0.013 0.029 8.14E-08 
rs1016287 T C 0.33 321969 0.023 0.003 0.017 0.029 2.25E-11 
rs11583200 C T 0.38 322095 0.018 0.003 0.012 0.024 1.48E-08 
rs2176040 A G 0.39 321972 0.014 0.003 0.008 0.020 6.06E-06 
rs11191560 C T 0.06 321893 0.031 0.005 0.021 0.041 8.45E-09 
rs3817334 T C 0.45 321959 0.026 0.003 0.020 0.032 5.14E-17 
rs758747 T C 0.27 308688 0.023 0.004 0.015 0.031 7.47E-10 
rs657452 A G 0.42 313651 0.023 0.003 0.017 0.029 5.48E-13 
rs9540493 A G 0.45 318961 0.017 0.003 0.011 0.023 1.42E-07 
rs1460676 C T 0.22 322089 0.02 0.004 0.012 0.028 8.98E-07 
rs3888190 A C 0.36 321930 0.031 0.003 0.025 0.037 3.14E-23 
rs7899106 G A 0.05 321770 0.04 0.007 0.026 0.054 2.96E-08 
rs2121279 T C 0.12 322065 0.025 0.004 0.017 0.033 2.31E-08 
rs205262 G A 0.27 315542 0.022 0.004 0.014 0.030 1.75E-10 
rs543874 G A 0.27 322008 0.048 0.004 0.040 0.056 2.62E-35 
rs6567160 C T 0.28 321958 0.056 0.004 0.048 0.064       <1.0E-40 
rs10182181 G A 0.5 321759 0.031 0.003 0.025 0.037 8.78E-24 
rs12566985 G A 0.43 319282 0.024 0.003 0.018 0.030 3.28E-15 
rs7138803 A G 0.44 322092 0.032 0.003 0.026 0.038 8.15E-24 
rs2207139 G A 0.1 322019 0.045 0.004 0.037 0.053 4.13E-29 
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rs2176598 T C 0.2 316848 0.02 0.004 0.012 0.028 2.97E-08 
rs10938397 G A 0.43 320955 0.04 0.003 0.034 0.046 3.20E-38 
rs1558902 A T 0.45 320073 0.082 0.003 0.076 0.088       <1.0E-40 
Note. N= number of observations, A1=effect allele, A2=other allele, SE=standard 
error, L_95CI= lower 95% confidence limit, U_95_CI=upper 95% confidence limit.  
Table 8.8 Associations between BMI SNPs and BMI in meta-analysis of ELSA & 
UKHLS studies (n=12,107) 
SNP Effect SE L_95_CI U_95_CI P-value 
rs3101336 -0.315 0.063 -0.439 -0.191 <0.001 
rs7243357 -0.288 0.082 -0.448 -0.128 <0.001 
rs11030104 -0.258 0.076 -0.407 -0.110 0.001 
rs12446632 -0.224 0.087 -0.395 -0.054 0.010 
rs1516725 -0.221 0.114 -0.444 0.003 0.053 
rs16951275 -0.191 0.072 -0.333 -0.049 0.008 
rs12885454 -0.189 0.064 -0.315 -0.062 0.003 
rs13021737 -0.188 0.082 -0.349 -0.027 0.022 
rs9400239 -0.177 0.068 -0.309 -0.044 0.009 
rs2287019 -0.175 0.079 -0.330 -0.019 0.027 
rs16907751 -0.156 0.105 -0.361 0.049 0.135 
rs2820292 -0.155 0.062 -0.277 -0.033 0.013 
rs1928295 -0.148 0.062 -0.269 -0.028 0.016 
rs12940622 -0.143 0.062 -0.264 -0.023 0.020 
rs17724992 -0.141 0.070 -0.277 -0.004 0.044 
rs2033732 -0.139 0.070 -0.277 -0.002 0.047 
rs9374842 -0.136 0.073 -0.280 0.007 0.062 
rs17405819 -0.135 0.067 -0.266 -0.003 0.045 
rs16851483 -0.134 0.107 -0.344 0.076 0.212 
rs6804842 -0.121 0.062 -0.243 0.000 0.050 
rs2365389 -0.121 0.062 -0.242 0.000 0.051 
rs10132280 -0.109 0.071 -0.247 0.029 0.123 
rs1808579 -0.104 0.063 -0.228 0.019 0.097 
rs7141420 -0.103 0.061 -0.224 0.017 0.094 
rs7599312 -0.090 0.069 -0.225 0.045 0.192 
rs2112347 -0.089 0.063 -0.213 0.035 0.161 
rs29941 -0.084 0.065 -0.212 0.044 0.198 
rs1167827 -0.072 0.062 -0.193 0.049 0.244 
rs6091540 -0.066 0.067 -0.198 0.066 0.329 
rs12429545 -0.060 0.091 -0.238 0.118 0.507 
rs11688816 -0.052 0.062 -0.173 0.069 0.404 
rs4740619 -0.046 0.061 -0.166 0.074 0.451 
rs7903146 -0.046 0.068 -0.180 0.088 0.503 
rs7164727 -0.046 0.066 -0.176 0.084 0.492 
rs4787491 -0.041 0.062 -0.162 0.080 0.507 
rs9925964 -0.038 0.064 -0.165 0.088 0.554 
rs13201877 -0.030 0.093 -0.212 0.153 0.748 
rs7239883 -0.027 0.063 -0.151 0.098 0.675 
rs6465468 -0.017 0.070 -0.155 0.121 0.809 
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rs6477694 -0.016 0.065 -0.143 0.110 0.800 
rs3810291 -0.010 0.070 -0.148 0.128 0.886 
rs11126666 -0.009 0.070 -0.147 0.129 0.895 
rs11165643 -0.003 0.062 -0.125 0.119 0.964 
rs4256980 -0.001 0.066 -0.130 0.128 0.987 
rs2033529 0.005 0.067 -0.127 0.137 0.938 
rs1528435 0.013 0.063 -0.110 0.137 0.832 
rs3849570 0.014 0.082 -0.146 0.175 0.860 
rs13078960 0.018 0.075 -0.130 0.166 0.811 
rs492400 0.025 0.062 -0.096 0.146 0.683 
rs1000940 0.031 0.067 -0.101 0.163 0.646 
rs2836754 0.031 0.065 -0.095 0.158 0.626 
rs977747 0.032 0.062 -0.090 0.153 0.608 
rs17024393 0.035 0.193 -0.344 0.415 0.855 
rs1441264 0.039 0.066 -0.092 0.169 0.560 
rs9914578 0.039 0.076 -0.110 0.189 0.605 
rs17094222 0.047 0.080 -0.110 0.203 0.560 
rs2650492 0.048 0.071 -0.092 0.188 0.502 
rs3736485 0.059 0.062 -0.063 0.180 0.346 
rs12401738 0.062 0.064 -0.063 0.187 0.333 
rs10968576 0.064 0.065 -0.064 0.192 0.328 
rs12286929 0.064 0.061 -0.056 0.184 0.294 
rs7715256 0.076 0.062 -0.047 0.198 0.226 
rs17203016 0.076 0.076 -0.072 0.225 0.311 
rs1016287 0.087 0.067 -0.044 0.218 0.194 
rs11583200 0.091 0.062 -0.031 0.214 0.142 
rs2176040 0.094 0.064 -0.031 0.219 0.142 
rs11191560 0.094 0.117 -0.135 0.323 0.420 
rs3817334 0.096 0.063 -0.027 0.220 0.126 
rs758747 0.100 0.076 -0.050 0.249 0.192 
rs657452 0.102 0.062 -0.020 0.224 0.102 
rs9540493 0.124 0.062 0.003 0.246 0.045 
rs1460676 0.125 0.084 -0.039 0.290 0.136 
rs3888190 0.132 0.069 -0.003 0.267 0.056 
rs7899106 0.136 0.136 -0.131 0.403 0.318 
rs2121279 0.137 0.093 -0.046 0.319 0.142 
rs205262 0.155 0.072 0.015 0.295 0.030 
rs543874 0.164 0.077 0.014 0.314 0.033 
rs6567160 0.170 0.072 0.029 0.311 0.018 
rs10182181 0.181 0.062 0.060 0.302 0.003 
rs12566985 0.184 0.062 0.063 0.306 0.003 
rs7138803 0.194 0.064 0.070 0.319 0.002 
  276 
rs2207139 0.195 0.083 0.033 0.358 0.018 
rs2176598 0.200 0.071 0.060 0.339 0.005 
rs10938397 0.256 0.078 0.103 0.409 0.001 
rs1558902 0.325 0.062 0.203 0.447 <0.001 
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Table 8.9 Pooled associations (meta-analysis) between BMI SNPs (88) and sleep 
duration in ELSA, UKB and UKHLS 
SNP Effect SE L_95_CI U_95_CI I-sq. (P-het) 
rs7243357 0.63 0.01 -0.46 -0.44 0% (0.375) 
rs2365389 0.54 0.00 -0.16 -0.14 0% (0.383) 
rs1016287 0.50 0.00 -0.28 -0.27 0% (0.389) 
rs11847697 0.39 0.01 -0.16 -0.12 0% (0.396) 
rs10132280 0.37 0.00 0.02 0.04 0% (0.409) 
rs2820292 0.37 0.00 -0.28 -0.26 0% (0.424) 
rs1516725 0.36 0.01 -0.53 -0.51 0% (0.424) 
rs2836754 0.36 0.00 0.53 0.55 0% (0.429) 
rs11583200 0.33 0.00 -0.16 -0.14 0% (0.442) 
rs12566985 0.32 0.00 -0.25 -0.23 0% (0.453) 
rs17203016 0.31 0.00 0.21 0.23 0% (0.456) 
rs2287019 0.31 0.01 -0.34 -0.32 0% (0.475) 
rs7141420 0.29 0.00 -0.06 -0.05 0% (0.502) 
rs977747 0.26 0.00 0.00 0.02 0% (0.509) 
rs10968576 0.25 0.00 -1.01 -1 0% (0.528) 
rs3736485 0.22 0.00 0.36 0.38 0% (0.541) 
rs12429545 0.19 0.01 0.02 0.04 0% (0.547) 
rs205262 0.18 0.00 0.35 0.37 0% (0.560) 
rs1928295 0.14 0.00 -0.42 -0.4 0% (0.563) 
rs16951275 0.13 0.00 -0.2 -0.18 0% (0.574) 
rs7715256 0.13 0.00 -0.43 -0.41 0% (0.596) 
rs758747 0.13 0.00 0.38 0.39 0% (0.603) 
rs4256980 0.12 0.00 -0.42 -0.4 0% (0.605) 
rs9540493 0.11 0.00 -0.32 -0.3 0% (0.614) 
rs7138803 0.08 0.00 0.3 0.32 0% (0.619) 
rs17094222 0.04 0.00 -0.05 -0.03 0% (0.627) 
rs11030104 0.03 0.01 -0.03 -0.01 0% (0.657) 
rs2033732 0.03 0.00 0.35 0.37 0% (0.670) 
rs2650492 0.02 0.00 0.11 0.13 0% (0.676) 
rs6477694 0.01 0.00 -0.36 -0.34 0% (0.690) 
rs2207139 -0.01 0.01 -0.98 -0.96 0% (0.697) 
rs9914578 -0.02 0.00 -0.33 -0.31 0% (0.705) 
rs12940622 -0.03 0.00 -0.13 -0.11 0% (0.728) 
rs12286929 -0.04 0.00 0.13 0.14 0% (0.767) 
rs6465468 -0.04 0.00 -0.05 -0.03 0% (0.782) 
rs1167827 -0.05 0.00 0.12 0.14 0% (0.783) 
rs17024393 -0.06 0.01 -0.21 -0.17 0% (0.785) 
rs9374842 -0.06 0.00 -0.47 -0.45 0% (0.791) 
rs29941 -0.09 0.00 0.36 0.38 0% (0.797) 
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rs16851483 -0.10 0.01 -0.17 -0.14 0% (0.799) 
rs2176598 -0.10 0.00 -0.33 -0.31 0% (0.809) 
rs1441264 -0.11 0.00 0.32 0.33 0% (0.821) 
rs9641123 -0.12 0.00 0.19 0.2 0% (0.827) 
rs2033529 -0.12 0.00 -0.13 -0.11 0% (0.834) 
rs3849570 -0.12 0.00 -0.26 -0.25 0% (0.886) 
rs17405819 -0.12 0.00 0.24 0.26 0% (0.894) 
rs3888190 -0.14 0.00 -0.06 -0.05 0% (0.903) 
rs1460676 -0.14 0.01 0.03 0.05 0% (0.905) 
rs3101336 -0.15 0.00 -0.11 -0.1 0% (0.906) 
rs6804842 -0.15 0.00 -0.21 -0.19 0% (0.911) 
rs7239883 -0.16 0.00 -0.01 0 0% (0.914) 
rs2121279 -0.19 0.01 0.1 0.12 0% (0.916) 
rs7903146 -0.19 0.00 -0.85 -0.84 0% (0.924) 
rs2176040 -0.20 0.00 0.01 0.03 0% (0.933) 
rs11191560 -0.20 0.01 -0.26 -0.23 0% (0.943) 
rs1808579 -0.24 0.00 -0.15 -0.13 0% (0.944) 
rs2112347 -0.25 0.00 -0.38 -0.37 0% (0.984) 
rs13078960 -0.25 0.00 -0.21 -0.19 0% (0.994) 
rs3810291 -0.26 0.00 0.12 0.14 0% (0.995) 
rs13201877 -0.27 0.01 -0.06 -0.04 0% (0.998) 
rs7164727 -0.28 0.00 -0.31 -0.29 14% (0.312) 
rs10938397 -0.28 0.00 -0.53 -0.51 16% (0.306) 
rs1558902 -0.28 0.00 0.63 0.64 19% (0.290) 
rs3817334 -0.30 0.00 -0.6 -0.59 19% (0.291) 
rs13021737 -0.31 0.01 -0.13 -0.11 21% (0.283) 
rs1000940 -0.32 0.00 -0.53 -0.51 25% (0.266) 
rs543874 -0.32 0.00 0.12 0.14 33% (0.226) 
rs657452 -0.33 0.00 -0.28 -0.27 36% (0.209) 
rs12885454 -0.35 0.00 0.07 0.09 39% (0.192) 
rs12401738 -0.35 0.00 -0.04 -0.02 39% (0.192) 
rs10182181 -0.35 0.00 -0.36 -0.35 41% (0.182) 
rs6091540 -0.36 0.00 0.32 0.33 43% (0.174) 
rs4787491 -0.37 0.00 0.25 0.26 44% (0.168) 
rs11126666 -0.41 0.00 -0.36 -0.34 44% (0.169) 
rs7899106 -0.41 0.01 0.16 0.2 46% (0.157) 
rs2245368 -0.42 0.01 -0.13 -0.11 46% (0.159) 
rs12446632 -0.45 0.01 -0.26 -0.24 47% (0.149) 
rs9400239 -0.46 0.00 -0.09 -0.08 53% (0.118) 
rs1528435 -0.50 0.00 -0.11 -0.09 57% (0.097) 
rs17724992 -0.51 0.00 -0.51 -0.49 67% (0.049) 
rs492400 -0.52 0.00 -0.51 -0.5 67% (0.050) 
rs4740619 -0.52 0.00 0.49 0.51 70% (0.342) 
  279 
rs9925964 -0.52 0.00 -0.29 -0.27 71% (0.031) 
rs6567160 -0.59 0.00 0.3 0.32 73% (0.023) 
rs7599312 -0.76 0.00 -0.12 -0.1 74% (0.022) 
rs11165643 -0.84 0.00 -0.36 -0.35 76% (0.015) 
rs11688816 -0.97 0.00 0.28 0.3 77% (0.014) 
rs16907751 -1.01 0.01 -0.78 -0.75 81% (0.006) 
Note. SE=standard error, L_95_CI=lower 95% confidence limit, U_95_CI=upper 
95% confidence limit, I-sq=% of heterogeneity, as per the I2 statistic, P-het= p-
value for heterogeneity.  
 
Figure 8.9 Bar chart showing variance explained at different p-value thresholds 
between 0.5 and 0.001 (corresponding to Table 6.2 in Chapter 6) 
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Figure 8.10 Forest plot for SNPs associated with sleep duration, after adjustment for 
BMI, in IPD (ELSA + UKHLS) 
 
